Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:isobutane
go back to main search page
Accession:CHEBI:30363 term browser browse the term
Definition:An alkane that is propane substituted by a methyl group at position 2.
Synonyms:exact_synonym: 2-methylpropane
 related_synonym: (CH3)2CH-CH3;   E943b;   Formula=C4H10;   InChI=1S/C4H10/c1-4(2)3/h4H,1-3H3;   InChIKey=NNPPMTNAJDCUHE-UHFFFAOYSA-N;   R-600a;   SMILES=CC(C)C
 xref: Beilstein:1730720;   CAS:75-28-5;   Gmelin:1301;   KEGG:D04623;   PMID:24179026;   PMID:24464945;   Reaxys:1730720;   Wikipedia:Isobutane



show annotations for term's descendants           Sort by:
aloxistatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CAPN1 calpain 1 multiple interactions EXP aloxistatin inhibits the reaction [CAPN1 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006
JBrowse link
G CAPN7 calpain 7 multiple interactions EXP aloxistatin inhibits the reaction [CAPN7 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr 3:15,206,246...15,252,916
Ensembl chr 3:15,206,152...15,252,916
JBrowse link
G CASP3 caspase 3 multiple interactions EXP
ISO
[aloxistatin co-treated with pepstatin] inhibits the reaction [[vistusertib co-treated with Chloroquine] results in increased activity of CASP3 protein]
[Swainsonine co-treated with aloxistatin] results in increased cleavage of CASP3 protein
CTD PMID:26853465 PMID:33186601 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP9 caspase 9 multiple interactions EXP aloxistatin inhibits the reaction [syringic acid analog results in increased secretion of CASP9 protein] CTD PMID:34523043 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CTSB cathepsin B multiple interactions EXP [aloxistatin co-treated with pepstatin] results in decreased expression of CTSB protein; aloxistatin inhibits the reaction [CTSB protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 PMID:32186374 NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
JBrowse link
G CTSD cathepsin D multiple interactions EXP [aloxistatin co-treated with pepstatin] results in decreased expression of CTSD protein CTD PMID:32186374 NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
JBrowse link
G CTSL cathepsin L multiple interactions EXP aloxistatin inhibits the reaction [CTSL protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
JBrowse link
G DDX3X DEAD-box helicase 3 X-linked multiple interactions EXP aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of DDX3X protein] CTD PMID:30821613 NCBI chr  X:41,333,308...41,364,472
Ensembl chr  X:41,333,348...41,364,472
JBrowse link
G EIF4A1 eukaryotic translation initiation factor 4A1 multiple interactions EXP aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4A1 protein] CTD PMID:30821613 NCBI chr17:7,572,825...7,579,006
Ensembl chr17:7,572,824...7,579,006
JBrowse link
G EIF4H eukaryotic translation initiation factor 4H multiple interactions EXP aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4H protein] CTD PMID:30821613 NCBI chr 7:74,174,356...74,197,096
Ensembl chr 7:74,174,231...74,197,122
JBrowse link
G GAPDH glyceraldehyde-3-phosphate dehydrogenase multiple interactions EXP aloxistatin inhibits the reaction [syringic acid analog results in increased secretion of GAPDH protein] CTD PMID:34523043 NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
JBrowse link
G LAMP2 lysosomal associated membrane protein 2 multiple interactions EXP [aloxistatin co-treated with pepstatin] results in increased expression of LAMP2 protein CTD PMID:32186374 NCBI chr  X:120,426,148...120,469,349
Ensembl chr  X:120,426,148...120,469,365
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta multiple interactions
increases lipidation
ISO
EXP
[aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] results in increased expression of MAP1LC3B protein
aloxistatin results in increased lipidation of MAP1LC3B protein
[aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] promotes the reaction [ABTL0812 results in increased expression of and results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] promotes the reaction [Brefeldin A results in increased expression of and results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] promotes the reaction [N-((1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl)octanamide results in increased expression of and results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] results in decreased degradation of MAP1LC3B protein modified form; aloxistatin promotes the reaction [indatraline results in increased lipidation of MAP1LC3B protein]
CTD PMID:26483381 PMID:27635674 PMID:32397857 PMID:33124469 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G SMN2 survival of motor neuron 2, centromeric multiple interactions EXP aloxistatin inhibits the reaction [CAPN1 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]; aloxistatin inhibits the reaction [CAPN7 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]; aloxistatin inhibits the reaction [CTSB protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]; aloxistatin inhibits the reaction [CTSL protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr 5:70,049,523...70,090,528
Ensembl chr 5:70,049,638...70,078,522
Ensembl chr 5:70,049,638...70,078,522
JBrowse link
G SQSTM1 sequestosome 1 multiple interactions
increases expression
EXP
ISO
[aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; aloxistatin promotes the reaction [indatraline results in increased expression of SQSTM1 protein]; aloxistatin promotes the reaction [Sertraline results in increased expression of SQSTM1 protein]
aloxistatin results in increased expression of SQSTM1 protein
[aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; [Dronabinol co-treated with aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; [HU 211 co-treated with aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein
CTD PMID:26483381 PMID:32186374 PMID:32773031 PMID:33124469 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
JBrowse link
DAPT term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACTA2 actin alpha 2, smooth muscle multiple interactions EXP 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]] CTD PMID:31348943 NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
JBrowse link
G AKT1 AKT serine/threonine kinase 1 multiple interactions EXP 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein] CTD PMID:31348943 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G APP amyloid beta precursor protein multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form] CTD PMID:22115781 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression
multiple interactions
ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of BAX protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]
CTD PMID:21209419 PMID:34897970 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression
multiple interactions
ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]
CTD PMID:21209419 PMID:34897970 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BMP6 bone morphogenetic protein 6 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA] CTD PMID:23566955 NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
JBrowse link
G CASP3 caspase 3 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of and results in increased activity of CASP3 protein CTD PMID:21209419 PMID:34897970 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP9 caspase 9 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]] CTD PMID:34897970 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CCND1 cyclin D1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of CCND1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA] CTD PMID:19160421 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CDH1 cadherin 1 multiple interactions EXP [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester co-treated with 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one] inhibits the reaction [polyhexamethyleneguanidine results in decreased expression of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased secretion of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased cleavage of CDH1 protein] CTD PMID:18791180 PMID:31348943 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G CDH2 cadherin 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH2 protein] CTD PMID:23876460 NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
JBrowse link
G CSF1 colony stimulating factor 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of CSF1 mRNA] CTD PMID:24223152 NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
JBrowse link
G ENO2 enolase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of ENO2 mRNA] CTD PMID:24929042 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of FLT1 protein] CTD PMID:21843347 NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
JBrowse link
G FOXO3 forkhead box O3 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein] CTD PMID:25108166 NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
JBrowse link
G HES1 hes family bHLH transcription factor 1 multiple interactions
decreases expression
EXP
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of HES1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HES1 mRNA]
CTD PMID:19160421 PMID:24223152 PMID:25005833 PMID:25108166 PMID:32041402 More... NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
JBrowse link
G HEY1 hes related family bHLH transcription factor with YRPW motif 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA] CTD PMID:19160421 NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857
JBrowse link
G HEY2 hes related family bHLH transcription factor with YRPW motif 2 multiple interactions EXP
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Niclosamide results in increased expression of HEY2 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HEY2 mRNA]
CTD PMID:19160421 PMID:32041402 NCBI chr 6:125,749,632...125,761,269
Ensembl chr 6:125,747,664...125,761,269
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of HIF1A protein] CTD PMID:25108166 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HMGB1 high mobility group box 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of HMGB1 protein] CTD PMID:21843347 NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
JBrowse link
G IL10 interleukin 10 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA] CTD PMID:24223152 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL1B protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]
CTD PMID:21843347 PMID:24223152 PMID:36988346 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL6 interleukin 6 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]
CTD PMID:21843347 PMID:24223152 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G ITGAM integrin subunit alpha M multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of ITGAM protein] CTD PMID:28130038 NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
JBrowse link
G IVL involucrin decreases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL protein CTD PMID:18633435 NCBI chr 1:152,908,546...152,911,886
Ensembl chr 1:152,908,546...152,911,886
JBrowse link
G JAG1 jagged canonical Notch ligand 1 decreases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 protein CTD PMID:18633435 NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
JBrowse link
G KRT1 keratin 1 multiple interactions
decreases expression
EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT1 mRNA
CTD PMID:18633435 PMID:23566955 NCBI chr12:52,674,736...52,680,407
Ensembl chr12:52,674,736...52,680,407
JBrowse link
G KRT10 keratin 10 multiple interactions
decreases expression
EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT10 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 protein
CTD PMID:18633435 PMID:23566955 NCBI chr17:40,818,117...40,822,614
Ensembl chr17:40,818,117...40,822,614
JBrowse link
G LGR5 leucine rich repeat containing G protein-coupled receptor 5 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of LGR5 mRNA] CTD PMID:32041402 NCBI chr12:71,439,129...71,586,310
Ensembl chr12:71,439,798...71,586,310
JBrowse link
G MAP2 microtubule associated protein 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA] CTD PMID:24929042 NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
JBrowse link
G MDM2 MDM2 proto-oncogene multiple interactions
increases expression
EXP Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein] CTD PMID:25005833 NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
JBrowse link
G MIR141 microRNA 141 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]] CTD PMID:34897970 NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]
CTD PMID:24223152 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]
CTD PMID:24223152 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NOTCH1 notch receptor 1 multiple interactions
decreases expression
EXP
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of and results in increased activity of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of NOTCH1 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Oxygen deficiency results in increased expression of NOTCH1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein modified form
CTD PMID:18633435 PMID:22039516 PMID:22115781 PMID:24223152 PMID:25108166 More... NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
JBrowse link
G NOTCH2 notch receptor 2 multiple interactions
decreases expression
EXP
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH2 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH2 protein
CTD PMID:22039516 PMID:36988346 NCBI chr 1:119,911,553...120,069,662
Ensembl chr 1:119,911,553...120,100,779
JBrowse link
G NOTCH3 notch receptor 3 decreases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH3 protein CTD PMID:36988346 NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
JBrowse link
G NOTCH4 notch receptor 4 decreases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH4 protein CTD PMID:36988346 NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
JBrowse link
G NUMB NUMB endocytic adaptor protein increases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of NUMB protein CTD PMID:25005833 NCBI chr14:73,275,216...73,458,546
Ensembl chr14:73,275,107...73,458,617
JBrowse link
G PML PML nuclear body scaffold multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha increases expression
multiple interactions
ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of PPARA protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of PPARA protein]
CTD PMID:36988346 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA] CTD PMID:18791180 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G RARA retinoic acid receptor alpha multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
JBrowse link
G RBPJ recombination signal binding protein for immunoglobulin kappa J region multiple interactions
increases expression
ISO
EXP
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RBPJ mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of RBPJ protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cycloheximide results in decreased expression of RBPJ protein]
CTD PMID:22302987 PMID:24223152 NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of RELA protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RELA protein] CTD PMID:24223152 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TGFB1 mRNA] CTD PMID:24223152 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TLR4 toll like receptor 4 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TLR4 mRNA] CTD PMID:24223152 NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]
CTD PMID:24223152 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TP53 tumor protein p53 decreases expression
multiple interactions
EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein
Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein]
CTD PMID:25005833 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TRAF6 TNF receptor associated factor 6 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 mRNA]
CTD PMID:24223152 NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
JBrowse link
G TUBB3 tubulin beta 3 class III multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of TUBB3 mRNA] CTD PMID:24929042 NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
JBrowse link
G VEGFA vascular endothelial growth factor A multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of VEGFA protein] CTD PMID:21843347 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VIL1 villin 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of VIL1 mRNA] CTD PMID:32041402 NCBI chr 2:218,419,123...218,453,295
Ensembl chr 2:218,419,121...218,453,295
JBrowse link
diisobutyl phthalate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A4GALT alpha 1,4-galactosyltransferase (P1PK blood group) multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of A4GALT mRNA CTD PMID:31199487 NCBI chr22:42,692,121...42,721,301
Ensembl chr22:42,692,121...42,721,298
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (JR blood group) multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ABCG2 mRNA CTD PMID:31199487 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 multiple interactions ISO
EXP
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]
CTD PMID:33316053 PMID:37552060 NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of ADIPOQ mRNA CTD PMID:37021957 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
JBrowse link
G ADRB3 adrenoceptor beta 3 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of ADRB3 mRNA CTD PMID:37021957 NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
JBrowse link
G AK5 adenylate kinase 5 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of AK5 mRNA CTD PMID:31199487 NCBI chr 1:77,282,019...77,559,966
Ensembl chr 1:77,282,019...77,559,966
JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDH1A1 mRNA CTD PMID:30768133 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member decreases expression ISO diisobutyl phthalate results in decreased expression of ALDH2 mRNA CTD PMID:33983380 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
JBrowse link
G ALDOC aldolase, fructose-bisphosphate C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein CTD PMID:31199487 PMID:37690569 NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
JBrowse link
G AMHR2 anti-Mullerian hormone receptor type 2 increases expression ISO diisobutyl phthalate results in increased expression of AMHR2 mRNA CTD PMID:22112501 NCBI chr12:53,423,855...53,431,672
Ensembl chr12:53,423,855...53,431,672
JBrowse link
G AR androgen receptor affects binding
multiple interactions
ISO
EXP
diisobutyl phthalate binds to AR protein
diisobutyl phthalate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; diisobutyl phthalate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]
CTD PMID:14565775 PMID:15840436 PMID:28571686 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G ARNT2 aryl hydrocarbon receptor nuclear translocator 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ARNT2 mRNA CTD PMID:31199487 NCBI chr15:80,404,382...80,597,933
Ensembl chr15:80,404,350...80,597,933
JBrowse link
G ASTN1 astrotactin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN1 mRNA CTD PMID:31199487 NCBI chr 1:176,857,321...177,164,712
Ensembl chr 1:176,857,302...177,164,973
JBrowse link
G ASTN2 astrotactin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA CTD PMID:31199487 NCBI chr 9:116,423,112...117,415,057
Ensembl chr 9:116,423,112...117,415,070
JBrowse link
G ATP1A3 ATPase Na+/K+ transporting subunit alpha 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ATP1A3 mRNA CTD PMID:31199487 NCBI chr19:41,966,582...41,994,230
Ensembl chr19:41,966,582...41,997,497
JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BAX mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BAX mRNA CTD PMID:28013214 PMID:37021957 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCAT1 branched chain amino acid transaminase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 NCBI chr12:24,810,024...24,949,340
Ensembl chr12:24,810,024...24,949,101
JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 PMID:35762964 PMID:37021957 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L10 BCL2 like 10 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2L10 mRNA CTD PMID:37021957 NCBI chr15:52,109,263...52,112,775
Ensembl chr15:52,109,263...52,112,775
JBrowse link
G BEND6 BEN domain containing 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA CTD PMID:31199487 NCBI chr 6:56,955,107...57,027,346
Ensembl chr 6:56,955,107...57,027,346
JBrowse link
G BPGM bisphosphoglycerate mutase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BPGM mRNA CTD PMID:31199487 NCBI chr 7:134,646,853...134,679,816
Ensembl chr 7:134,646,811...134,679,816
JBrowse link
G CACNG7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CACNG7 mRNA CTD PMID:31199487 NCBI chr19:53,909,278...53,943,950
Ensembl chr19:53,909,278...53,943,950
JBrowse link
G CADM3 cell adhesion molecule 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADM3 mRNA CTD PMID:31199487 NCBI chr 1:159,171,615...159,203,313
Ensembl chr 1:159,171,609...159,203,313
JBrowse link
G CADPS calcium dependent secretion activator multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADPS mRNA CTD PMID:31199487 NCBI chr 3:62,398,348...62,875,416
Ensembl chr 3:62,398,346...62,875,416
JBrowse link
G CAMK4 calcium/calmodulin dependent protein kinase IV multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAMK4 mRNA CTD PMID:31199487 NCBI chr 5:111,223,583...111,494,886
Ensembl chr 5:111,223,653...111,494,886
JBrowse link
G CASP2 caspase 2 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP2 mRNA CTD PMID:37021957 NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
JBrowse link
G CASP3 caspase 3 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP3 mRNA CTD PMID:37839492 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP8 caspase 8 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA CTD PMID:28013214 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CAT catalase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAT mRNA CTD PMID:28013214 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL2 mRNA CTD PMID:37021957 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCL5 C-C motif chemokine ligand 5 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA CTD PMID:37021957 NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
JBrowse link
G CCND2 cyclin D2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CCND2 mRNA CTD PMID:28013214 NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
JBrowse link
G CDK4 cyclin dependent kinase 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDK4 mRNA CTD PMID:35762964 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CDKN1A mRNA
CTD PMID:33316053 PMID:35762964 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:37839492 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CDKN2A mRNA CTD PMID:28013214 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
JBrowse link
G CEBPA CCAAT enhancer binding protein alpha multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA CTD PMID:37021957 NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
JBrowse link
G CELSR3 cadherin EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CELSR3 mRNA CTD PMID:31199487 NCBI chr 3:48,636,463...48,662,886
Ensembl chr 3:48,636,463...48,662,886
JBrowse link
G CGA glycoprotein hormones, alpha polypeptide multiple interactions ISO
EXP
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of HSD3B2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PTX3 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of RGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of STAR mRNA]; Cyclic AMP inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]]
CTD PMID:33316053 PMID:37552060 NCBI chr 6:87,085,498...87,095,106
Ensembl chr 6:87,085,498...87,095,106
JBrowse link
G CHGA chromogranin A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGA mRNA CTD PMID:31199487 NCBI chr14:92,922,664...92,935,285
Ensembl chr14:92,923,150...92,935,285
JBrowse link
G CHGB chromogranin B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGB mRNA CTD PMID:31199487 NCBI chr20:5,911,510...5,925,353
Ensembl chr20:5,911,510...5,925,353
JBrowse link
G CITED1 Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CITED1 mRNA CTD PMID:31199487 NCBI chr  X:72,301,646...72,307,157
Ensembl chr  X:72,301,638...72,307,187
JBrowse link
G CLSTN3 calsyntenin 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CLSTN3 mRNA CTD PMID:31199487 NCBI chr12:7,129,093...7,158,945
Ensembl chr12:7,129,698...7,158,945
JBrowse link
G CNTNAP1 contactin associated protein 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CNTNAP1 mRNA CTD PMID:31199487 NCBI chr17:42,682,531...42,699,993
Ensembl chr17:42,682,531...42,699,993
JBrowse link
G CRMP1 collapsin response mediator protein 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA CTD PMID:31199487 NCBI chr 4:5,820,764...5,893,086
Ensembl chr 4:5,748,084...5,893,086
JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 multiple interactions EXP [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA] CTD PMID:37552060 NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
JBrowse link
G CYP11A1 cytochrome P450 family 11 subfamily A member 1 decreases expression
multiple interactions
ISO
EXP
diisobutyl phthalate results in decreased expression of CYP11A1 mRNA; diisobutyl phthalate results in decreased expression of CYP11A1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA]
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA
CTD PMID:16458459 PMID:21633115 PMID:22112501 PMID:28013214 PMID:30802670 More... NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
JBrowse link
G CYP11B1 cytochrome P450 family 11 subfamily B member 1 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of CYP11B1 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11B1 mRNA
CTD PMID:22112501 PMID:33983380 NCBI chr 8:142,872,357...142,879,825
Ensembl chr 8:142,872,356...142,879,846
JBrowse link
G CYP11B2 cytochrome P450 family 11 subfamily B member 2 multiple interactions
decreases expression
ISO [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11B2 mRNA
diisobutyl phthalate results in decreased expression of CYP11B2 mRNA
CTD PMID:33983380 NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
JBrowse link
G CYP17A1 cytochrome P450 family 17 subfamily A member 1 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of CYP17A1 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP17A1 mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA
CTD PMID:22112501 PMID:28655647 PMID:30802670 PMID:33983380 PMID:37788136 NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
JBrowse link
G CYP19A1 cytochrome P450 family 19 subfamily A member 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:28013214 PMID:34597818 NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
JBrowse link
G CYP26B1 cytochrome P450 family 26 subfamily B member 1 multiple interactions ISO [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA CTD PMID:37788136 NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
JBrowse link
G CYP51A1 cytochrome P450 family 51 subfamily A member 1 decreases expression ISO diisobutyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:33983380 NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
JBrowse link
G DCLK3 doublecortin like kinase 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DCLK3 mRNA CTD PMID:31199487 NCBI chr 3:36,712,421...36,764,553
Ensembl chr 3:36,712,421...36,764,553
JBrowse link
G DDC dopa decarboxylase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DDC mRNA CTD PMID:31199487 NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
JBrowse link
G DHCR7 7-dehydrocholesterol reductase multiple interactions
decreases expression
ISO [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of DHCR7 mRNA
diisobutyl phthalate results in decreased expression of DHCR7 mRNA
CTD PMID:33983380 NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
JBrowse link
G DOCK3 dedicator of cytokinesis 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DOCK3 mRNA CTD PMID:31199487 NCBI chr 3:50,674,927...51,384,198
Ensembl chr 3:50,674,927...51,384,198
JBrowse link
G DPF1 double PHD fingers 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DPF1 mRNA CTD PMID:31199487 NCBI chr19:38,211,006...38,229,695
Ensembl chr19:38,211,006...38,229,714
JBrowse link
G DYNC1I1 dynein cytoplasmic 1 intermediate chain 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DYNC1I1 mRNA CTD PMID:31199487 NCBI chr 7:95,772,554...96,110,322
Ensembl chr 7:95,772,506...96,110,322
JBrowse link
G EBP EBP cholestenol delta-isomerase decreases expression ISO diisobutyl phthalate results in decreased expression of EBP mRNA CTD PMID:33983380 NCBI chr  X:48,521,808...48,528,716
Ensembl chr  X:48,521,799...48,528,716
JBrowse link
G ECE2 endothelin converting enzyme 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA CTD PMID:31199487 NCBI chr 3:184,276,022...184,293,031
Ensembl chr 3:184,276,011...184,293,031
JBrowse link
G EDN1 endothelin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EDN1 mRNA CTD PMID:31199487 NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
JBrowse link
G EDN2 endothelin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA] CTD PMID:33316053 NCBI chr 1:41,478,775...41,484,683
Ensembl chr 1:41,478,775...41,484,683
JBrowse link
G ELMOD1 ELMO domain containing 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ELMOD1 mRNA CTD PMID:31199487 NCBI chr11:107,591,147...107,666,779
Ensembl chr11:107,591,091...107,666,779
JBrowse link
G EMX2 empty spiracles homeobox 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EMX2 mRNA CTD PMID:31199487 NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546
JBrowse link
G EPDR1 ependymin related 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EPDR1 mRNA CTD PMID:31199487 NCBI chr 7:37,920,640...37,951,936
Ensembl chr 7:37,920,640...37,951,936
JBrowse link
G ESPN espin multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESPN mRNA CTD PMID:31199487 NCBI chr 1:6,424,776...6,461,370
Ensembl chr 1:6,424,776...6,461,367
JBrowse link
G ESR1 estrogen receptor 1 multiple interactions
increases activity
EXP
ISO
diisobutyl phthalate binds to and results in increased activity of ESR1 protein; diisobutyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [diisobutyl phthalate binds to and results in increased activity of ESR1 protein]
diisobutyl phthalate results in increased activity of ESR1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESR1 mRNA
CTD PMID:15840436 PMID:27633901 PMID:28013214 PMID:28571686 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G ESR2 estrogen receptor 2 multiple interactions
increases activity
EXP diisobutyl phthalate binds to and results in increased activity of ESR2 protein; diisobutyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
diisobutyl phthalate results in increased activity of ESR2 protein
CTD PMID:27633901 PMID:28571686 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G FABP5 fatty acid binding protein 5 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777
JBrowse link
G FAM163A family with sequence similarity 163 member A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FAM163A mRNA CTD PMID:31199487 NCBI chr 1:179,727,776...179,816,198
Ensembl chr 1:179,743,291...179,816,198
JBrowse link
G FDPS farnesyl diphosphate synthase decreases expression ISO diisobutyl phthalate results in decreased expression of FDPS mRNA CTD PMID:33983380 NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
JBrowse link
G FEZ1 fasciculation and elongation protein zeta 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FEZ1 mRNA CTD PMID:31199487 NCBI chr11:125,442,881...125,496,265
Ensembl chr11:125,442,881...125,592,568
JBrowse link
G FGF2 fibroblast growth factor 2 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA CTD PMID:37021957 NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
JBrowse link
G FKBP1B FKBP prolyl isomerase 1B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FKBP1B mRNA CTD PMID:31199487 NCBI chr 2:24,033,206...24,063,681
Ensembl chr 2:24,049,701...24,063,681
JBrowse link
G FLG filaggrin multiple interactions EXP [FLG gene polymorphism affects the susceptibility to diisobutyl phthalate] which affects the abundance of mono-isobutyl phthalate CTD PMID:24380925 NCBI chr 1:152,302,165...152,325,239
Ensembl chr 1:152,302,165...152,325,239
JBrowse link
G FSHB follicle stimulating hormone subunit beta multiple interactions ISO [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of FSHB protein CTD PMID:34597818 NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
JBrowse link
G FSHR follicle stimulating hormone receptor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FSHR mRNA CTD PMID:28013214 NCBI chr 2:48,962,157...49,154,515
Ensembl chr 2:48,962,157...49,154,527
JBrowse link
G FXYD7 FXYD domain containing ion transport regulator 7 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FXYD7 mRNA CTD PMID:31199487 NCBI chr19:35,143,255...35,154,302
Ensembl chr19:35,143,250...35,154,302
JBrowse link
G GFRA3 GDNF family receptor alpha 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA3 mRNA CTD PMID:31199487 NCBI chr 5:138,252,380...138,274,621
Ensembl chr 5:138,252,380...138,274,621
JBrowse link
G GFRA4 GDNF family receptor alpha 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA4 mRNA CTD PMID:31199487 NCBI chr20:3,659,248...3,663,399
Ensembl chr20:3,659,248...3,663,399
JBrowse link
G GGTA1 glycoprotein alpha-galactosyltransferase 1 (inactive) multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GGTA1 mRNA CTD PMID:31199487 NCBI chr 9:121,444,990...121,499,844
Ensembl chr 9:121,444,991...121,499,844
JBrowse link
G GNG2 G protein subunit gamma 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GNG2 mRNA CTD PMID:31199487 NCBI chr14:51,826,174...51,969,795
Ensembl chr14:51,826,195...51,979,342
JBrowse link
G GPX1 glutathione peroxidase 1 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPX1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GPX1 mRNA CTD PMID:28013214 PMID:37021957 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
JBrowse link
G GSR glutathione-disulfide reductase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSR mRNA CTD PMID:28013214 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase decreases expression ISO diisobutyl phthalate results in decreased expression of HMGCR mRNA CTD PMID:28655647 PMID:33983380 NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression ISO diisobutyl phthalate results in decreased expression of HMGCS1 mRNA CTD PMID:28655647 PMID:33983380 NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
JBrowse link
G HOXB8 homeobox B8 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXB8 mRNA CTD PMID:31199487 NCBI chr17:48,612,346...48,615,292
Ensembl chr17:48,611,377...48,615,292
JBrowse link
G HOXD3 homeobox D3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXD3 mRNA CTD PMID:31199487 NCBI chr 2:176,152,529...176,173,098
Ensembl chr 2:176,136,612...176,173,102
JBrowse link
G HSD17B3 hydroxysteroid 17-beta dehydrogenase 3 increases expression ISO diisobutyl phthalate results in increased expression of HSD17B3 mRNA CTD PMID:28655647 NCBI chr 9:96,235,306...96,302,176
Ensembl chr 9:96,235,306...96,302,176
JBrowse link
G HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD3B1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of HSD3B1 mRNA
CTD PMID:28013214 PMID:35762964 NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
JBrowse link
G HSD3B2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 multiple interactions EXP [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of HSD3B2 mRNA] CTD PMID:37552060 NCBI chr 1:119,414,931...119,423,034
Ensembl chr 1:119,414,931...119,423,035
JBrowse link
G HSPA12A heat shock protein family A (Hsp70) member 12A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA CTD PMID:31199487 NCBI chr10:116,671,192...116,850,747
Ensembl chr10:116,671,192...116,850,251
JBrowse link
G IDO2 indoleamine 2,3-dioxygenase 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of IDO2 mRNA CTD PMID:31199487 NCBI chr 8:39,934,651...40,016,392
Ensembl chr 8:39,934,614...40,016,392
JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of IL1B mRNA CTD PMID:37021957 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL6 interleukin 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA] CTD PMID:33316053 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G INHA inhibin subunit alpha decreases expression ISO diisobutyl phthalate results in decreased expression of INHA mRNA CTD PMID:33983380 NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
JBrowse link
G INSIG1 insulin induced gene 1 decreases expression ISO diisobutyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:33983380 NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
JBrowse link
G INSL3 insulin like 3 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of INSL3 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of INSL3 mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of INSL3 mRNA
CTD PMID:22112501 PMID:33983380 PMID:37788136 NCBI chr19:17,816,512...17,821,519
Ensembl chr19:17,816,512...17,821,574
JBrowse link
G KIF5A kinesin family member 5A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA CTD PMID:37690569 NCBI chr12:57,550,044...57,586,633
Ensembl chr12:57,546,026...57,586,633
JBrowse link
G KIF5C kinesin family member 5C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5C mRNA CTD PMID:31199487 NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
JBrowse link
G L1CAM L1 cell adhesion molecule multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of L1CAM protein CTD PMID:31199487 PMID:37690569 NCBI chr  X:153,861,514...153,886,173
Ensembl chr  X:153,861,514...153,886,173
JBrowse link
G LCN2 lipocalin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
JBrowse link
G LDLR low density lipoprotein receptor decreases expression ISO diisobutyl phthalate results in decreased expression of LDLR mRNA CTD PMID:33983380 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
JBrowse link
G LHB luteinizing hormone subunit beta multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased secretion of LHB protein CTD PMID:37839492 NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
JBrowse link
G LHCGR luteinizing hormone/choriogonadotropin receptor multiple interactions ISO [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of LHCGR mRNA CTD PMID:33983380 NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
JBrowse link
G LONRF2 LON peptidase N-terminal domain and ring finger 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA CTD PMID:31199487 NCBI chr 2:100,271,875...100,322,501
Ensembl chr 2:100,271,875...100,322,501
JBrowse link
G LPL lipoprotein lipase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA CTD PMID:30768133 NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
JBrowse link
G LRRC4B leucine rich repeat containing 4B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LRRC4B mRNA CTD PMID:31199487 NCBI chr19:50,516,892...50,568,435
Ensembl chr19:50,516,892...50,568,435
JBrowse link
G LYNX1 Ly6/neurotoxin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LYNX1 mRNA CTD PMID:31199487 NCBI chr 8:142,771,197...142,777,872
Ensembl chr 8:142,771,197...142,777,810
JBrowse link
G MAP6 microtubule associated protein 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAP6 mRNA CTD PMID:31199487 NCBI chr11:75,586,918...75,669,038
Ensembl chr11:75,586,918...75,669,038
JBrowse link
G MAPT microtubule associated protein tau multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAPT mRNA CTD PMID:31199487 NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
JBrowse link
G MIR141 microRNA 141 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR141 CTD PMID:31199487 NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191
JBrowse link
G MIR184 microRNA 184 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184 mRNA CTD PMID:31199487 PMID:35762964 NCBI chr15:79,209,788...79,209,871
Ensembl chr15:79,209,788...79,209,871
JBrowse link
G MLLT11 MLLT11 transcription factor 7 cofactor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA CTD PMID:31199487 NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
JBrowse link
G MMP14 matrix metallopeptidase 14 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA] CTD PMID:33316053 NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
JBrowse link
G MMP16 matrix metallopeptidase 16 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA] CTD PMID:33316053 NCBI chr 8:88,032,011...88,327,483
Ensembl chr 8:88,032,011...88,328,025
JBrowse link
G MMP9 matrix metallopeptidase 9 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA] CTD PMID:33316053 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
JBrowse link
G MVD mevalonate diphosphate decarboxylase decreases expression ISO diisobutyl phthalate results in decreased expression of MVD mRNA CTD PMID:33983380 NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161
JBrowse link
G NCS1 neuronal calcium sensor 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NCS1 mRNA CTD PMID:31199487 NCBI chr 9:130,172,404...130,237,303
Ensembl chr 9:130,172,404...130,237,303
JBrowse link
G NDRG4 NDRG family member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NDRG4 mRNA CTD PMID:31199487 NCBI chr16:58,463,715...58,515,387
Ensembl chr16:58,462,846...58,513,628
JBrowse link
G NEFH neurofilament heavy chain multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFH mRNA CTD PMID:31199487 NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
JBrowse link
G NEFL neurofilament light chain multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
JBrowse link
G NELL1 neural EGFL like 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NELL1 mRNA CTD PMID:31199487 NCBI chr11:20,669,551...21,575,686
Ensembl chr11:20,669,551...21,575,686
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of NFE2L2 mRNA CTD PMID:37021957 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NGFR nerve growth factor receptor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NGFR mRNA CTD PMID:31199487 NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
JBrowse link
G NR0B1 nuclear receptor subfamily 0 group B member 1 decreases expression ISO diisobutyl phthalate results in decreased expression of NR0B1 mRNA CTD PMID:33983380 NCBI chr  X:30,304,206...30,309,390
Ensembl chr  X:30,304,206...30,309,390
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP diisobutyl phthalate results in increased activity of NR1I2 protein alternative form CTD PMID:21227907 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 multiple interactions
affects binding
increases activity
EXP [diisobutyl phthalate co-treated with Androstanols] results in increased activity of NR1I3 protein alternative form
diisobutyl phthalate binds to NR1I3 protein
diisobutyl phthalate results in increased activity of NR1I3 protein alternative form
CTD PMID:21227907 PMID:25938866 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
JBrowse link
G NRXN2 neurexin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NRXN2 mRNA CTD PMID:31199487 NCBI chr11:64,606,174...64,723,197
Ensembl chr11:64,606,174...64,723,197
JBrowse link
G NSDHL NAD(P) dependent steroid dehydrogenase-like decreases expression ISO diisobutyl phthalate results in decreased expression of NSDHL mRNA CTD PMID:33983380 NCBI chr  X:152,831,063...152,869,729
Ensembl chr  X:152,830,967...152,869,729
JBrowse link
G NSG1 neuronal vesicle trafficking associated 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG1 mRNA CTD PMID:31199487 NCBI chr 4:4,386,532...4,419,058
Ensembl chr 4:4,348,140...4,419,058
JBrowse link
G NSG2 neuronal vesicle trafficking associated 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG2 mRNA CTD PMID:31199487 NCBI chr 5:174,045,706...174,109,179
Ensembl chr 5:174,045,706...174,243,501
JBrowse link
G OLFM1 olfactomedin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 NCBI chr 9:135,075,505...135,121,184
Ensembl chr 9:135,075,422...135,121,180
JBrowse link
G PCP4 Purkinje cell protein 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PCP4 mRNA CTD PMID:31199487 NCBI chr21:39,867,438...39,929,392
Ensembl chr21:39,867,438...39,929,397
JBrowse link
G PGR progesterone receptor multiple interactions ISO
EXP
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]; Cyclic AMP inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]]
CTD PMID:33316053 PMID:37552060 NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G PLAT plasminogen activator, tissue type multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA] CTD PMID:33316053 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
JBrowse link
G PLIN1 perilipin 1 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of PLIN1 mRNA CTD PMID:37021957 NCBI chr15:89,664,367...89,679,367
Ensembl chr15:89,664,367...89,679,427
JBrowse link
G PLPPR3 phospholipid phosphatase related 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA CTD PMID:31199487 NCBI chr19:812,488...823,797
Ensembl chr19:812,488...821,955
JBrowse link
G PLS1 plastin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLS1 mRNA CTD PMID:31199487 NCBI chr 3:142,596,393...142,713,664
Ensembl chr 3:142,596,393...142,713,664
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PPARA mRNA CTD PMID:28013214 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions
increases expression
increases activity
EXP diisobutyl phthalate binds to and results in increased activity of PPARG protein
diisobutyl phthalate results in increased expression of PPARG protein
diisobutyl phthalate results in increased activity of PPARG protein
CTD PMID:24155963 PMID:26172262 PMID:27633901 PMID:29061543 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G PPARGC1A PPARG coactivator 1 alpha multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of PPARGC1A mRNA CTD PMID:37021957 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
JBrowse link
G PPP2R2B protein phosphatase 2 regulatory subunit Bbeta multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PPP2R2B mRNA CTD PMID:31199487 NCBI chr 5:146,580,742...147,081,520
Ensembl chr 5:146,580,742...147,084,784
JBrowse link
G PRIMA1 proline rich membrane anchor 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PRIMA1 mRNA CTD PMID:31199487 NCBI chr14:93,718,298...93,788,994
Ensembl chr14:93,718,298...93,788,485
JBrowse link
G PRPH peripherin multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PRPH mRNA CTD PMID:31199487 NCBI chr12:49,295,147...49,298,686
Ensembl chr12:49,295,147...49,298,686
JBrowse link
G PTGES prostaglandin E synthase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTGES mRNA CTD PMID:31199487 NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
JBrowse link
G PTGR1 prostaglandin reductase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTGR1 mRNA CTD PMID:31199487 NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA] CTD PMID:33316053 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G PTPRN protein tyrosine phosphatase receptor type N multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTPRN mRNA CTD PMID:31199487 NCBI chr 2:219,289,623...219,309,401
Ensembl chr 2:219,289,623...219,309,648
JBrowse link
G PTX3 pentraxin 3 multiple interactions EXP [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PTX3 mRNA] CTD PMID:37552060 NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
JBrowse link
G QSOX1 quiescin sulfhydryl oxidase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of QSOX1 mRNA CTD PMID:31199487 NCBI chr 1:180,154,869...180,204,030
Ensembl chr 1:180,154,869...180,204,030
JBrowse link
G RAB3B RAB3B, member RAS oncogene family multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB3B mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB3B protein CTD PMID:31199487 PMID:37690569 NCBI chr 1:51,907,956...51,990,700
Ensembl chr 1:51,907,956...51,990,700
JBrowse link
G RAB6B RAB6B, member RAS oncogene family multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B protein CTD PMID:31199487 PMID:37690569 NCBI chr 3:133,824,235...133,895,882
Ensembl chr 3:133,824,235...133,895,882
JBrowse link
G RASSF4 Ras association domain family member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA CTD PMID:31199487 NCBI chr10:44,959,802...44,995,891
Ensembl chr10:44,959,407...44,995,891
JBrowse link
G RESP18 regulated endocrine specific protein 18 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RESP18 mRNA CTD PMID:31199487 NCBI chr 2:219,327,407...219,336,656
Ensembl chr 2:219,327,407...219,333,177
JBrowse link
G RGS2 regulator of G protein signaling 2 multiple interactions EXP [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of RGS2 mRNA] CTD PMID:37552060 NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275
JBrowse link
G RNF183 ring finger protein 183 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of RNF183 mRNA CTD PMID:31199487 NCBI chr 9:113,297,093...113,303,376
Ensembl chr 9:113,297,093...113,303,376
JBrowse link
G RTN1 reticulon 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RTN1 mRNA CTD PMID:31199487 NCBI chr14:59,595,976...59,870,776
Ensembl chr14:59,595,976...59,870,776
JBrowse link
G RTN4R reticulon 4 receptor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RTN4R mRNA CTD PMID:31199487 NCBI chr22:20,241,415...20,268,318
Ensembl chr22:20,241,415...20,283,246
JBrowse link
G RXRG retinoid X receptor gamma decreases expression ISO diisobutyl phthalate results in decreased expression of RXRG mRNA CTD PMID:22112501 NCBI chr 1:165,400,922...165,445,126
Ensembl chr 1:165,400,922...165,445,355
JBrowse link
G SCARB1 scavenger receptor class B member 1 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of SCARB1 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of SCARB1 mRNA
CTD PMID:22112501 PMID:28655647 PMID:33983380 NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
JBrowse link
G SCG3 secretogranin III multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCG3 mRNA CTD PMID:31199487 NCBI chr15:51,681,503...51,721,026
Ensembl chr15:51,681,492...51,721,026
JBrowse link
G SCN3B sodium voltage-gated channel beta subunit 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCN3B mRNA CTD PMID:31199487 NCBI chr11:123,629,188...123,654,624
Ensembl chr11:123,629,187...123,655,244
JBrowse link
G SCRN1 secernin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCRN1 mRNA CTD PMID:31199487 NCBI chr 7:29,920,103...29,990,289
Ensembl chr 7:29,920,104...29,990,289
JBrowse link
G SERPINB2 serpin family B member 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA] CTD PMID:33316053 NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
JBrowse link
G SERPINE1 serpin family E member 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA] CTD PMID:33316053 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SH3GL3 SH3 domain containing GRB2 like 3, endophilin A3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA CTD PMID:31199487 NCBI chr15:83,447,341...83,633,820
Ensembl chr15:83,447,228...83,618,743
JBrowse link
G SH3TC2 SH3 domain and tetratricopeptide repeats 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3TC2 mRNA CTD PMID:31199487 NCBI chr 5:148,982,150...149,063,062
Ensembl chr 5:148,923,639...149,063,163
JBrowse link
G SHC2 SHC adaptor protein 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA CTD PMID:31199487 NCBI chr19:416,589...461,033
Ensembl chr19:416,589...461,033
JBrowse link
G SLC13A2 solute carrier family 13 member 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC13A2 mRNA CTD PMID:31199487 NCBI chr17:28,473,644...28,497,781
Ensembl chr17:28,473,293...28,497,781
JBrowse link
G SLC29A4 solute carrier family 29 member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC29A4 mRNA CTD PMID:31199487 NCBI chr 7:5,282,943...5,306,912
Ensembl chr 7:5,274,369...5,306,912
JBrowse link
G SLC5A7 solute carrier family 5 member 7 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC5A7 mRNA CTD PMID:31199487 NCBI chr 2:107,986,524...108,013,994
Ensembl chr 2:107,986,523...108,013,994
JBrowse link
G SLCO2A1 solute carrier organic anion transporter family member 2A1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA] CTD PMID:33316053 NCBI chr 3:133,932,701...134,029,925
Ensembl chr 3:133,932,701...134,052,184
JBrowse link
G SMIM24 small integral membrane protein 24 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SMIM24 mRNA CTD PMID:31199487 NCBI chr19:3,473,986...3,480,525
Ensembl chr19:3,473,986...3,480,525
JBrowse link
G SNHG11 small nucleolar RNA host gene 11 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SNHG11 mRNA CTD PMID:31199487 NCBI chr20:38,446,654...38,450,921
Ensembl chr20:38,446,343...38,450,940
JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SOD1 mRNA CTD PMID:28013214 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SOX9 SRY-box transcription factor 9 increases expression ISO diisobutyl phthalate results in increased expression of SOX9 mRNA CTD PMID:22112501 NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
JBrowse link
G STAR steroidogenic acute regulatory protein decreases expression
multiple interactions
ISO
EXP
diisobutyl phthalate results in decreased expression of STAR mRNA; diisobutyl phthalate results in decreased expression of STAR protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of STAR mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of STAR mRNA; [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of STAR mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of STAR mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in increased expression of STAR mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STAR mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of STAR mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of STAR mRNA
CTD PMID:16458459 PMID:21633115 PMID:22112501 PMID:28013214 PMID:28655647 More... NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
JBrowse link
G STK32C serine/threonine kinase 32C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA CTD PMID:31199487 NCBI chr10:132,207,482...132,332,235
Ensembl chr10:132,207,492...132,331,847
JBrowse link
G STMN4 stathmin 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA CTD PMID:31199487 NCBI chr 8:27,235,308...27,258,404
Ensembl chr 8:27,235,308...27,258,420
JBrowse link
G SYT11 synaptotagmin 11 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SYT11 mRNA CTD PMID:31199487 NCBI chr 1:155,859,567...155,885,199
Ensembl chr 1:155,859,567...155,885,199
JBrowse link
G SYT5 synaptotagmin 5 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SYT5 mRNA CTD PMID:31199487 NCBI chr19:55,171,196...55,180,289
Ensembl chr19:55,171,196...55,180,289
JBrowse link
G TBX2 T-box transcription factor 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TBX2 mRNA CTD PMID:31199487 NCBI chr17:61,399,843...61,409,466
Ensembl chr17:61,399,843...61,409,466
JBrowse link
G TCF23 transcription factor 23 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TCF23 mRNA CTD PMID:31199487 NCBI chr 2:27,149,004...27,156,974
Ensembl chr 2:27,149,004...27,156,974
JBrowse link
G TCTE1 t-complex-associated-testis-expressed 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TCTE1 mRNA CTD PMID:31199487 NCBI chr 6:44,278,734...44,297,698
Ensembl chr 6:44,278,734...44,297,698
JBrowse link
G THRB thyroid hormone receptor beta multiple interactions EXP diisobutyl phthalate binds to and results in decreased activity of THRB protein CTD PMID:27633901 NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA] CTD PMID:33316053 NCBI chr  X:47,582,436...47,586,789
Ensembl chr  X:47,582,408...47,586,789
JBrowse link
G TM7SF2 transmembrane 7 superfamily member 2 decreases expression ISO diisobutyl phthalate results in decreased expression of TM7SF2 mRNA CTD PMID:33983380 NCBI chr11:65,111,872...65,116,230
Ensembl chr11:65,111,845...65,116,384
JBrowse link
G TMEFF2 transmembrane protein with EGF like and two follistatin like domains 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEFF2 mRNA CTD PMID:31199487 NCBI chr 2:191,949,046...192,194,933
Ensembl chr 2:191,949,043...192,194,933
JBrowse link
G TMEM130 transmembrane protein 130 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM130 mRNA CTD PMID:31199487 NCBI chr 7:98,846,490...98,870,014
Ensembl chr 7:98,846,488...98,870,771
JBrowse link
G TMEM35A transmembrane protein 35A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA CTD PMID:31199487 NCBI chr  X:101,078,879...101,096,367
Ensembl chr  X:101,078,879...101,096,367
JBrowse link
G TMEM63C transmembrane protein 63C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM63C mRNA CTD PMID:31199487 NCBI chr14:77,181,798...77,259,495
Ensembl chr14:77,116,568...77,259,495
JBrowse link
G TRPC6 transient receptor potential cation channel subfamily C member 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TRPC6 mRNA CTD PMID:31199487 NCBI chr11:101,451,564...101,584,007
Ensembl chr11:101,451,564...101,872,562
JBrowse link
G TSHB thyroid stimulating hormone subunit beta multiple interactions EXP [diisobutyl phthalate results in increased abundance of mono-isobutyl phthalate] which results in decreased secretion of TSHB protein CTD PMID:29734584 NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302
JBrowse link
G TTYH1 tweety family member 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TTYH1 mRNA CTD PMID:31199487 NCBI chr19:54,415,464...54,436,904
Ensembl chr19:54,415,219...54,436,904
JBrowse link
G TUBB2B tubulin beta 2B class IIb multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB2B protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB2B mRNA CTD PMID:31199487 PMID:37690569 NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
JBrowse link
G TUBB3 tubulin beta 3 class III multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB3 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB3 mRNA CTD PMID:31199487 PMID:37690569 NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
JBrowse link
G TUBB4A tubulin beta 4A class IVa multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB4A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB4A mRNA CTD PMID:31199487 PMID:37690569 NCBI chr19:6,494,319...6,502,848
Ensembl chr19:6,494,319...6,502,848
JBrowse link
G UBASH3B ubiquitin associated and SH3 domain containing B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA CTD PMID:31199487 NCBI chr11:122,655,722...122,814,473
Ensembl chr11:122,655,722...122,814,473
JBrowse link
G UBXN11 UBX domain protein 11 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBXN11 mRNA CTD PMID:31199487 PMID:37690569 NCBI chr 1:26,282,282...26,318,355
Ensembl chr 1:26,281,328...26,318,363
JBrowse link
G UCP1 uncoupling protein 1 multiple interactions ISO [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of UCP1 mRNA CTD PMID:37021957 NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
JBrowse link
G WNT4 Wnt family member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 NCBI chr 1:22,117,313...22,143,097
Ensembl chr 1:22,117,313...22,143,969
JBrowse link
G WNT6 Wnt family member 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA CTD PMID:31199487 NCBI chr 2:218,859,805...218,874,233
Ensembl chr 2:218,859,805...218,874,233
JBrowse link
G WNT9B Wnt family member 9B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT9B mRNA CTD PMID:31199487 NCBI chr17:46,833,189...46,886,738
Ensembl chr17:46,833,201...46,886,730
JBrowse link
G WT1 WT1 transcription factor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
JBrowse link
G ZCCHC12 zinc finger CCHC-type containing 12 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ZCCHC12 mRNA CTD PMID:31199487 NCBI chr  X:118,823,824...118,826,968
Ensembl chr  X:118,823,824...118,826,968
JBrowse link
G ZFAT zinc finger and AT-hook domain containing multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ZFAT mRNA CTD PMID:31199487 NCBI chr 8:134,477,788...134,832,339
Ensembl chr 8:134,477,788...134,713,049
JBrowse link
G ZP2 zona pellucida glycoprotein 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ZP2 mRNA CTD PMID:31199487 NCBI chr16:21,197,450...21,214,510
Ensembl chr16:21,197,450...21,214,510
JBrowse link
fenpyroximate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA1 ATP binding cassette subfamily A member 1 increases expression EXP fenpyroximate results in increased expression of ABCA1 mRNA CTD PMID:33512557 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
JBrowse link
G ACHE acetylcholinesterase (Yt blood group) decreases activity ISO fenpyroximate results in decreased activity of ACHE protein CTD PMID:35580743 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
G AKR1B1 aldo-keto reductase family 1 member B decreases expression EXP fenpyroximate results in decreased expression of AKR1B1 mRNA CTD PMID:33512557 NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
JBrowse link
G AKR7A2 aldo-keto reductase family 7 member A2 decreases expression EXP fenpyroximate results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144
JBrowse link
G AKT1 AKT serine/threonine kinase 1 decreases expression EXP fenpyroximate results in decreased expression of AKT1 mRNA CTD PMID:33512557 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G ALDH9A1 aldehyde dehydrogenase 9 family member A1 decreases expression EXP fenpyroximate results in decreased expression of ALDH9A1 mRNA CTD PMID:33512557 NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562
JBrowse link
G AMER1 APC membrane recruitment protein 1 decreases expression EXP fenpyroximate results in decreased expression of AMER1 mRNA CTD PMID:33512557 NCBI chr  X:64,185,117...64,205,708
Ensembl chr  X:64,185,117...64,205,708
JBrowse link
G ANO10 anoctamin 10 decreases expression EXP fenpyroximate results in decreased expression of ANO10 mRNA CTD PMID:33512557 NCBI chr 3:43,365,848...43,691,594
Ensembl chr 3:43,354,859...43,691,594
JBrowse link
G AP3M1 adaptor related protein complex 3 subunit mu 1 decreases expression EXP fenpyroximate results in decreased expression of AP3M1 mRNA CTD PMID:33512557 NCBI chr10:74,120,255...74,150,828
Ensembl chr10:74,120,255...74,150,842
JBrowse link
G APEX1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases expression EXP fenpyroximate results in increased expression of APEX1 mRNA CTD PMID:33512557 NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
JBrowse link
G ARG1 arginase 1 decreases expression EXP fenpyroximate results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
JBrowse link
G ARHGAP9 Rho GTPase activating protein 9 increases expression EXP fenpyroximate results in increased expression of ARHGAP9 mRNA CTD PMID:33512557 NCBI chr12:57,472,269...57,488,824
Ensembl chr12:57,472,264...57,488,814
JBrowse link
G ARRDC4 arrestin domain containing 4 decreases expression EXP fenpyroximate results in decreased expression of ARRDC4 mRNA CTD PMID:33512557 NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
JBrowse link
G ASNS asparagine synthetase (glutamine-hydrolyzing) increases expression EXP fenpyroximate results in increased expression of ASNS mRNA CTD PMID:33512557 NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
JBrowse link
G ASS1 argininosuccinate synthase 1 increases expression EXP fenpyroximate results in increased expression of ASS1 mRNA CTD PMID:33512557 NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
JBrowse link
G ATF4 activating transcription factor 4 increases expression EXP fenpyroximate results in increased expression of ATF4 mRNA CTD PMID:33512557 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
JBrowse link
G ATF5 activating transcription factor 5 increases expression EXP fenpyroximate results in increased expression of ATF5 mRNA CTD PMID:33512557 NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
JBrowse link
G ATMIN ATM interactor decreases expression EXP fenpyroximate results in decreased expression of ATMIN mRNA CTD PMID:33512557 NCBI chr16:81,035,842...81,047,350
Ensembl chr16:81,035,842...81,047,350
JBrowse link
G ATP5F1B ATP synthase F1 subunit beta decreases expression EXP fenpyroximate results in decreased expression of ATP5F1B mRNA CTD PMID:33512557 NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
JBrowse link
G ATP5F1C ATP synthase F1 subunit gamma decreases expression EXP fenpyroximate results in decreased expression of ATP5F1C mRNA CTD PMID:33512557 NCBI chr10:7,788,177...7,807,801
Ensembl chr10:7,788,147...7,807,815
JBrowse link
G ATP6V1B2 ATPase H+ transporting V1 subunit B2 decreases expression EXP fenpyroximate results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 NCBI chr 8:20,197,381...20,221,696
Ensembl chr 8:20,197,381...20,226,819
JBrowse link
G AURKA aurora kinase A increases expression EXP fenpyroximate results in increased expression of AURKA mRNA CTD PMID:33512557 NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
JBrowse link
G B2M beta-2-microglobulin increases expression EXP fenpyroximate results in increased expression of B2M mRNA CTD PMID:33512557 NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851
JBrowse link
G B3GALT6 beta-1,3-galactosyltransferase 6 decreases expression EXP fenpyroximate results in decreased expression of B3GALT6 mRNA CTD PMID:33512557 NCBI chr 1:1,232,237...1,235,041
Ensembl chr 1:1,232,237...1,235,041
JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression EXP fenpyroximate results in increased expression of BAX mRNA CTD PMID:36933581 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression EXP fenpyroximate results in decreased expression of BCL2 mRNA CTD PMID:36933581 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L13 BCL2 like 13 decreases expression EXP fenpyroximate results in decreased expression of BCL2L13 mRNA CTD PMID:33512557 NCBI chr22:17,628,877...17,730,855
Ensembl chr22:17,628,855...17,730,855
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 increases expression EXP fenpyroximate results in increased expression of BIRC5 mRNA CTD PMID:33512557 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G BMF Bcl2 modifying factor decreases expression EXP fenpyroximate results in decreased expression of BMF mRNA CTD PMID:33512557 NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
JBrowse link
G BPHL biphenyl hydrolase like decreases expression EXP fenpyroximate results in decreased expression of BPHL mRNA CTD PMID:33512557 NCBI chr 6:3,118,376...3,153,578
Ensembl chr 6:3,118,374...3,153,578
JBrowse link
G BZW1 basic leucine zipper and W2 domains 1 decreases expression EXP fenpyroximate results in decreased expression of BZW1 mRNA CTD PMID:33512557 NCBI chr 2:200,811,589...200,827,338
Ensembl chr 2:200,810,594...200,827,338
JBrowse link
G C2CD5 C2 calcium dependent domain containing 5 decreases expression EXP fenpyroximate results in decreased expression of C2CD5 mRNA CTD PMID:33512557 NCBI chr12:22,448,583...22,544,542
Ensembl chr12:22,448,583...22,544,546
JBrowse link
G CANX calnexin increases expression EXP fenpyroximate results in increased expression of CANX mRNA CTD PMID:33512557 NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
JBrowse link
G CARS1 cysteinyl-tRNA synthetase 1 increases expression EXP fenpyroximate results in increased expression of CARS1 mRNA CTD PMID:33512557 NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
JBrowse link
G CASP3 caspase 3 increases activity
multiple interactions
EXP fenpyroximate results in increased activity of CASP3 protein
Acetylcysteine inhibits the reaction [fenpyroximate results in increased activity of CASP3 protein]
CTD PMID:35580743 PMID:36933581 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP9 caspase 9 increases activity EXP fenpyroximate results in increased activity of CASP9 protein CTD PMID:36933581 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CAT catalase increases activity
affects activity
EXP
ISO
fenpyroximate results in increased activity of CAT protein
fenpyroximate affects the activity of CAT protein
CTD PMID:35580743 PMID:36933581 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CBR1 carbonyl reductase 1 decreases expression EXP fenpyroximate results in decreased expression of CBR1 mRNA CTD PMID:33512557 NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166
JBrowse link
G CBX4 chromobox 4 increases expression EXP fenpyroximate results in increased expression of CBX4 mRNA CTD PMID:33512557 NCBI chr17:79,833,156...79,839,440
Ensembl chr17:79,833,156...79,839,440
JBrowse link
G CCNB1 cyclin B1 increases expression EXP fenpyroximate results in increased expression of CCNB1 mRNA CTD PMID:33512557 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
JBrowse link
G CCNB2 cyclin B2 increases expression EXP fenpyroximate results in increased expression of CCNB2 mRNA CTD PMID:33512557 NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
JBrowse link
G CD24 CD24 molecule decreases expression EXP fenpyroximate results in decreased expression of CD24 mRNA CTD PMID:33512557 NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
JBrowse link
G CDH10 cadherin 10 decreases expression EXP fenpyroximate results in decreased expression of CDH10 mRNA CTD PMID:33512557 NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978
JBrowse link
G CDH2 cadherin 2 decreases expression EXP fenpyroximate results in decreased expression of CDH2 mRNA CTD PMID:33512557 NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
JBrowse link
G CDK1 cyclin dependent kinase 1 increases expression EXP fenpyroximate results in increased expression of CDK1 mRNA CTD PMID:33512557 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
JBrowse link
G CDK5R1 cyclin dependent kinase 5 regulatory subunit 1 decreases expression EXP fenpyroximate results in decreased expression of CDK5R1 mRNA CTD PMID:33512557 NCBI chr17:32,486,993...32,491,253
Ensembl chr17:32,486,993...32,491,253
JBrowse link
G CDK6 cyclin dependent kinase 6 increases expression EXP fenpyroximate results in increased expression of CDK6 mRNA CTD PMID:33512557 NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
JBrowse link
G CDKN3 cyclin dependent kinase inhibitor 3 increases expression EXP fenpyroximate results in increased expression of CDKN3 mRNA CTD PMID:33512557 NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
JBrowse link
G CEBPB CCAAT enhancer binding protein beta increases expression EXP fenpyroximate results in increased expression of CEBPB mRNA CTD PMID:33512557 NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
JBrowse link
G CEL carboxyl ester lipase decreases expression EXP fenpyroximate results in decreased expression of CEL mRNA CTD PMID:33512557 NCBI chr 9:133,061,981...133,071,861
Ensembl chr 9:133,061,981...133,071,861
JBrowse link
G CFL2 cofilin 2 decreases expression EXP fenpyroximate results in decreased expression of CFL2 mRNA CTD PMID:33512557 NCBI chr14:34,709,113...34,714,593
Ensembl chr14:34,709,113...34,714,823
JBrowse link
G CHAC1 ChaC glutathione specific gamma-glutamylcyclotransferase 1 increases expression EXP fenpyroximate results in increased expression of CHAC1 mRNA CTD PMID:33512557 NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
JBrowse link
G CHEK1 checkpoint kinase 1 increases expression EXP fenpyroximate results in increased expression of CHEK1 mRNA CTD PMID:33512557 NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
JBrowse link
G CHKA choline kinase alpha increases expression EXP fenpyroximate results in increased expression of CHKA mRNA CTD PMID:33512557 NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
JBrowse link
G CKS1B CDC28 protein kinase regulatory subunit 1B increases expression EXP fenpyroximate results in increased expression of CKS1B mRNA CTD PMID:33512557 NCBI chr 1:154,974,681...154,979,251
Ensembl chr 1:154,974,653...154,979,251
JBrowse link
G CKS2 CDC28 protein kinase regulatory subunit 2 increases expression EXP fenpyroximate results in increased expression of CKS2 mRNA CTD PMID:33512557 NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
JBrowse link
G CLIC4 chloride intracellular channel 4 increases expression EXP fenpyroximate results in increased expression of CLIC4 mRNA CTD PMID:33512557 NCBI chr 1:24,745,447...24,844,321
Ensembl chr 1:24,745,382...24,844,321
JBrowse link
G CNPY3 canopy FGF signaling regulator 3 increases expression EXP fenpyroximate results in increased expression of CNPY3 mRNA CTD PMID:33512557 NCBI chr 6:42,928,002...42,939,294
Ensembl chr 6:42,929,480...42,939,294
JBrowse link
G CNTN1 contactin 1 increases expression EXP fenpyroximate results in increased expression of CNTN1 mRNA CTD PMID:33512557 NCBI chr12:40,692,439...41,072,415
Ensembl chr12:40,692,439...41,072,415
JBrowse link
G COA6 cytochrome c oxidase assembly factor 6 increases expression EXP fenpyroximate results in increased expression of COA6 mRNA CTD PMID:33512557 NCBI chr 1:234,373,456...234,385,080
Ensembl chr 1:234,373,456...234,385,080
JBrowse link
G COL16A1 collagen type XVI alpha 1 chain increases expression EXP fenpyroximate results in increased expression of COL16A1 mRNA CTD PMID:33512557 NCBI chr 1:31,652,263...31,704,017
Ensembl chr 1:31,652,263...31,704,319
JBrowse link
G COPS5 COP9 signalosome subunit 5 decreases expression EXP fenpyroximate results in decreased expression of COPS5 mRNA CTD PMID:33512557 NCBI chr 8:67,043,079...67,062,133
Ensembl chr 8:67,043,079...67,083,783
JBrowse link
G CREBRF CREB3 regulatory factor increases expression EXP fenpyroximate results in increased expression of CREBRF mRNA CTD PMID:33512557 NCBI chr 5:173,056,352...173,139,284
Ensembl chr 5:173,056,352...173,139,284
JBrowse link
G CREG1 cellular repressor of E1A stimulated genes 1 increases expression EXP fenpyroximate results in increased expression of CREG1 mRNA CTD PMID:33512557 NCBI chr 1:167,541,013...167,553,762
Ensembl chr 1:167,529,117...167,553,805
JBrowse link
G CRELD2 cysteine rich with EGF like domains 2 increases expression EXP fenpyroximate results in increased expression of CRELD2 mRNA CTD PMID:33512557 NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540
JBrowse link
G CRTAP cartilage associated protein increases expression EXP fenpyroximate results in increased expression of CRTAP mRNA CTD PMID:33512557 NCBI chr 3:33,114,014...33,147,773
Ensembl chr 3:33,114,014...33,147,773
JBrowse link
G CTNNAL1 catenin alpha like 1 increases expression EXP fenpyroximate results in increased expression of CTNNAL1 mRNA CTD PMID:33512557 NCBI chr 9:108,942,577...109,013,499
Ensembl chr 9:108,942,569...109,013,522
JBrowse link
G CTNND1 catenin delta 1 decreases expression EXP fenpyroximate results in decreased expression of CTNND1 mRNA CTD PMID:33512557 NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
JBrowse link
G CTPS1 CTP synthase 1 decreases expression EXP fenpyroximate results in decreased expression of CTPS1 mRNA CTD PMID:33512557 NCBI chr 1:40,979,696...41,012,565
Ensembl chr 1:40,979,300...41,012,565
JBrowse link
G CTTN cortactin decreases expression EXP fenpyroximate results in decreased expression of CTTN mRNA CTD PMID:33512557 NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression EXP fenpyroximate results in increased expression of CYP1A1 mRNA CTD PMID:32194361 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 decreases expression EXP fenpyroximate results in decreased expression of CYP2C19 protein CTD PMID:32194361 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 increases expression EXP fenpyroximate results in increased expression of CYP3A5 mRNA CTD PMID:34642769 NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP fenpyroximate results in decreased expression of CYP7A1 mRNA; fenpyroximate results in decreased expression of CYP7A1 protein CTD PMID:32194361 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
JBrowse link
G DAAM1 dishevelled associated activator of morphogenesis 1 decreases expression EXP fenpyroximate results in decreased expression of DAAM1 mRNA CTD PMID:33512557 NCBI chr14:59,188,667...59,371,405
Ensembl chr14:59,188,646...59,371,405
JBrowse link
G DAXX death domain associated protein decreases expression EXP fenpyroximate results in decreased expression of DAXX mRNA CTD PMID:33512557 NCBI chr 6:33,318,558...33,322,959
Ensembl chr 6:33,318,558...33,323,016
JBrowse link
G DCK deoxycytidine kinase decreases expression EXP fenpyroximate results in decreased expression of DCK mRNA CTD PMID:33512557 NCBI chr 4:70,993,649...71,030,914
Ensembl chr 4:70,992,538...71,030,914
JBrowse link
G DDC dopa decarboxylase decreases expression EXP fenpyroximate results in decreased expression of DDC mRNA CTD PMID:34642769 NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP fenpyroximate results in increased expression of DDIT3 mRNA CTD PMID:33512557 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
JBrowse link
G DEPDC1B DEP domain containing 1B increases expression EXP fenpyroximate results in increased expression of DEPDC1B mRNA CTD PMID:33512557 NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,190
JBrowse link
G DFFB DNA fragmentation factor subunit beta decreases expression EXP fenpyroximate results in decreased expression of DFFB mRNA CTD PMID:33512557 NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
JBrowse link
G DLGAP5 DLG associated protein 5 increases expression EXP fenpyroximate results in increased expression of DLGAP5 mRNA CTD PMID:33512557 NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608
JBrowse link
G DNAJB14 DnaJ heat shock protein family (Hsp40) member B14 increases expression EXP fenpyroximate results in increased expression of DNAJB14 mRNA CTD PMID:33512557 NCBI chr 4:99,896,248...99,946,618
Ensembl chr 4:99,896,248...99,946,618
JBrowse link
G DNTTIP2 deoxynucleotidyltransferase terminal interacting protein 2 decreases expression EXP fenpyroximate results in decreased expression of DNTTIP2 mRNA CTD PMID:33512557 NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918
JBrowse link
G DRD2 dopamine receptor D2 decreases expression EXP fenpyroximate results in decreased expression of DRD2 mRNA CTD PMID:33512557 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
JBrowse link
G DUSP4 dual specificity phosphatase 4 increases expression EXP fenpyroximate results in increased expression of DUSP4 mRNA CTD PMID:33512557 NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
JBrowse link
G EEF1G eukaryotic translation elongation factor 1 gamma decreases expression EXP fenpyroximate results in decreased expression of EEF1G mRNA CTD PMID:33512557 NCBI chr11:62,559,596...62,573,891
Ensembl chr11:62,559,596...62,574,086
JBrowse link
G EGR1 early growth response 1 increases expression EXP fenpyroximate results in increased expression of EGR1 mRNA CTD PMID:33512557 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G EIF2S2 eukaryotic translation initiation factor 2 subunit beta increases expression EXP fenpyroximate results in increased expression of EIF2S2 mRNA CTD PMID:33512557 NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
JBrowse link
G EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 increases expression EXP fenpyroximate results in increased expression of EIF4EBP1 mRNA CTD PMID:33512557 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
JBrowse link
G ELMOD1 ELMO domain containing 1 decreases expression EXP fenpyroximate results in decreased expression of ELMOD1 mRNA CTD PMID:33512557 NCBI chr11:107,591,147...107,666,779
Ensembl chr11:107,591,091...107,666,779
JBrowse link
G EP300 E1A binding protein p300 decreases expression EXP fenpyroximate results in decreased expression of EP300 mRNA CTD PMID:33512557 NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
JBrowse link
G EPHB2 EPH receptor B2 decreases expression EXP fenpyroximate results in decreased expression of EPHB2 mRNA CTD PMID:33512557 NCBI chr 1:22,710,838...22,921,500
Ensembl chr 1:22,710,839...22,921,500
JBrowse link
G ERO1A endoplasmic reticulum oxidoreductase 1 alpha increases expression EXP fenpyroximate results in increased expression of ERO1A mRNA CTD PMID:33512557 NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
JBrowse link
G ERO1B endoplasmic reticulum oxidoreductase 1 beta increases expression EXP fenpyroximate results in increased expression of ERO1B mRNA CTD PMID:33512557 NCBI chr 1:236,215,101...236,281,958
Ensembl chr 1:236,214,681...236,282,019
JBrowse link
G ESR2 estrogen receptor 2 multiple interactions EXP fenpyroximate inhibits the reaction [Estradiol results in increased activity of ESR2 protein] CTD PMID:30818834 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G ESRRA estrogen related receptor alpha multiple interactions EXP fenpyroximate inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]; fenpyroximate inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 NCBI chr11:64,305,524...64,316,743
Ensembl chr11:64,305,497...64,316,743
JBrowse link
G EXOSC4 exosome component 4 decreases expression EXP fenpyroximate results in decreased expression of EXOSC4 mRNA CTD PMID:33512557 NCBI chr 8:144,064,056...144,080,648
Ensembl chr 8:144,078,648...144,080,648
JBrowse link
G EXOSC8 exosome component 8 increases expression EXP fenpyroximate results in increased expression of EXOSC8 mRNA CTD PMID:33512557 NCBI chr13:37,000,786...37,009,614
Ensembl chr13:36,998,816...37,025,881
JBrowse link
G FAM72A family with sequence similarity 72 member A increases expression EXP fenpyroximate results in increased expression of FAM72A mRNA CTD PMID:33512557 NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414
JBrowse link
G FAM72C family with sequence similarity 72 member C increases expression EXP fenpyroximate results in increased expression of FAM72C mRNA CTD PMID:33512557 NCBI chr 1:143,955,287...143,973,564
Ensembl chr 1:143,955,287...143,971,986
JBrowse link
G FBL fibrillarin increases expression EXP fenpyroximate results in increased expression of FBL mRNA CTD PMID:33512557 NCBI chr19:39,834,458...39,846,379
Ensembl chr19:39,834,458...39,846,379
JBrowse link
G FBXO7 F-box protein 7 decreases expression EXP fenpyroximate results in decreased expression of FBXO7 mRNA CTD PMID:33512557 NCBI chr22:32,474,811...32,498,829
Ensembl chr22:32,474,676...32,498,829
JBrowse link
G FGF2 fibroblast growth factor 2 increases expression EXP fenpyroximate results in increased expression of FGF2 mRNA CTD PMID:33512557 NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
JBrowse link
G FTH1 ferritin heavy chain 1 increases expression EXP fenpyroximate results in increased expression of FTH1 mRNA CTD PMID:33512557 NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
JBrowse link
G FTL ferritin light chain increases expression EXP fenpyroximate results in increased expression of FTL mRNA CTD PMID:33512557 NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 decreases expression EXP fenpyroximate results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
JBrowse link
G G6PD glucose-6-phosphate dehydrogenase decreases expression EXP fenpyroximate results in decreased expression of G6PD mRNA CTD PMID:33512557 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572
JBrowse link
G GADD45B growth arrest and DNA damage inducible beta increases expression EXP fenpyroximate results in increased expression of GADD45B mRNA CTD PMID:33512557 NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
JBrowse link
G GADD45G growth arrest and DNA damage inducible gamma increases expression EXP fenpyroximate results in increased expression of GADD45G mRNA CTD PMID:33512557 NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555
JBrowse link
G GAP43 growth associated protein 43 decreases expression EXP fenpyroximate results in decreased expression of GAP43 mRNA CTD PMID:33512557 NCBI chr 3:115,623,510...115,721,483
Ensembl chr 3:115,623,510...115,721,490
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression EXP fenpyroximate results in increased expression of GCLM mRNA CTD PMID:33512557 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GDF15 growth differentiation factor 15 increases expression EXP fenpyroximate results in increased expression of GDF15 mRNA CTD PMID:33512557 NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
JBrowse link
G GFUS GDP-L-fucose synthase increases expression EXP fenpyroximate results in increased expression of GFUS mRNA CTD PMID:33512557 NCBI chr 8:143,612,618...143,618,048
Ensembl chr 8:143,612,618...143,618,048
JBrowse link
G GLDC glycine decarboxylase decreases expression EXP fenpyroximate results in decreased expression of GLDC mRNA CTD PMID:33512557 NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
JBrowse link
G GLI3 GLI family zinc finger 3 decreases expression EXP fenpyroximate results in decreased expression of GLI3 mRNA CTD PMID:33512557 NCBI chr 7:41,960,949...42,264,268
Ensembl chr 7:41,960,949...42,264,100
JBrowse link
G GLRX glutaredoxin decreases expression EXP fenpyroximate results in decreased expression of GLRX mRNA CTD PMID:33512557 NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
JBrowse link
G GNAI2 G protein subunit alpha i2 decreases expression EXP fenpyroximate results in decreased expression of GNAI2 mRNA CTD PMID:33512557 NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
JBrowse link
G GRB10 growth factor receptor bound protein 10 increases expression EXP fenpyroximate results in increased expression of GRB10 mRNA CTD PMID:33512557 NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
JBrowse link
G GRM4 glutamate metabotropic receptor 4 decreases expression EXP fenpyroximate results in decreased expression of GRM4 mRNA CTD PMID:33512557 NCBI chr 6:34,018,643...34,155,622
Ensembl chr 6:34,018,643...34,155,622
JBrowse link
G GSTM2 glutathione S-transferase mu 2 decreases expression EXP fenpyroximate results in decreased expression of GSTM2 mRNA CTD PMID:33512557 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
JBrowse link
G H1-2 H1.2 linker histone, cluster member increases expression EXP fenpyroximate results in increased expression of H1-2 mRNA CTD PMID:33512557 NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
JBrowse link
G H2AC11 H2A clustered histone 11 increases expression EXP fenpyroximate results in increased expression of H2AC11 mRNA CTD PMID:33512557 NCBI chr 6:27,133,043...27,133,535
Ensembl chr 6:27,133,043...27,133,535
JBrowse link
G H2AC15 H2A clustered histone 15 increases expression EXP fenpyroximate results in increased expression of H2AC15 mRNA CTD PMID:33512557 NCBI chr 6:27,837,880...27,838,375
Ensembl chr 6:27,837,880...27,838,375
JBrowse link
G H2AC19 H2A clustered histone 19 increases expression EXP fenpyroximate results in increased expression of H2AC19 mRNA CTD PMID:33512557 NCBI chr 1:149,851,061...149,851,594
Ensembl chr 1:149,851,061...149,851,594
JBrowse link
G H2AC6 H2A clustered histone 6 increases expression EXP fenpyroximate results in increased expression of H2AC6 mRNA CTD PMID:33512557 NCBI chr 6:26,124,172...26,124,690
Ensembl chr 6:26,124,145...26,139,116
JBrowse link
G H2AC8 H2A clustered histone 8 increases expression EXP fenpyroximate results in increased expression of H2AC8 mRNA CTD PMID:33512557 NCBI chr 6:26,216,921...26,217,437
Ensembl chr 6:26,216,921...26,217,437
JBrowse link
G H2BC13 H2B clustered histone 13 increases expression EXP fenpyroximate results in increased expression of H2BC13 mRNA CTD PMID:33512557 NCBI chr 6:27,807,479...27,807,929
Ensembl chr 6:27,807,479...27,807,929
JBrowse link
G H2BC14 H2B clustered histone 14 increases expression EXP fenpyroximate results in increased expression of H2BC14 mRNA CTD PMID:33512557 NCBI chr 6:27,815,022...27,815,489
Ensembl chr 6:27,815,022...27,815,489
JBrowse link
G H2BC15 H2B clustered histone 15 increases expression EXP fenpyroximate results in increased expression of H2BC15 mRNA CTD PMID:33512557 NCBI chr 6:27,838,569...27,839,110
Ensembl chr 6:27,838,545...27,855,709
JBrowse link
G H2BC3 H2B clustered histone 3 increases expression EXP fenpyroximate results in increased expression of H2BC3 mRNA CTD PMID:33512557 NCBI chr 6:26,043,227...26,043,713
Ensembl chr 6:26,043,227...26,043,713
JBrowse link
G H2BC5 H2B clustered histone 5 increases expression EXP fenpyroximate results in increased expression of H2BC5 mRNA CTD PMID:33512557 NCBI chr 6:26,158,121...26,171,349
Ensembl chr 6:26,158,122...26,171,349
JBrowse link
G H2BC9 H2B clustered histone 9 increases expression EXP fenpyroximate results in increased expression of H2BC9 mRNA CTD PMID:33512557 NCBI chr 6:26,251,614...26,252,075
Ensembl chr 6:26,251,614...26,252,075
JBrowse link
G H3C10 H3 clustered histone 10 increases expression EXP fenpyroximate results in increased expression of H3C10 mRNA CTD PMID:33512557 NCBI chr 6:27,810,051...27,810,536
Ensembl chr 6:27,810,051...27,811,300
JBrowse link
G H3C2 H3 clustered histone 2 increases expression EXP fenpyroximate results in increased expression of H3C2 mRNA CTD PMID:33512557 NCBI chr 6:26,031,589...26,032,099
Ensembl chr 6:26,031,589...26,032,099
JBrowse link
G H3C3 H3 clustered histone 3 increases expression EXP fenpyroximate results in increased expression of H3C3 mRNA CTD PMID:33512557 NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869
JBrowse link
G H3C4 H3 clustered histone 4 increases expression EXP fenpyroximate results in increased expression of H3C4 mRNA CTD PMID:33512557 NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,196,784...26,197,286
JBrowse link
G HAPSTR1 HUWE1 associated protein modifying stress responses increases expression EXP fenpyroximate results in increased expression of HAPSTR1 mRNA CTD PMID:33512557 NCBI chr16:9,091,644...9,121,635
Ensembl chr16:9,091,644...9,121,635
JBrowse link
G HCST hematopoietic cell signal transducer increases expression EXP fenpyroximate results in increased expression of HCST mRNA CTD PMID:33512557 NCBI chr19:35,902,529...35,904,377
Ensembl chr19:35,902,529...35,904,377
JBrowse link
G HDAC2 histone deacetylase 2 decreases expression EXP fenpyroximate results in decreased expression of HDAC2 mRNA CTD PMID:33512557 NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
JBrowse link
G HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression EXP fenpyroximate results in increased expression of HERPUD1 mRNA CTD PMID:33512557 NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
JBrowse link
G HES1 hes family bHLH transcription factor 1 increases expression EXP fenpyroximate results in increased expression of HES1 mRNA CTD PMID:33512557 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
JBrowse link
G HMOX1 heme oxygenase 1 increases expression EXP fenpyroximate results in increased expression of HMOX1 mRNA CTD PMID:33512557 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HNRNPM heterogeneous nuclear ribonucleoprotein M decreases expression EXP fenpyroximate results in decreased expression of HNRNPM mRNA CTD PMID:33512557 NCBI chr19:8,444,975...8,489,114
Ensembl chr19:8,444,767...8,489,114
JBrowse link
G HSP90B1 heat shock protein 90 beta family member 1 increases expression EXP fenpyroximate results in increased expression of HSP90B1 mRNA CTD PMID:33512557 NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
JBrowse link
G HSPA1B heat shock protein family A (Hsp70) member 1B increases expression EXP fenpyroximate results in increased expression of HSPA1B mRNA CTD PMID:33512557 NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
JBrowse link
G HSPE1 heat shock protein family E (Hsp10) member 1 increases expression EXP fenpyroximate results in increased expression of HSPE1 mRNA CTD PMID:33512557 NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
JBrowse link
G HTATSF1 HIV-1 Tat specific factor 1 decreases expression EXP fenpyroximate results in decreased expression of HTATSF1 mRNA CTD PMID:33512557 NCBI chr  X:136,497,229...136,512,346
Ensembl chr  X:136,497,079...136,512,346
JBrowse link
G ID1 inhibitor of DNA binding 1 decreases expression EXP fenpyroximate results in decreased expression of ID1 mRNA CTD PMID:33512557 NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
JBrowse link
G ID2 inhibitor of DNA binding 2 increases expression EXP fenpyroximate results in increased expression of ID2 mRNA CTD PMID:33512557 NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
JBrowse link
G IFRD1 interferon related developmental regulator 1 increases expression EXP fenpyroximate results in increased expression of IFRD1 mRNA CTD PMID:33512557 NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
JBrowse link
G IGF1R insulin like growth factor 1 receptor decreases expression EXP fenpyroximate results in decreased expression of IGF1R mRNA CTD PMID:33512557 NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
JBrowse link
G IGFBP2 insulin like growth factor binding protein 2 decreases expression EXP fenpyroximate results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
JBrowse link
G INA internexin neuronal intermediate filament protein alpha decreases expression EXP fenpyroximate results in decreased expression of INA mRNA CTD PMID:33512557 NCBI chr10:103,277,138...103,290,346
Ensembl chr10:103,277,138...103,290,346
JBrowse link
G IPO5 importin 5 increases expression EXP fenpyroximate results in increased expression of IPO5 mRNA CTD PMID:33512557 NCBI chr13:97,953,675...98,024,296
Ensembl chr13:97,953,658...98,024,296
JBrowse link
G ITPR2 inositol 1,4,5-trisphosphate receptor type 2 decreases expression EXP fenpyroximate results in decreased expression of ITPR2 mRNA CTD PMID:33512557 NCBI chr12:26,335,352...26,833,194
Ensembl chr12:26,335,352...26,833,194
JBrowse link
G JMJD6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase increases expression EXP fenpyroximate results in increased expression of JMJD6 mRNA CTD PMID:33512557 NCBI chr17:76,712,836...76,726,606
Ensembl chr17:76,712,832...76,726,799
JBrowse link
G KDM3A lysine demethylase 3A decreases expression EXP fenpyroximate results in decreased expression of KDM3A mRNA CTD PMID:33512557 NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716
JBrowse link
G KDM5B lysine demethylase 5B decreases expression EXP fenpyroximate results in decreased expression of KDM5B mRNA CTD PMID:33512557 NCBI chr 1:202,724,495...202,808,421
Ensembl chr 1:202,724,495...202,808,487
JBrowse link
G KIF15 kinesin family member 15 increases expression EXP fenpyroximate results in increased expression of KIF15 mRNA CTD PMID:33512557 NCBI chr 3:44,761,794...44,868,687
Ensembl chr 3:44,761,721...44,873,376
JBrowse link
G KIF20A kinesin family member 20A increases expression EXP fenpyroximate results in increased expression of KIF20A mRNA CTD PMID:33512557 NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
JBrowse link
G KIF5C kinesin family member 5C decreases expression EXP fenpyroximate results in decreased expression of KIF5C mRNA CTD PMID:33512557 NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
JBrowse link
G KLHL24 kelch like family member 24 increases expression EXP fenpyroximate results in increased expression of KLHL24 mRNA CTD PMID:34642769 NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
JBrowse link
G KNL1 kinetochore scaffold 1 increases expression EXP fenpyroximate results in increased expression of KNL1 mRNA CTD PMID:33512557 NCBI chr15:40,594,249...40,664,342
Ensembl chr15:40,594,020...40,664,342
JBrowse link
G KYAT3 kynurenine aminotransferase 3 decreases expression EXP fenpyroximate results in decreased expression of KYAT3 mRNA CTD PMID:33512557 NCBI chr 1:88,921,044...88,992,960
Ensembl chr 1:88,935,773...88,992,953
JBrowse link
G LOXL1 lysyl oxidase like 1 decreases expression EXP fenpyroximate results in decreased expression of LOXL1 mRNA CTD PMID:33512557 NCBI chr15:73,926,462...73,952,136
Ensembl chr15:73,925,989...73,952,137
JBrowse link
G LRRC41 leucine rich repeat containing 41 decreases expression EXP fenpyroximate results in decreased expression of LRRC41 mRNA CTD PMID:33512557 NCBI chr 1:46,277,462...46,303,616
Ensembl chr 1:46,261,196...46,303,616
JBrowse link
G MANF mesencephalic astrocyte derived neurotrophic factor increases expression EXP fenpyroximate results in increased expression of MANF mRNA CTD PMID:33512557 NCBI chr 3:51,385,291...51,389,397
Ensembl chr 3:51,385,291...51,389,397
JBrowse link
G MAP1B microtubule associated protein 1B decreases expression EXP fenpyroximate results in decreased expression of MAP1B mRNA CTD PMID:33512557 NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
JBrowse link
G MAP6 microtubule associated protein 6 decreases expression EXP fenpyroximate results in decreased expression of MAP6 mRNA CTD PMID:33512557 NCBI chr11:75,586,918...75,669,038
Ensembl chr11:75,586,918...75,669,038
JBrowse link
G MCM7 minichromosome maintenance complex component 7 increases expression EXP fenpyroximate results in increased expression of MCM7 mRNA CTD PMID:33512557 NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940
JBrowse link
G MDK midkine increases expression EXP fenpyroximate results in increased expression of MDK mRNA CTD PMID:33512557 NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
JBrowse link
G ME1 malic enzyme 1 increases expression EXP fenpyroximate results in increased expression of ME1 mRNA CTD PMID:33512557 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
JBrowse link
G MKI67 marker of proliferation Ki-67 increases expression EXP fenpyroximate results in increased expression of MKI67 mRNA CTD PMID:33512557 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
JBrowse link
G MLLT11 MLLT11 transcription factor 7 cofactor decreases expression EXP fenpyroximate results in decreased expression of MLLT11 mRNA CTD PMID:33512557 NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
JBrowse link
G MNAT1 MNAT1 component of CDK activating kinase decreases expression EXP fenpyroximate results in decreased expression of MNAT1 mRNA CTD PMID:33512557 NCBI chr14:60,734,761...60,969,965
Ensembl chr14:60,734,742...60,969,965
JBrowse link
G MORN2 MORN repeat containing 2 decreases expression EXP fenpyroximate results in decreased expression of MORN2 mRNA CTD PMID:33512557 NCBI chr 2:38,875,976...38,882,709
Ensembl chr 2:38,875,976...38,929,072
JBrowse link
G MSI2 musashi RNA binding protein 2 decreases expression EXP fenpyroximate results in decreased expression of MSI2 mRNA CTD PMID:33512557 NCBI chr17:57,255,851...57,701,581
Ensembl chr17:57,255,851...57,684,689
JBrowse link
G MTA1 metastasis associated 1 decreases expression EXP fenpyroximate results in decreased expression of MTA1 mRNA CTD PMID:33512557 NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729
JBrowse link
G MTHFD2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression EXP fenpyroximate results in increased expression of MTHFD2 mRNA CTD PMID:33512557 NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
JBrowse link
G NAV1 neuron navigator 1 decreases expression EXP fenpyroximate results in decreased expression of NAV1 mRNA CTD PMID:33512557 NCBI chr 1:201,539,127...201,826,969
Ensembl chr 1:201,539,127...201,826,969
JBrowse link
G NCAN neurocan decreases expression EXP fenpyroximate results in decreased expression of NCAN mRNA CTD PMID:33512557 NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
JBrowse link
G NDUFA1 NADH:ubiquinone oxidoreductase subunit A1 increases expression EXP fenpyroximate results in increased expression of NDUFA1 mRNA CTD PMID:33512557 NCBI chr  X:119,871,832...119,876,662
Ensembl chr  X:119,871,832...119,876,662
JBrowse link
G NEK2 NIMA related kinase 2 increases expression EXP fenpyroximate results in increased expression of NEK2 mRNA CTD PMID:33512557 NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
JBrowse link
G NFATC3 nuclear factor of activated T cells 3 decreases expression EXP fenpyroximate results in decreased expression of NFATC3 mRNA CTD PMID:33512557 NCBI chr16:68,085,370...68,229,259
Ensembl chr16:68,084,751...68,229,259
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 increases activity EXP fenpyroximate results in increased activity of NFE2L2 protein CTD PMID:30818834 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NFIL3 nuclear factor, interleukin 3 regulated decreases expression EXP fenpyroximate results in decreased expression of NFIL3 mRNA CTD PMID:33512557 NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
JBrowse link
G NFKBIB NFKB inhibitor beta decreases expression EXP fenpyroximate results in decreased expression of NFKBIB mRNA CTD PMID:33512557 NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
JBrowse link
G NIT1 nitrilase 1 decreases expression EXP fenpyroximate results in decreased expression of NIT1 mRNA CTD PMID:33512557 NCBI chr 1:161,118,105...161,125,445
Ensembl chr 1:161,118,086...161,125,445
JBrowse link
G NMNAT3 nicotinamide nucleotide adenylyltransferase 3 decreases response to substance ISO NMNAT3 protein results in decreased susceptibility to fenpyroximate CTD PMID:18463239 NCBI chr 3:139,560,180...139,678,050
Ensembl chr 3:139,560,180...139,678,017
JBrowse link
G NOS3 nitric oxide synthase 3 increases expression EXP fenpyroximate results in increased expression of NOS3 mRNA CTD PMID:34642769 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
JBrowse link
G NOTCH3 notch receptor 3 decreases expression EXP fenpyroximate results in decreased expression of NOTCH3 mRNA CTD PMID:33512557 NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression EXP fenpyroximate results in increased expression of NQO1 mRNA CTD PMID:33512557 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NR2F1 nuclear receptor subfamily 2 group F member 1 decreases expression EXP fenpyroximate results in decreased expression of NR2F1 mRNA CTD PMID:33512557 NCBI chr 5:93,583,222...93,594,611
Ensembl chr 5:93,583,222...93,594,611
JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 increases expression EXP fenpyroximate results in increased expression of NR3C1 mRNA CTD PMID:33512557 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
JBrowse link
G NR5A1 nuclear receptor subfamily 5 group A member 1 decreases expression EXP fenpyroximate results in decreased expression of NR5A1 mRNA CTD PMID:33512557 NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
JBrowse link
G NRCAM neuronal cell adhesion molecule decreases expression EXP fenpyroximate results in decreased expression of NRCAM mRNA CTD PMID:33512557 NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
JBrowse link
G NRXN1 neurexin 1 decreases expression EXP fenpyroximate results in decreased expression of NRXN1 mRNA CTD PMID:33512557 NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575
JBrowse link
G NTRK1 neurotrophic receptor tyrosine kinase 1 decreases expression EXP fenpyroximate results in decreased expression of NTRK1 mRNA CTD PMID:33512557 NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
JBrowse link
G OAZ1 ornithine decarboxylase antizyme 1 increases expression EXP fenpyroximate results in increased expression of OAZ1 mRNA CTD PMID:33512557 NCBI chr19:2,269,486...2,273,488
Ensembl chr19:2,269,509...2,273,490
JBrowse link
G OLFML2B olfactomedin like 2B decreases expression EXP fenpyroximate results in decreased expression of OLFML2B mRNA CTD PMID:33512557 NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869
JBrowse link
G OSTC oligosaccharyltransferase complex non-catalytic subunit increases expression EXP fenpyroximate results in increased expression of OSTC mRNA CTD PMID:33512557 NCBI chr 4:108,650,599...108,667,820
Ensembl chr 4:108,650,585...108,667,820
JBrowse link
G PAFAH1B3 platelet activating factor acetylhydrolase 1b catalytic subunit 3 decreases expression EXP fenpyroximate results in decreased expression of PAFAH1B3 mRNA CTD PMID:33512557 NCBI chr19:42,297,033...42,302,800
Ensembl chr19:42,297,033...42,303,546
JBrowse link
G PARK7 Parkinsonism associated deglycase decreases response to substance ISO PARK7 protein results in decreased susceptibility to fenpyroximate CTD PMID:21219333 NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
JBrowse link
G PARP2 poly(ADP-ribose) polymerase 2 increases expression EXP fenpyroximate results in increased expression of PARP2 mRNA CTD PMID:33512557 NCBI chr14:20,343,635...20,357,904
Ensembl chr14:20,343,615...20,357,904
JBrowse link
G PDIA6 protein disulfide isomerase family A member 6 increases expression EXP fenpyroximate results in increased expression of PDIA6 mRNA CTD PMID:33512557 NCBI chr 2:10,783,391...10,837,712
Ensembl chr 2:10,783,391...10,837,977
JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 decreases expression EXP fenpyroximate results in decreased expression of PEBP1 mRNA CTD PMID:33512557 NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
JBrowse link
G PEG10 paternally expressed 10 decreases expression EXP fenpyroximate results in decreased expression of PEG10 mRNA CTD PMID:33512557 NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
JBrowse link
G PFKP phosphofructokinase, platelet increases expression EXP fenpyroximate results in increased expression of PFKP mRNA CTD PMID:34642769 NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718
JBrowse link
G PGM3 phosphoglucomutase 3 increases expression EXP fenpyroximate results in increased expression of PGM3 mRNA CTD PMID:33512557 NCBI chr 6:83,148,705...83,193,900
Ensembl chr 6:83,147,324...83,193,936
JBrowse link
G PGR progesterone receptor multiple interactions EXP fenpyroximate inhibits the reaction [Promegestone results in increased activity of PGR protein] CTD PMID:30818834 NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G PHGDH phosphoglycerate dehydrogenase increases expression EXP fenpyroximate results in increased expression of PHGDH mRNA CTD PMID:33512557 NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218
JBrowse link
G PHLDA1 pleckstrin homology like domain family A member 1 decreases expression EXP fenpyroximate results in decreased expression of PHLDA1 mRNA CTD PMID:33512557 NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
JBrowse link
G PIK3C2B phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta decreases expression EXP fenpyroximate results in decreased expression of PIK3C2B mRNA CTD PMID:33512557 NCBI chr 1:204,422,633...204,494,805
Ensembl chr 1:204,422,628...204,494,805
JBrowse link
G PINK1 PTEN induced kinase 1 decreases expression EXP fenpyroximate results in decreased expression of PINK1 mRNA CTD PMID:33512557 NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
JBrowse link
G PIP4K2B phosphatidylinositol-5-phosphate 4-kinase type 2 beta decreases expression EXP fenpyroximate results in decreased expression of PIP4K2B mRNA CTD PMID:33512557 NCBI chr17:38,765,691...38,799,556
Ensembl chr17:38,765,691...38,800,126
JBrowse link
G PITPNA phosphatidylinositol transfer protein alpha decreases expression EXP fenpyroximate results in decreased expression of PITPNA mRNA CTD PMID:33512557 NCBI chr17:1,517,718...1,562,792
Ensembl chr17:1,517,718...1,562,792
JBrowse link
G PLIN2 perilipin 2 increases expression EXP fenpyroximate results in increased expression of PLIN2 mRNA CTD PMID:33512557 NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,290
JBrowse link
G POLE3 DNA polymerase epsilon 3, accessory subunit increases expression EXP fenpyroximate results in increased expression of POLE3 mRNA CTD PMID:33512557 NCBI chr 9:113,407,235...113,410,749
Ensembl chr 9:113,407,235...113,410,675
JBrowse link
G PPARGC1A PPARG coactivator 1 alpha multiple interactions EXP fenpyroximate inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein] CTD PMID:30818834 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
JBrowse link
G PPP2R1A protein phosphatase 2 scaffold subunit Aalpha decreases expression EXP fenpyroximate results in decreased expression of PPP2R1A mRNA CTD PMID:33512557 NCBI chr19:52,190,052...52,229,518
Ensembl chr19:52,170,936...52,229,518
JBrowse link
G PRKAG1 protein kinase AMP-activated non-catalytic subunit gamma 1 decreases expression EXP fenpyroximate results in decreased expression of PRKAG1 mRNA CTD PMID:33512557 NCBI chr12:49,002,274...49,018,776
Ensembl chr12:49,002,274...49,018,807
JBrowse link
G PRKAR1A protein kinase cAMP-dependent type I regulatory subunit alpha decreases expression EXP fenpyroximate results in decreased expression of PRKAR1A mRNA CTD PMID:33512557 NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
JBrowse link
G PRKN parkin RBR E3 ubiquitin protein ligase decreases expression EXP fenpyroximate results in decreased expression of PRKN mRNA CTD PMID:33512557 NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
JBrowse link
G PRR11 proline rich 11 increases expression EXP fenpyroximate results in increased expression of PRR11 mRNA CTD PMID:33512557 NCBI chr17:59,155,746...59,206,709
Ensembl chr17:59,155,732...59,206,709
JBrowse link
G PSAT1 phosphoserine aminotransferase 1 increases expression EXP fenpyroximate results in increased expression of PSAT1 mRNA CTD PMID:33512557 NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
JBrowse link
G PSMA1 proteasome 20S subunit alpha 1 increases expression EXP fenpyroximate results in increased expression of PSMA1 mRNA CTD PMID:33512557 NCBI chr11:14,504,876...14,643,662
Ensembl chr11:14,504,874...14,643,635
JBrowse link
G PTK2B protein tyrosine kinase 2 beta decreases expression EXP fenpyroximate results in decreased expression of PTK2B mRNA CTD PMID:33512557 NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
JBrowse link
G RIPK1 receptor interacting serine/threonine kinase 1 decreases expression EXP fenpyroximate results in decreased expression of RIPK1 mRNA CTD PMID:33512557 NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
JBrowse link
G RNF4 ring finger protein 4 increases expression EXP fenpyroximate results in increased expression of RNF4 mRNA CTD PMID:33512557 NCBI chr 4:2,469,106...2,515,857
Ensembl chr 4:2,462,220...2,515,857
JBrowse link
G RNPS1 RNA binding protein with serine rich domain 1 decreases expression EXP fenpyroximate results in decreased expression of RNPS1 mRNA CTD PMID:33512557 NCBI chr16:2,253,116...2,268,126
Ensembl chr16:2,253,116...2,268,397
JBrowse link
G RPA3 replication protein A3 increases expression EXP fenpyroximate results in increased expression of RPA3 mRNA CTD PMID:33512557 NCBI chr 7:7,636,518...7,718,607
Ensembl chr 7:7,636,518...7,718,607
JBrowse link
G RPL11 ribosomal protein L11 increases expression EXP fenpyroximate results in increased expression of RPL11 mRNA CTD PMID:33512557 NCBI chr 1:23,691,779...23,696,835
Ensembl chr 1:23,691,742...23,696,835
JBrowse link
G RPL17 ribosomal protein L17 increases expression EXP fenpyroximate results in increased expression of RPL17 mRNA CTD PMID:33512557 NCBI chr18:49,488,481...49,492,465
Ensembl chr18:49,488,453...49,492,508
JBrowse link
G RPL27 ribosomal protein L27 increases expression EXP fenpyroximate results in increased expression of RPL27 mRNA CTD PMID:33512557 NCBI chr17:42,998,273...43,002,959
Ensembl chr17:42,998,273...43,002,959
JBrowse link
G RPL28 ribosomal protein L28 increases expression EXP fenpyroximate results in increased expression of RPL28 mRNA CTD PMID:33512557 NCBI chr19:55,385,932...55,403,342
Ensembl chr19:55,385,932...55,403,250
JBrowse link
G RPL32 ribosomal protein L32 increases expression EXP fenpyroximate results in increased expression of RPL32 mRNA CTD PMID:33512557 NCBI chr 3:12,834,485...12,841,582
Ensembl chr 3:12,834,485...12,841,582
JBrowse link
G RPL36 ribosomal protein L36 increases expression EXP fenpyroximate results in increased expression of RPL36 mRNA CTD PMID:33512557 NCBI chr19:5,690,295...5,691,875
Ensembl chr19:5,674,947...5,691,875
JBrowse link
G RPL36AL ribosomal protein L36a like increases expression EXP fenpyroximate results in increased expression of RPL36AL mRNA CTD PMID:33512557 NCBI chr14:49,618,530...49,620,626
Ensembl chr14:49,618,530...49,620,626
JBrowse link
G RPL9 ribosomal protein L9 increases expression EXP fenpyroximate results in increased expression of RPL9 mRNA CTD PMID:33512557 NCBI chr 4:39,454,124...39,458,922
Ensembl chr 4:39,452,587...39,458,931
JBrowse link
G RPS13 ribosomal protein S13 increases expression EXP fenpyroximate results in increased expression of RPS13 mRNA CTD PMID:33512557 NCBI chr11:17,074,388...17,077,667
Ensembl chr11:17,074,388...17,077,715
JBrowse link
G RPS18 ribosomal protein S18 increases expression EXP fenpyroximate results in increased expression of RPS18 mRNA CTD PMID:33512557 NCBI chr 6:33,272,075...33,276,511
Ensembl chr 6:33,272,075...33,276,511
JBrowse link
G RPS2 ribosomal protein S2 increases expression EXP fenpyroximate results in increased expression of RPS2 mRNA CTD PMID:33512557 NCBI chr16:1,962,058...1,964,826
Ensembl chr16:1,962,058...1,964,841
JBrowse link
G RPS25 ribosomal protein S25 increases expression EXP fenpyroximate results in increased expression of RPS25 mRNA CTD PMID:33512557 NCBI chr11:119,015,717...119,018,343
Ensembl chr11:119,015,712...119,018,691
JBrowse link
G RPS27A ribosomal protein S27a increases expression EXP fenpyroximate results in increased expression of RPS27A mRNA CTD PMID:33512557 NCBI chr 2:55,231,903...55,235,853
Ensembl chr 2:55,231,903...55,235,853
JBrowse link
G RPS3 ribosomal protein S3 increases expression EXP fenpyroximate results in increased expression of RPS3 mRNA CTD PMID:33512557 NCBI chr11:75,399,518...75,422,302
Ensembl chr11:75,399,515...75,422,280
JBrowse link
G RPS5 ribosomal protein S5 increases expression EXP fenpyroximate results in increased expression of RPS5 mRNA CTD PMID:33512557 NCBI chr19:58,387,269...58,394,804
Ensembl chr19:58,386,400...58,394,806
JBrowse link
G RPS7 ribosomal protein S7 increases expression EXP fenpyroximate results in increased expression of RPS7 mRNA CTD PMID:33512557 NCBI chr 2:3,575,260...3,580,920
Ensembl chr 2:3,575,260...3,580,920
JBrowse link
G RSL24D1 ribosomal L24 domain containing 1 increases expression EXP fenpyroximate results in increased expression of RSL24D1 mRNA CTD PMID:33512557 NCBI chr15:55,180,806...55,196,941
Ensembl chr15:55,180,806...55,197,049
JBrowse link
G S100A13 S100 calcium binding protein A13 increases expression EXP fenpyroximate results in increased expression of S100A13 mRNA CTD PMID:33512557 NCBI chr 1:153,618,799...153,634,361
Ensembl chr 1:153,618,787...153,631,360
JBrowse link
G S100A4 S100 calcium binding protein A4 increases expression EXP fenpyroximate results in increased expression of S100A4 mRNA CTD PMID:33512557 NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
JBrowse link
G S100P S100 calcium binding protein P increases expression EXP fenpyroximate results in increased expression of S100P mRNA; fenpyroximate results in increased expression of S100P protein CTD PMID:32194361 NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
JBrowse link
G SATB1 SATB homeobox 1 decreases expression EXP fenpyroximate results in decreased expression of SATB1 mRNA CTD PMID:33512557 NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
JBrowse link
G SELENOS selenoprotein S increases expression EXP fenpyroximate results in increased expression of SELENOS mRNA CTD PMID:33512557 NCBI chr15:101,270,809...101,277,485
Ensembl chr15:101,270,817...101,277,500
JBrowse link
G SEMA4B semaphorin 4B decreases expression EXP fenpyroximate results in decreased expression of SEMA4B mRNA CTD PMID:33512557 NCBI chr15:90,184,920...90,229,661
Ensembl chr15:90,160,604...90,229,679
JBrowse link
G SEMA6D semaphorin 6D decreases expression EXP fenpyroximate results in decreased expression of SEMA6D mRNA CTD PMID:33512557 NCBI chr15:47,184,089...47,774,228
Ensembl chr15:47,184,101...47,774,228
JBrowse link
G SEPTIN10 septin 10 increases expression EXP fenpyroximate results in increased expression of SEPTIN10 mRNA CTD PMID:33512557 NCBI chr 2:109,542,799...109,613,966
Ensembl chr 2:109,542,799...109,614,143
JBrowse link
G SERTAD1 SERTA domain containing 1 increases expression EXP fenpyroximate results in increased expression of SERTAD1 mRNA CTD PMID:33512557 NCBI chr19:40,421,589...40,425,992
Ensembl chr19:40,421,589...40,425,992
JBrowse link
G SESN2 sestrin 2 increases expression EXP fenpyroximate results in increased expression of SESN2 mRNA CTD PMID:33512557 NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
JBrowse link
G SHCBP1 SHC binding and spindle associated 1 increases expression EXP fenpyroximate results in increased expression of SHCBP1 mRNA CTD PMID:33512557 NCBI chr16:46,578,591...46,621,379
Ensembl chr16:46,578,591...46,621,379
JBrowse link
G SLC17A6 solute carrier family 17 member 6 decreases expression EXP fenpyroximate results in decreased expression of SLC17A6 mRNA CTD PMID:33512557 NCBI chr11:22,338,381...22,379,503
Ensembl chr11:22,338,381...22,379,503
JBrowse link
G SLC35A5 solute carrier family 35 member A5 decreases expression EXP fenpyroximate results in decreased expression of SLC35A5 mRNA CTD PMID:33512557 NCBI chr 3:112,561,320...112,585,579
Ensembl chr 3:112,561,709...112,585,579
JBrowse link
G SLC38A1 solute carrier family 38 member 1 increases expression EXP fenpyroximate results in increased expression of SLC38A1 mRNA CTD PMID:33512557 NCBI chr12:46,183,063...46,269,043
Ensembl chr12:46,183,063...46,270,017
JBrowse link
G SLC3A2 solute carrier family 3 member 2 increases expression EXP fenpyroximate results in increased expression of SLC3A2 mRNA CTD PMID:33512557 NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
JBrowse link
G SLC7A5 solute carrier family 7 member 5 increases expression EXP fenpyroximate results in increased expression of SLC7A5 mRNA CTD PMID:33512557 NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
JBrowse link
G SMC3 structural maintenance of chromosomes 3 increases expression EXP fenpyroximate results in increased expression of SMC3 mRNA CTD PMID:33512557 NCBI chr10:110,567,695...110,606,048
Ensembl chr10:110,567,684...110,606,048
JBrowse link
G SMNDC1 survival motor neuron domain containing 1 decreases expression EXP fenpyroximate results in decreased expression of SMNDC1 mRNA CTD PMID:33512557 NCBI chr10:110,290,730...110,304,920
Ensembl chr10:110,290,730...110,304,938
JBrowse link
G SNAI2 snail family transcriptional repressor 2 increases expression EXP fenpyroximate results in increased expression of SNAI2 mRNA CTD PMID:33512557 NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
JBrowse link
G SNCA synuclein alpha increases response to substance EXP SNCA protein results in increased susceptibility to fenpyroximate CTD PMID:16239214 NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
JBrowse link
G SNHG8 small nucleolar RNA host gene 8 increases expression EXP fenpyroximate results in increased expression of SNHG8 mRNA CTD PMID:33512557 NCBI chr 4:118,278,762...118,279,823
Ensembl chr 4:118,278,703...118,285,316
JBrowse link
G SNRPD3 small nuclear ribonucleoprotein D3 polypeptide increases expression EXP fenpyroximate results in increased expression of SNRPD3 mRNA CTD PMID:33512557 NCBI chr22:24,555,650...24,574,971
Ensembl chr22:24,555,958...24,582,052
JBrowse link
G SOCS2 suppressor of cytokine signaling 2 decreases expression EXP fenpyroximate results in decreased expression of SOCS2 mRNA CTD PMID:33512557 NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
JBrowse link
G SPAG5 sperm associated antigen 5 increases expression EXP fenpyroximate results in increased expression of SPAG5 mRNA CTD PMID:33512557 NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
JBrowse link
G SPC25 SPC25 component of NDC80 kinetochore complex increases expression EXP fenpyroximate results in increased expression of SPC25 mRNA CTD PMID:33512557 NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371
JBrowse link
G SPDEF SAM pointed domain containing ETS transcription factor decreases expression EXP fenpyroximate results in decreased expression of SPDEF mRNA CTD PMID:33512557 NCBI chr 6:34,537,802...34,556,329
Ensembl chr 6:34,537,802...34,556,333
JBrowse link
G SRSF10 serine and arginine rich splicing factor 10 increases expression EXP fenpyroximate results in increased expression of SRSF10 mRNA CTD PMID:33512557 NCBI chr 1:23,964,347...23,980,327
Ensembl chr 1:23,964,347...23,980,927
JBrowse link
G STK25 serine/threonine kinase 25 decreases expression EXP fenpyroximate results in decreased expression of STK25 mRNA CTD PMID:33512557 NCBI chr 2:241,492,670...241,509,572
Ensembl chr 2:241,492,670...241,509,730
JBrowse link
G SYTL1 synaptotagmin like 1 increases expression EXP fenpyroximate results in increased expression of SYTL1 mRNA CTD PMID:33512557 NCBI chr 1:27,342,022...27,353,932
Ensembl chr 1:27,342,020...27,353,937
JBrowse link
G TACC3 transforming acidic coiled-coil containing protein 3 increases expression EXP fenpyroximate results in increased expression of TACC3 mRNA CTD PMID:33512557 NCBI chr 4:1,721,521...1,745,171
Ensembl chr 4:1,712,858...1,745,171
JBrowse link
G TCF4 transcription factor 4 decreases expression EXP fenpyroximate results in decreased expression of TCF4 mRNA CTD PMID:33512557 NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787
JBrowse link
G TERF2IP TERF2 interacting protein decreases expression EXP fenpyroximate results in decreased expression of TERF2IP mRNA CTD PMID:33512557 NCBI chr16:75,647,773...75,657,432
Ensembl chr16:75,647,773...75,761,872
JBrowse link
G TFDP1 transcription factor Dp-1 decreases expression EXP fenpyroximate results in decreased expression of TFDP1 mRNA CTD PMID:33512557 NCBI chr13:113,584,688...113,641,473
Ensembl chr13:113,584,721...113,641,473
JBrowse link
G TGFB3 transforming growth factor beta 3 decreases expression EXP fenpyroximate results in decreased expression of TGFB3 mRNA CTD PMID:33512557 NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
JBrowse link
G THRA thyroid hormone receptor alpha increases activity EXP fenpyroximate results in increased activity of THRA protein CTD PMID:20143881 NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
JBrowse link
G TLK2 tousled like kinase 2 decreases expression EXP fenpyroximate results in decreased expression of TLK2 mRNA CTD PMID:33512557 NCBI chr17:62,470,914...62,615,481
Ensembl chr17:62,458,658...62,615,481
JBrowse link
G TM9SF3 transmembrane 9 superfamily member 3 decreases expression EXP fenpyroximate results in decreased expression of TM9SF3 mRNA CTD PMID:33512557 NCBI chr10:96,518,110...96,587,012
Ensembl chr10:96,518,110...96,587,452
JBrowse link
G TMEM185A transmembrane protein 185A decreases expression EXP fenpyroximate results in decreased expression of TMEM185A mRNA CTD PMID:33512557 NCBI chr  X:149,596,556...149,631,792
Ensembl chr  X:149,596,556...149,631,912
JBrowse link
G TNC tenascin C decreases expression EXP fenpyroximate results in decreased expression of TNC mRNA CTD PMID:33512557 NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
JBrowse link
G TOP2A DNA topoisomerase II alpha increases expression EXP fenpyroximate results in increased expression of TOP2A mRNA CTD PMID:33512557 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
JBrowse link
G TP53 tumor protein p53 increases expression EXP fenpyroximate results in increased expression of TP53 mRNA CTD PMID:36933581 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TPX2 TPX2 microtubule nucleation factor increases expression EXP fenpyroximate results in increased expression of TPX2 mRNA CTD PMID:33512557 NCBI chr20:31,739,290...31,801,800
Ensembl chr20:31,739,271...31,801,805
JBrowse link
G TRIB3 tribbles pseudokinase 3 increases expression EXP fenpyroximate results in increased expression of TRIB3 mRNA CTD PMID:33512557 NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
JBrowse link
G TRIM13 tripartite motif containing 13 decreases expression EXP fenpyroximate results in decreased expression of TRIM13 mRNA CTD PMID:33512557 NCBI chr13:49,997,042...50,018,467
Ensembl chr13:49,995,888...50,020,481
JBrowse link
G TRPV1 transient receptor potential cation channel subfamily V member 1 decreases expression EXP fenpyroximate results in decreased expression of TRPV1 mRNA CTD PMID:33512557 NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411
JBrowse link
G TSC22D3 TSC22 domain family member 3 increases expression EXP fenpyroximate results in increased expression of TSC22D3 mRNA CTD PMID:33512557 NCBI chr  X:107,713,221...107,775,988
Ensembl chr  X:107,713,221...107,777,342
JBrowse link
G TSG101 tumor susceptibility 101 decreases expression EXP fenpyroximate results in decreased expression of TSG101 mRNA CTD PMID:33512557 NCBI chr11:18,480,311...18,526,942
Ensembl chr11:18,468,336...18,526,951
JBrowse link
G TSPAN3 tetraspanin 3 decreases expression EXP fenpyroximate results in decreased expression of TSPAN3 mRNA CTD PMID:33512557 NCBI chr15:77,041,404...77,071,109
Ensembl chr15:77,041,404...77,083,984
JBrowse link
G TST thiosulfate sulfurtransferase decreases expression EXP fenpyroximate results in decreased expression of TST mRNA CTD PMID:33512557 NCBI chr22:37,010,859...37,020,183
Ensembl chr22:37,010,859...37,020,183
JBrowse link
G TUBB2B tubulin beta 2B class IIb decreases expression EXP fenpyroximate results in decreased expression of TUBB2B mRNA CTD PMID:33512557 NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
JBrowse link
G TXNDC5 thioredoxin domain containing 5 increases expression EXP fenpyroximate results in increased expression of TXNDC5 mRNA CTD PMID:33512557 NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
JBrowse link
G TXNIP thioredoxin interacting protein decreases expression EXP fenpyroximate results in decreased expression of TXNIP mRNA CTD PMID:33512557 NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression EXP fenpyroximate results in increased expression of TXNRD1 mRNA CTD PMID:33512557 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
G UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 increases expression EXP fenpyroximate results in increased expression of UBA52 mRNA CTD PMID:33512557 NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
JBrowse link
G UBE2C ubiquitin conjugating enzyme E2 C increases expression EXP fenpyroximate results in increased expression of UBE2C mRNA CTD PMID:33512557 NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
JBrowse link
G UBE2Q2 ubiquitin conjugating enzyme E2 Q2 decreases expression EXP fenpyroximate results in decreased expression of UBE2Q2 mRNA CTD PMID:33512557 NCBI chr15:75,843,447...75,901,078
Ensembl chr15:75,843,307...75,901,078
JBrowse link
G UQCRQ ubiquinol-cytochrome c reductase complex III subunit VII increases expression EXP fenpyroximate results in increased expression of UQCRQ mRNA CTD PMID:33512557 NCBI chr 5:132,866,642...132,868,847
Ensembl chr 5:132,866,630...132,868,847
JBrowse link
G VAPB VAMP associated protein B and C decreases expression EXP fenpyroximate results in decreased expression of VAPB mRNA CTD PMID:34642769 NCBI chr20:58,389,229...58,451,101
Ensembl chr20:58,389,229...58,451,101
JBrowse link
G VEGFA vascular endothelial growth factor A increases expression EXP fenpyroximate results in increased expression of VEGFA mRNA CTD PMID:33512557 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VGLL4 vestigial like family member 4 decreases expression EXP fenpyroximate results in decreased expression of VGLL4 mRNA CTD PMID:33512557 NCBI chr 3:11,556,067...11,721,815
Ensembl chr 3:11,556,069...11,771,350
JBrowse link
G VPS72 vacuolar protein sorting 72 homolog decreases expression EXP fenpyroximate results in decreased expression of VPS72 mRNA CTD PMID:33512557 NCBI chr 1:151,176,304...151,190,197
Ensembl chr 1:151,176,304...151,195,321
JBrowse link
G WARS1 tryptophanyl-tRNA synthetase 1 increases expression EXP fenpyroximate results in increased expression of WARS1 mRNA CTD PMID:33512557 NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
JBrowse link
G XBP1 X-box binding protein 1 increases expression EXP fenpyroximate results in increased expression of XBP1 mRNA CTD PMID:33512557 NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
JBrowse link
G YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta decreases expression EXP fenpyroximate results in decreased expression of YWHAB mRNA CTD PMID:33512557 NCBI chr20:44,885,705...44,908,532
Ensembl chr20:44,885,702...44,908,532
JBrowse link
G ZBTB41 zinc finger and BTB domain containing 41 decreases expression EXP fenpyroximate results in decreased expression of ZBTB41 mRNA CTD PMID:33512557 NCBI chr 1:197,153,682...197,201,293
Ensembl chr 1:197,153,682...197,201,293
JBrowse link
G ZFAND2A zinc finger AN1-type containing 2A increases expression EXP fenpyroximate results in increased expression of ZFAND2A mRNA CTD PMID:33512557 NCBI chr 7:1,148,850...1,160,196
Ensembl chr 7:1,152,071...1,160,759
JBrowse link
G ZNG1E Zn regulated GTPase metalloprotein activator 1E decreases expression EXP fenpyroximate results in decreased expression of ZNG1E mRNA CTD PMID:33512557 NCBI chr 9:65,652,979...65,734,041
Ensembl chr 9:65,668,805...65,734,041
JBrowse link
G ZNG1F Zn regulated GTPase metalloprotein activator 1F decreases expression EXP fenpyroximate results in decreased expression of ZNG1F mRNA CTD PMID:33512557 NCBI chr 9:41,131,309...41,205,735
Ensembl chr 9:41,131,306...41,199,261
Ensembl chr 9:41,131,306...41,199,261
JBrowse link
G ZRANB2 zinc finger RANBP2-type containing 2 increases expression EXP fenpyroximate results in increased expression of ZRANB2 mRNA CTD PMID:33512557 NCBI chr 1:71,063,291...71,081,035
Ensembl chr 1:71,063,291...71,081,289
JBrowse link
isobutanol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACAT1 acetyl-CoA acetyltransferase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACAT1 mRNA CTD PMID:29432896 NCBI chr11:108,116,705...108,147,603
Ensembl chr11:108,116,695...108,147,603
JBrowse link
G ACSF2 acyl-CoA synthetase family member 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACSF2 mRNA CTD PMID:29432896 NCBI chr17:50,426,218...50,474,845
Ensembl chr17:50,426,158...50,474,845
JBrowse link
G ACSS2 acyl-CoA synthetase short chain family member 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSS2 mRNA CTD PMID:29432896 NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962
JBrowse link
G ADGRG1 adhesion G protein-coupled receptor G1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ADGRG1 mRNA CTD PMID:29432896 NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580
JBrowse link
G ADIRF adipogenesis regulatory factor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ADIRF mRNA CTD PMID:29432896 NCBI chr10:86,968,482...86,970,915
Ensembl chr10:86,968,432...86,983,934
JBrowse link
G ADORA2B adenosine A2b receptor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ADORA2B mRNA CTD PMID:29432896 NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746
JBrowse link
G AHNAK2 AHNAK nucleoprotein 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AHNAK2 mRNA CTD PMID:29432896 NCBI chr14:104,937,253...104,978,374
Ensembl chr14:104,937,244...104,978,374
JBrowse link
G AKAP12 A-kinase anchoring protein 12 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of AKAP12 mRNA CTD PMID:29432896 NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,967...151,358,559
JBrowse link
G ALDH1L2 aldehyde dehydrogenase 1 family member L2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ALDH1L2 mRNA CTD PMID:29432896 NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643
JBrowse link
G ALDH7A1 aldehyde dehydrogenase 7 family member A1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDH7A1 mRNA CTD PMID:29432896 NCBI chr 5:126,541,841...126,595,219
Ensembl chr 5:126,531,200...126,595,362
JBrowse link
G ALDH9A1 aldehyde dehydrogenase 9 family member A1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDH9A1 mRNA CTD PMID:29432896 NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562
JBrowse link
G ALDOC aldolase, fructose-bisphosphate C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDOC mRNA CTD PMID:29432896 NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
JBrowse link
G ANGPTL4 angiopoietin like 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ANGPTL4 mRNA CTD PMID:29432896 NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
JBrowse link
G ANXA11 annexin A11 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ANXA11 mRNA CTD PMID:29432896 NCBI chr10:80,150,889...80,205,808
Ensembl chr10:80,150,889...80,205,572
JBrowse link
G ANXA2 annexin A2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ANXA2 mRNA CTD PMID:29432896 NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
JBrowse link
G ANXA8 annexin A8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ANXA8 mRNA CTD PMID:29432896 NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
JBrowse link
G AOX1 aldehyde oxidase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AOX1 mRNA CTD PMID:29432896 NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064
JBrowse link
G AP1B1 adaptor related protein complex 1 subunit beta 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AP1B1 mRNA CTD PMID:29432896 NCBI chr22:29,327,680...29,388,570
Ensembl chr22:29,327,680...29,388,583
JBrowse link
G AP1S2 adaptor related protein complex 1 subunit sigma 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AP1S2 mRNA CTD PMID:29432896 NCBI chr  X:15,825,806...15,854,813
Ensembl chr  X:15,825,806...15,854,931
JBrowse link
G AP2S1 adaptor related protein complex 2 subunit sigma 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AP2S1 mRNA CTD PMID:29432896 NCBI chr19:46,838,167...46,850,846
Ensembl chr19:46,838,136...46,850,846
JBrowse link
G AP3D1 adaptor related protein complex 3 subunit delta 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of AP3D1 mRNA CTD PMID:29432896 NCBI chr19:2,100,988...2,164,616
Ensembl chr19:2,100,988...2,164,468
JBrowse link
G APBB3 amyloid beta precursor protein binding family B member 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of APBB3 mRNA CTD PMID:29432896 NCBI chr 5:140,558,268...140,564,598
Ensembl chr 5:140,558,268...140,564,781
JBrowse link
G ARAP3 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARAP3 mRNA CTD PMID:29432896 NCBI chr 5:141,653,402...141,682,230
Ensembl chr 5:141,653,401...141,682,230
JBrowse link
G ARHGEF16 Rho guanine nucleotide exchange factor 16 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ARHGEF16 mRNA CTD PMID:29432896 NCBI chr 1:3,454,665...3,481,113
Ensembl chr 1:3,454,665...3,481,113
JBrowse link
G ARID5B AT-rich interaction domain 5B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARID5B mRNA CTD PMID:29432896 NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
JBrowse link
G ARL4A ADP ribosylation factor like GTPase 4A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARL4A mRNA CTD PMID:29432896 NCBI chr 7:12,686,903...12,690,958
Ensembl chr 7:12,686,856...12,690,958
JBrowse link
G ARL5A ADP ribosylation factor like GTPase 5A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARL5A mRNA CTD PMID:29432896 NCBI chr 2:151,798,797...151,828,421
Ensembl chr 2:151,788,984...151,828,492
JBrowse link
G ATP5F1EP2 ATP synthase F1 subunit epsilon pseudogene 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATP5F1EP2 mRNA CTD PMID:29432896 NCBI chr13:27,945,206...27,945,573
Ensembl chr13:27,945,260...27,945,415
JBrowse link
G ATP5MG ATP synthase membrane subunit g multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATP5MG mRNA CTD PMID:29432896 NCBI chr11:118,401,606...118,409,847
Ensembl chr11:118,401,346...118,433,278
JBrowse link
G ATP5PF ATP synthase peripheral stalk subunit F6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATP5PF mRNA CTD PMID:29432896 NCBI chr21:25,724,500...25,735,653
Ensembl chr21:25,716,503...25,735,673
JBrowse link
G ATP6V0B ATPase H+ transporting V0 subunit b multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ATP6V0B mRNA CTD PMID:29432896 NCBI chr 1:43,974,960...43,978,295
Ensembl chr 1:43,974,487...43,978,295
JBrowse link
G ATP6V0E1 ATPase H+ transporting V0 subunit e1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATP6V0E1 mRNA CTD PMID:29432896 NCBI chr 5:172,983,771...173,035,445
Ensembl chr 5:172,983,771...173,035,445
JBrowse link
G ATP8B2 ATPase phospholipid transporting 8B2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATP8B2 mRNA CTD PMID:29432896 NCBI chr 1:154,325,525...154,351,304
Ensembl chr 1:154,325,525...154,351,304
JBrowse link
G ATP9A ATPase phospholipid transporting 9A (putative) multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ATP9A mRNA CTD PMID:29432896 NCBI chr20:51,596,514...51,768,390
Ensembl chr20:51,596,514...51,768,390
JBrowse link
G B4GALT5 beta-1,4-galactosyltransferase 5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of B4GALT5 mRNA CTD PMID:29432896 NCBI chr20:49,632,945...49,713,878
Ensembl chr20:49,632,945...49,713,878
JBrowse link
G BCAR3 BCAR3 adaptor protein, NSP family member multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BCAR3 mRNA CTD PMID:29432896 NCBI chr 1:93,561,741...93,848,151
Ensembl chr 1:93,561,741...93,847,150
JBrowse link
G BCKDK branched chain keto acid dehydrogenase kinase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BCKDK mRNA CTD PMID:29432896 NCBI chr16:31,108,386...31,117,640
Ensembl chr16:31,106,107...31,112,791
JBrowse link
G BEX1 brain expressed X-linked 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BEX1 mRNA CTD PMID:29432896 NCBI chr  X:103,062,651...103,064,171
Ensembl chr  X:103,062,651...103,064,171
JBrowse link
G BHLHE40 basic helix-loop-helix family member e40 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BHLHE40 mRNA CTD PMID:29432896 NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323
JBrowse link
G BIK BCL2 interacting killer multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of BIK mRNA CTD PMID:29432896 NCBI chr22:43,110,750...43,129,712
Ensembl chr22:43,110,750...43,129,712
JBrowse link
G BNIP3 BCL2 interacting protein 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BNIP3 mRNA CTD PMID:29432896 NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
JBrowse link
G C8orf88 chromosome 8 open reading frame 88 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of C8ORF88 mRNA CTD PMID:29432896 NCBI chr 8:90,958,471...90,985,393
Ensembl chr 8:90,958,471...90,985,238
JBrowse link
G CACYBP calcyclin binding protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CACYBP mRNA CTD PMID:29432896 NCBI chr 1:174,999,435...175,012,027
Ensembl chr 1:174,999,163...175,012,027
JBrowse link
G CARD10 caspase recruitment domain family member 10 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CARD10 mRNA CTD PMID:29432896 NCBI chr22:37,490,362...37,519,415
Ensembl chr22:37,490,362...37,519,542
JBrowse link
G CASP2 caspase 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CASP2 mRNA CTD PMID:29432896 NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
JBrowse link
G CAV2 caveolin 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CAV2 mRNA CTD PMID:29432896 NCBI chr 7:116,499,738...116,508,541
Ensembl chr 7:116,287,380...116,508,541
JBrowse link
G CCDC12 coiled-coil domain containing 12 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CCDC12 mRNA CTD PMID:29432896 NCBI chr 3:46,921,730...46,981,994
Ensembl chr 3:46,921,726...46,982,010
JBrowse link
G CCDC92 coiled-coil domain containing 92 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CCDC92 mRNA CTD PMID:29432896 NCBI chr12:123,935,626...123,972,831
Ensembl chr12:123,918,660...123,972,831
JBrowse link
G CCDC93 coiled-coil domain containing 93 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CCDC93 mRNA CTD PMID:29432896 NCBI chr 2:117,915,481...118,014,070
Ensembl chr 2:117,915,478...118,014,133
JBrowse link
G CCN2 cellular communication network factor 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CCN2 mRNA CTD PMID:29432896 NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
JBrowse link
G CCND2 cyclin D2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CCND2 mRNA CTD PMID:29432896 NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
JBrowse link
G CD24 CD24 molecule multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CD24 mRNA CTD PMID:29432896 NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
JBrowse link
G CD63 CD63 molecule multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CD63 mRNA CTD PMID:29432896 NCBI chr12:55,723,535...55,730,041
Ensembl chr12:55,725,323...55,729,707
JBrowse link
G CD99L2 CD99 molecule like 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CD99L2 mRNA CTD PMID:29432896 NCBI chr  X:150,766,336...150,898,668
Ensembl chr  X:150,766,336...150,898,816
JBrowse link
G CDC20 cell division cycle 20 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CDC20 mRNA CTD PMID:29432896 NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
JBrowse link
G CDH1 cadherin 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which affects the expression of CDH1 mRNA; [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CDH1 mRNA CTD PMID:29432896 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G CDH3 cadherin 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CDH3 mRNA CTD PMID:29432896 NCBI chr16:68,645,310...68,733,771
Ensembl chr16:68,636,189...68,727,468
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CDKN1A mRNA CTD PMID:29432896 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CENPA centromere protein A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CENPA mRNA CTD PMID:29432896 NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067
JBrowse link
G CENPF centromere protein F multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CENPF mRNA CTD PMID:29432896 NCBI chr 1:214,603,195...214,664,571
Ensembl chr 1:214,603,185...214,664,574
JBrowse link
G CEP192 centrosomal protein 192 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CEP192 mRNA CTD PMID:29432896 NCBI chr18:12,991,362...13,125,036
Ensembl chr18:12,991,362...13,125,052
JBrowse link
G CFAP251 cilia and flagella associated protein 251 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CFAP251 mRNA CTD PMID:29432896 NCBI chr12:121,918,592...122,003,919
Ensembl chr12:121,918,592...122,003,927
JBrowse link
G CHCHD2P6 coiled-coil-helix-coiled-coil-helix domain containing 2 pseudogene 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CHCHD2P6 mRNA CTD PMID:29432896 NCBI chr 1:15,604,528...15,605,314
Ensembl chr 1:15,604,597...15,605,043
JBrowse link
G CHD9 chromodomain helicase DNA binding protein 9 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CHD9 mRNA CTD PMID:29432896 NCBI chr16:53,054,991...53,327,497
Ensembl chr16:53,054,991...53,329,150
JBrowse link
G CHRNA2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions EXP isobutyl alcohol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]] CTD PMID:11821649 NCBI chr 8:27,459,756...27,479,261
Ensembl chr 8:27,459,756...27,479,883
JBrowse link
G CHRNB4 cholinergic receptor nicotinic beta 4 subunit multiple interactions EXP isobutyl alcohol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]] CTD PMID:11821649 NCBI chr15:78,624,111...78,661,641
Ensembl chr15:78,624,111...78,727,754
JBrowse link
G CHTOP chromatin target of PRMT1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CHTOP mRNA CTD PMID:29432896 NCBI chr 1:153,634,066...153,646,306
Ensembl chr 1:153,633,982...153,646,306
JBrowse link
G CITED4 Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CITED4 mRNA CTD PMID:29432896 NCBI chr 1:40,861,054...40,862,363
Ensembl chr 1:40,861,054...40,862,363
JBrowse link
G CKLF chemokine like factor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKLF mRNA CTD PMID:29432896 NCBI chr16:66,552,563...66,566,287
Ensembl chr16:66,552,563...66,566,251
JBrowse link
G CKS2 CDC28 protein kinase regulatory subunit 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKS2 mRNA CTD PMID:29432896 NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
JBrowse link
G CLCN6 chloride voltage-gated channel 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CLCN6 mRNA CTD PMID:29432896 NCBI chr 1:11,806,191...11,843,130
Ensembl chr 1:11,806,096...11,848,079
JBrowse link
G CLDN1 claudin 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CLDN1 mRNA CTD PMID:29432896 NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
JBrowse link
G CNN2 calponin 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CNN2 mRNA CTD PMID:29432896 NCBI chr19:1,026,608...1,039,065
Ensembl chr19:1,026,586...1,039,068
JBrowse link
G CNPY4 canopy FGF signaling regulator 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CNPY4 mRNA CTD PMID:29432896 NCBI chr 7:100,119,634...100,125,508
Ensembl chr 7:100,119,634...100,125,508
JBrowse link
G COA3 cytochrome c oxidase assembly factor 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CCDC56 mRNA CTD PMID:29432896 NCBI chr17:42,797,625...42,798,704
Ensembl chr17:42,795,147...42,798,704
JBrowse link
G COMMD1 copper metabolism domain containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COMMD1 mRNA CTD PMID:29432896 NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,247
JBrowse link
G COQ3 coenzyme Q3, methyltransferase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COQ3 mRNA CTD PMID:29432896 NCBI chr 6:99,369,401...99,394,195
Ensembl chr 6:99,369,401...99,394,195
JBrowse link
G COQ5 coenzyme Q5, methyltransferase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COQ5 mRNA CTD PMID:29432896 NCBI chr12:120,503,279...120,529,158
Ensembl chr12:120,503,279...120,534,434
JBrowse link
G COTL1 coactosin like F-actin binding protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COTL1 mRNA CTD PMID:29432896 NCBI chr16:84,565,596...84,618,078
Ensembl chr16:84,565,596...84,618,078
JBrowse link
G COX16 cytochrome c oxidase assembly factor COX16 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX16 mRNA CTD PMID:29432896 NCBI chr14:70,325,081...70,359,683
Ensembl chr14:70,325,081...70,416,984
JBrowse link
G COX7C cytochrome c oxidase subunit 7C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX7C mRNA CTD PMID:29432896 NCBI chr 5:86,617,941...86,620,962
Ensembl chr 5:86,617,928...86,620,962
JBrowse link
G CPA4 carboxypeptidase A4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPA4 mRNA CTD PMID:29432896 NCBI chr 7:130,293,161...130,324,180
Ensembl chr 7:130,293,134...130,324,180
JBrowse link
G CPD carboxypeptidase D multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPD mRNA CTD PMID:29432896 NCBI chr17:30,378,927...30,469,989
Ensembl chr17:30,378,927...30,469,989
JBrowse link
G CREB3L2 cAMP responsive element binding protein 3 like 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CREB3L2 mRNA CTD PMID:29432896 NCBI chr 7:137,874,979...138,002,086
Ensembl chr 7:137,874,979...138,002,086
JBrowse link
G CRIPT CXXC repeat containing interactor of PDZ3 domain multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CRIPT mRNA CTD PMID:29432896 NCBI chr 2:46,617,215...46,630,176
Ensembl chr 2:46,616,416...46,630,176
JBrowse link
G CRISPLD2 cysteine rich secretory protein LCCL domain containing 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CRISPLD2 mRNA CTD PMID:29432896 NCBI chr16:84,819,985...84,909,508
Ensembl chr16:84,819,985...84,920,768
JBrowse link
G CSK C-terminal Src kinase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CSK mRNA CTD PMID:29432896 NCBI chr15:74,782,080...74,803,197
Ensembl chr15:74,782,080...74,803,197
JBrowse link
G CSNK1E casein kinase 1 epsilon multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CSNK1E mRNA CTD PMID:29432896 NCBI chr22:38,290,691...38,318,084
Ensembl chr22:38,290,691...38,318,084
JBrowse link
G CUL1 cullin 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CUL1 mRNA CTD PMID:29432896 NCBI chr 7:148,697,756...148,801,110
Ensembl chr 7:148,697,914...148,801,110
JBrowse link
G CUTA cutA divalent cation tolerance homolog multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CUTA mRNA CTD PMID:29432896 NCBI chr 6:33,416,442...33,418,107
Ensembl chr 6:33,416,442...33,418,317
JBrowse link
G CWC15 CWC15 spliceosome associated protein homolog multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CWC15 mRNA CTD PMID:29432896 NCBI chr11:94,962,620...94,973,556
Ensembl chr11:94,962,620...94,973,586
JBrowse link
G CXXC5 CXXC finger protein 5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CXXC5 mRNA CTD PMID:29432896 NCBI chr 5:139,647,299...139,683,882
Ensembl chr 5:139,647,299...139,683,882
JBrowse link
G CYBA cytochrome b-245 alpha chain multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CYBA mRNA CTD PMID:29432896 NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
JBrowse link
G CYGB cytoglobin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CYGB mRNA CTD PMID:29432896 NCBI chr17:76,527,356...76,551,193
Ensembl chr17:76,527,356...76,551,175
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CYP1A1 mRNA CTD PMID:29432896 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP4X1 cytochrome P450 family 4 subfamily X member 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CYP4X1 mRNA CTD PMID:29432896 NCBI chr 1:46,961,364...47,055,432
Ensembl chr 1:47,023,669...47,050,751
JBrowse link
G CYSRT1 cysteine rich tail 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CYSRT1 mRNA CTD PMID:29432896 NCBI chr 9:137,225,174...137,226,315
Ensembl chr 9:137,225,174...137,226,315
JBrowse link
G DAPK3 death associated protein kinase 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DAPK3 mRNA CTD PMID:29432896 NCBI chr19:3,958,453...3,971,099
Ensembl chr19:3,958,453...3,971,123
JBrowse link
G DBI diazepam binding inhibitor, acyl-CoA binding protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DBI mRNA CTD PMID:29432896 NCBI chr 2:119,366,977...119,372,543
Ensembl chr 2:119,366,924...119,372,550
JBrowse link
G DBT dihydrolipoamide branched chain transacylase E2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DBT mRNA CTD PMID:29432896 NCBI chr 1:100,186,919...100,249,834
Ensembl chr 1:100,186,919...100,249,834
JBrowse link
G DCAF15 DDB1 and CUL4 associated factor 15 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DCAF15 mRNA CTD PMID:29432896 NCBI chr19:13,952,509...13,961,449
Ensembl chr19:13,952,509...13,961,449
JBrowse link
G DCBLD2 discoidin, CUB and LCCL domain containing 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DCBLD2 mRNA CTD PMID:29432896 NCBI chr 3:98,795,941...98,901,695
Ensembl chr 3:98,795,941...98,901,695
JBrowse link
G DCP2 decapping mRNA 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DCP2 mRNA CTD PMID:29432896 NCBI chr 5:112,976,798...113,022,195
Ensembl chr 5:112,976,702...113,022,195
JBrowse link
G DCTN5 dynactin subunit 5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DCTN5 mRNA CTD PMID:29432896 NCBI chr16:23,641,466...23,677,472
Ensembl chr16:23,641,466...23,677,472
JBrowse link
G DDIT4 DNA damage inducible transcript 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DDIT4 mRNA CTD PMID:29432896 NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DDR1 mRNA CTD PMID:29432896 NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
JBrowse link
G DECR2 2,4-dienoyl-CoA reductase 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DECR2 mRNA CTD PMID:29432896 NCBI chr16:401,885...412,482
Ensembl chr16:401,858...412,487
JBrowse link
G DENND1A DENN domain containing 1A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DENND1A mRNA CTD PMID:29432896 NCBI chr 9:123,379,658...123,930,126
Ensembl chr 9:123,379,654...123,930,152
JBrowse link
G DKK1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DKK1 mRNA CTD PMID:29432896 NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
JBrowse link
G DLEU1 deleted in lymphocytic leukemia 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DLEU1 mRNA CTD PMID:29432896 NCBI chr13:50,082,169...50,528,643
Ensembl chr13:50,082,169...50,906,856
JBrowse link
G DNAAF10 dynein axonemal assembly factor 10 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DNAAF10 mRNA CTD PMID:29432896 NCBI chr 2:68,129,805...68,157,527
Ensembl chr 2:68,122,936...68,157,549
JBrowse link
G DNAJA1 DnaJ heat shock protein family (Hsp40) member A1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DNAJA1 mRNA CTD PMID:29432896 NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
JBrowse link
G DNAJB6 DnaJ heat shock protein family (Hsp40) member B6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DNAJB6 mRNA CTD PMID:29432896 NCBI chr 7:157,337,004...157,417,439
Ensembl chr 7:157,335,381...157,417,439
JBrowse link
G DNASE1L1 deoxyribonuclease 1 like 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DNASE1L1 mRNA CTD PMID:29432896 NCBI chr  X:154,401,236...154,412,101
Ensembl chr  X:154,401,236...154,412,112
JBrowse link
G EBP EBP cholestenol delta-isomerase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of EBP mRNA CTD PMID:29432896 NCBI chr  X:48,521,808...48,528,716
Ensembl chr  X:48,521,799...48,528,716
JBrowse link
G EEF1D eukaryotic translation elongation factor 1 delta multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EEF1D mRNA CTD PMID:29432896 NCBI chr 8:143,579,728...143,597,415
Ensembl chr 8:143,579,697...143,599,541
JBrowse link
G EFNB1 ephrin B1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EFNB1 mRNA CTD PMID:29432896 NCBI chr  X:68,829,021...68,842,160
Ensembl chr  X:68,829,021...68,842,160
JBrowse link
G EFNB2 ephrin B2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of EFNB2 mRNA CTD PMID:29432896 NCBI chr13:106,489,745...106,535,662
Ensembl chr13:106,489,745...106,535,662
JBrowse link
G EGR1 early growth response 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EGR1 mRNA CTD PMID:29432896 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G ELOVL6 ELOVL fatty acid elongase 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELOVL6 mRNA CTD PMID:29432896 NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199
JBrowse link
G ELP6 elongator acetyltransferase complex subunit 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELP6 mRNA CTD PMID:29432896 NCBI chr 3:47,495,640...47,513,712
Ensembl chr 3:47,495,640...47,513,712
JBrowse link
G ERH ERH mRNA splicing and mitosis factor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ERH mRNA CTD PMID:29432896 NCBI chr14:69,380,128...69,398,299
Ensembl chr14:69,380,128...69,398,299
JBrowse link
G EXOC2 exocyst complex component 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of EXOC2 mRNA CTD PMID:29432896 NCBI chr 6:485,154...693,139
Ensembl chr 6:485,154...693,139
JBrowse link
G EXOSC2 exosome component 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of EXOSC2 mRNA CTD PMID:29432896 NCBI chr 9:130,693,760...130,704,894
Ensembl chr 9:130,693,721...130,707,288
JBrowse link
G EZR ezrin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of EZR mRNA CTD PMID:29432896 NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
JBrowse link
G F2RL1 F2R like trypsin receptor 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of F2RL1 mRNA CTD PMID:29432896 NCBI chr 5:76,819,030...76,835,315
Ensembl chr 5:76,818,933...76,835,315
JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of F3 mRNA CTD PMID:29432896 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
JBrowse link
G FAM217B family with sequence similarity 217 member B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FAM217B mRNA CTD PMID:29432896 NCBI chr20:59,933,779...59,948,680
Ensembl chr20:59,933,764...59,948,680
JBrowse link
G FAM98A family with sequence similarity 98 member A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FAM98A mRNA CTD PMID:29432896 NCBI chr 2:33,583,660...33,599,299
Ensembl chr 2:33,532,744...33,599,347
JBrowse link
G FANCE FA complementation group E multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FANCE mRNA CTD PMID:29432896 NCBI chr 6:35,452,338...35,467,102
Ensembl chr 6:35,452,338...35,467,104
JBrowse link
G FANCL FA complementation group L multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FANCL mRNA CTD PMID:29432896 NCBI chr 2:58,159,243...58,241,380
Ensembl chr 2:58,159,243...58,241,410
JBrowse link
G FBXO2 F-box protein 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXO2 mRNA CTD PMID:29432896 NCBI chr 1:11,648,387...11,654,429
Ensembl chr 1:11,637,018...11,655,785
JBrowse link
G FBXW5 F-box and WD repeat domain containing 5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXW5 mRNA CTD PMID:29432896 NCBI chr 9:136,940,435...136,944,738
Ensembl chr 9:136,940,435...136,944,738
JBrowse link
G FEZ1 fasciculation and elongation protein zeta 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FEZ1 mRNA CTD PMID:29432896 NCBI chr11:125,442,881...125,496,265
Ensembl chr11:125,442,881...125,592,568
JBrowse link
G FGFR3 fibroblast growth factor receptor 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FGFR3 mRNA CTD PMID:29432896 NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
JBrowse link
G FGL1 fibrinogen like 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FGL1 mRNA CTD PMID:29432896 NCBI chr 8:17,864,389...17,895,538
Ensembl chr 8:17,864,380...17,910,365
JBrowse link
G FNBP1 formin binding protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FNBP1 mRNA CTD PMID:29432896 NCBI chr 9:129,887,187...130,053,879
Ensembl chr 9:129,887,187...130,043,189
JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FOS mRNA CTD PMID:29432896 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
JBrowse link
G FOSL1 FOS like 1, AP-1 transcription factor subunit multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FOSL1 mRNA CTD PMID:29432896 NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
JBrowse link
G FOXJ2 forkhead box J2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FOXJ2 mRNA CTD PMID:29432896 NCBI chr12:8,032,716...8,055,517
Ensembl chr12:8,032,716...8,055,517
JBrowse link
G FOXO3 forkhead box O3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FOXO3 mRNA CTD PMID:29432896 NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
JBrowse link
G FST follistatin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FST mRNA CTD PMID:29432896 NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,626...53,487,134
JBrowse link
G FTSJ1 FtsJ RNA 2'-O-methyltransferase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FTSJ1 mRNA CTD PMID:29432896 NCBI chr  X:48,476,021...48,486,364
Ensembl chr  X:48,476,021...48,486,364
JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GADD45A mRNA CTD PMID:29432896 NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
JBrowse link
G GALNT11 polypeptide N-acetylgalactosaminyltransferase 11 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GALNT11 mRNA CTD PMID:29432896 NCBI chr 7:152,025,674...152,122,340
Ensembl chr 7:152,025,674...152,122,340
JBrowse link
G GBP1 guanylate binding protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GBP1 mRNA CTD PMID:29432896 NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
JBrowse link
G GJB2 gap junction protein beta 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GJB2 mRNA CTD PMID:29432896 NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
JBrowse link
G GLDC glycine decarboxylase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GLDC mRNA CTD PMID:29432896 NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
JBrowse link
G GLIPR2 GLI pathogenesis related 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLIPR2 mRNA CTD PMID:29432896 NCBI chr 9:36,136,536...36,163,913
Ensembl chr 9:36,136,536...36,163,913
JBrowse link
G GLIS3 GLIS family zinc finger 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLIS3 mRNA CTD PMID:29432896 NCBI chr 9:3,824,127...4,490,465
Ensembl chr 9:3,824,127...4,348,392
JBrowse link
G GLMP glycosylated lysosomal membrane protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLMP mRNA CTD PMID:29432896 NCBI chr 1:156,292,688...156,295,679
Ensembl chr 1:156,290,089...156,295,689
JBrowse link
G GLRX glutaredoxin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLRX mRNA CTD PMID:29432896 NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
JBrowse link
G GNG10 G protein subunit gamma 10 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GNG10 mRNA CTD PMID:29432896 NCBI chr 9:111,661,605...111,670,226
Ensembl chr 9:111,661,605...111,670,226
JBrowse link
G GPC1 glypican 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPC1 mRNA CTD PMID:29432896 NCBI chr 2:240,435,663...240,468,076
Ensembl chr 2:240,435,663...240,468,076
JBrowse link
G GPD1L glycerol-3-phosphate dehydrogenase 1 like multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GPD1L mRNA CTD PMID:29432896 NCBI chr 3:32,106,620...32,168,709
Ensembl chr 3:32,105,689...32,168,709
JBrowse link
G GPR137 G protein-coupled receptor 137 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GPR137 mRNA CTD PMID:29432896 NCBI chr11:64,270,531...64,289,500
Ensembl chr11:64,270,062...64,289,494
JBrowse link
G GRPEL1 GrpE like 1, mitochondrial multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GRPEL1 mRNA CTD PMID:29432896 NCBI chr 4:7,058,895...7,068,064
Ensembl chr 4:7,058,671...7,068,085
JBrowse link
G GTF2B general transcription factor IIB multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GTF2B mRNA CTD PMID:29432896 NCBI chr 1:88,852,633...88,891,567
Ensembl chr 1:88,852,633...88,891,944
JBrowse link
G GTF2F1 general transcription factor IIF subunit 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GTF2F1 mRNA CTD PMID:29432896 NCBI chr19:6,379,572...6,393,164
Ensembl chr19:6,379,572...6,393,981
JBrowse link
G GTPBP4 GTP binding protein 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GTPBP4 mRNA CTD PMID:29432896 NCBI chr10:988,434...1,019,932
Ensembl chr10:988,434...1,019,932
JBrowse link
G GYPC glycophorin C (Gerbich blood group) multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GYPC mRNA CTD PMID:29432896 NCBI chr 2:126,656,158...126,696,667
Ensembl chr 2:126,656,133...126,696,667
JBrowse link
G H3P16 H3 histone pseudogene 16 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of H3P16 mRNA CTD PMID:29432896 NCBI chr 4:139,697,626...139,698,635
Ensembl chr 4:139,698,144...139,698,554
JBrowse link
G HIRIP3 HIRA interacting protein 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HIRIP3 mRNA CTD PMID:29432896 NCBI chr16:29,992,321...29,996,096
Ensembl chr16:29,992,330...29,996,074
JBrowse link
G HMGB1P10 high mobility group box 1 pseudogene 10 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HMGB1P10 mRNA CTD PMID:29432896 NCBI chr22:26,560,428...26,561,616
Ensembl chr22:26,560,526...26,561,088
JBrowse link
G HMGB3 high mobility group box 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HMGB3 mRNA CTD PMID:29432896 NCBI chr  X:150,980,507...150,990,771
Ensembl chr  X:150,980,509...150,990,771
JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HMGCR mRNA CTD PMID:29432896 NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HMGCS1 mRNA CTD PMID:29432896 NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
JBrowse link
G HNRNPA3 heterogeneous nuclear ribonucleoprotein A3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of HNRNPA3 mRNA CTD PMID:29432896 NCBI chr 2:177,212,794...177,223,959
Ensembl chr 2:177,212,694...177,223,959
JBrowse link
G HNRNPK heterogeneous nuclear ribonucleoprotein K multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HNRNPK mRNA CTD PMID:29432896 NCBI chr 9:83,968,083...83,980,615
Ensembl chr 9:83,968,083...83,980,631
JBrowse link
G HOXB2 homeobox B2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HOXB2 mRNA CTD PMID:29432896 NCBI chr17:48,542,655...48,545,109
Ensembl chr17:48,540,894...48,545,109
JBrowse link
G HPS6 HPS6 biogenesis of lysosomal organelles complex 2 subunit 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HPS6 mRNA CTD PMID:29432896 NCBI chr10:102,065,349...102,068,036
Ensembl chr10:102,065,349...102,068,036
JBrowse link
G HSD17B8 hydroxysteroid 17-beta dehydrogenase 8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HSD17B8 mRNA CTD PMID:29432896 NCBI chr 6:33,204,655...33,206,831
Ensembl chr 6:33,204,655...33,206,831
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HSPA8 mRNA CTD PMID:29432896 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G HSPB1 heat shock protein family B (small) member 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of HSPB1 mRNA CTD PMID:29432896 NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
JBrowse link
G IL1B interleukin 1 beta multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IL1B mRNA CTD PMID:29432896 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL24 interleukin 24 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IL24 mRNA CTD PMID:29432896 NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
JBrowse link
G INO80C INO80 complex subunit C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of INO80C mRNA CTD PMID:29432896 NCBI chr18:35,468,333...35,497,960
Ensembl chr18:35,452,230...35,497,979
JBrowse link
G INSIG1 insulin induced gene 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of INSIG1 mRNA CTD PMID:29432896 NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
JBrowse link
G ITGB4 integrin subunit beta 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ITGB4 mRNA CTD PMID:29432896 NCBI chr17:75,721,459...75,757,818
Ensembl chr17:75,721,328...75,757,818
JBrowse link
G ITGB5 integrin subunit beta 5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ITGB5 mRNA CTD PMID:29432896 NCBI chr 3:124,761,948...124,901,418
Ensembl chr 3:124,761,948...124,901,418
JBrowse link
G JAG2 jagged canonical Notch ligand 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of JAG2 mRNA CTD PMID:29432896 NCBI chr14:105,140,995...105,168,776
Ensembl chr14:105,140,982...105,168,824
JBrowse link
G JMJD8 jumonji domain containing 8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of JMJD8 mRNA CTD PMID:29432896 NCBI chr16:681,670...684,334
Ensembl chr16:681,670...684,528
JBrowse link
G JUP junction plakoglobin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of JUP mRNA CTD PMID:29432896 NCBI chr17:41,754,609...41,786,711
Ensembl chr17:41,754,604...41,786,931
JBrowse link
G KAT8 lysine acetyltransferase 8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KAT8 mRNA CTD PMID:29432896 NCBI chr16:31,117,664...31,131,393
Ensembl chr16:31,114,489...31,131,393
JBrowse link
G KLF6 KLF transcription factor 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KLF6 mRNA CTD PMID:29432896 NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
JBrowse link
G KNTC1 kinetochore associated 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KNTC1 mRNA CTD PMID:29432896 NCBI chr12:122,527,249...122,626,396
Ensembl chr12:122,527,246...122,626,396
JBrowse link
G KRBA1 KRAB-A domain containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KRBA1 mRNA CTD PMID:29432896 NCBI chr 7:149,714,951...149,734,575
Ensembl chr 7:149,714,781...149,734,575
JBrowse link
G KRT16 keratin 16 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT16 mRNA CTD PMID:29432896 NCBI chr17:41,609,778...41,612,767
Ensembl chr17:41,609,778...41,615,899
JBrowse link
G KRT17P3 keratin 17 pseudogene 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT17P3 mRNA CTD PMID:29432896 NCBI chr17:30,567,760...30,571,815
Ensembl chr17:30,567,700...30,571,748
JBrowse link
G KRT18P31 keratin 18 pseudogene 31 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KRT18P31 mRNA CTD PMID:29432896 NCBI chr 5:36,885,159...36,886,560
Ensembl chr 5:36,885,206...36,886,497
JBrowse link
G KRT5 keratin 5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT5 mRNA CTD PMID:29432896 NCBI chr12:52,514,575...52,520,394
Ensembl chr12:52,514,575...52,520,530
JBrowse link
G KRT6B keratin 6B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT6B mRNA CTD PMID:29432896 NCBI chr12:52,446,651...52,452,146
Ensembl chr12:52,446,651...52,452,146
JBrowse link
G KRT6C keratin 6C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT6C mRNA CTD PMID:29432896 NCBI chr12:52,468,516...52,473,805
Ensembl chr12:52,468,516...52,473,805
JBrowse link
G KRTCAP2 keratinocyte associated protein 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KRTCAP2 mRNA CTD PMID:29432896 NCBI chr 1:155,169,408...155,173,304
Ensembl chr 1:155,169,408...155,173,475
JBrowse link
G LAMTOR4 late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LAMTOR4 mRNA CTD PMID:29432896 NCBI chr 7:100,148,918...100,154,203
Ensembl chr 7:100,148,912...100,155,944
JBrowse link
G LBH LBH regulator of WNT signaling pathway multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LBH mRNA CTD PMID:29432896 NCBI chr 2:30,231,534...30,260,028
Ensembl chr 2:30,231,534...30,323,730
JBrowse link
G LDLR low density lipoprotein receptor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LDLR mRNA CTD PMID:29432896 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
JBrowse link
G LGALS1 galectin 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LGALS1 mRNA CTD PMID:29432896 NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802
JBrowse link
G LIMA1 LIM domain and actin binding 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of LIMA1 mRNA CTD PMID:29432896 NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520
JBrowse link
G LITAF lipopolysaccharide induced TNF factor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of LITAF mRNA CTD PMID:29432896 NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
JBrowse link
G LIX1L limb and CNS expressed 1 like multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LIX1L mRNA CTD PMID:29432896 NCBI chr 1:145,933,423...145,958,017
Ensembl chr 1:145,933,423...145,958,017
JBrowse link
G LMOD3 leiomodin 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LMOD3 mRNA CTD PMID:29432896 NCBI chr 3:69,106,065...69,122,595
Ensembl chr 3:69,106,065...69,123,032
JBrowse link
G LPIN1 lipin 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA CTD PMID:29432896 NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409
JBrowse link
G LRRC20 leucine rich repeat containing 20 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LRRC20 mRNA CTD PMID:29432896 NCBI chr10:70,298,975...70,382,625
Ensembl chr10:70,298,970...70,382,650
JBrowse link
G LUZP1 leucine zipper protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LUZP1 mRNA CTD PMID:29432896 NCBI chr 1:23,083,642...23,178,122
Ensembl chr 1:23,084,030...23,177,808
JBrowse link
G LYRM2 LYR motif containing 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LYRM2 mRNA CTD PMID:29432896 NCBI chr 6:89,632,224...89,638,747
Ensembl chr 6:89,568,144...89,638,749
JBrowse link
G MANF mesencephalic astrocyte derived neurotrophic factor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MANF mRNA CTD PMID:29432896 NCBI chr 3:51,385,291...51,389,397
Ensembl chr 3:51,385,291...51,389,397
JBrowse link
G MAP7D1 MAP7 domain containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MAP7D1 mRNA CTD PMID:29432896 NCBI chr 1:36,156,160...36,180,849
Ensembl chr 1:36,155,579...36,180,849
JBrowse link
G MAT2B methionine adenosyltransferase 2 non-catalytic beta subunit multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MAT2B mRNA CTD PMID:29432896 NCBI chr 5:163,503,064...163,519,354
Ensembl chr 5:163,503,114...163,519,558
JBrowse link
G MBTPS1 membrane bound transcription factor peptidase, site 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MBTPS1 mRNA CTD PMID:29432896 NCBI chr16:84,053,763...84,116,942
Ensembl chr16:84,053,761...84,116,942
JBrowse link
G MCM7 minichromosome maintenance complex component 7 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MCM7 mRNA CTD PMID:29432896 NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940
JBrowse link
G MED7 mediator complex subunit 7 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MED7 mRNA CTD PMID:29432896 NCBI chr 5:157,137,424...157,142,865
Ensembl chr 5:157,137,424...157,159,019
JBrowse link
G MFSD3 major facilitator superfamily domain containing 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MFSD3 mRNA CTD PMID:29432896 NCBI chr 8:144,509,070...144,511,213
Ensembl chr 8:144,509,070...144,511,213
JBrowse link
G MGARP mitochondria localized glutamic acid rich protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MGARP mRNA CTD PMID:29432896 NCBI chr 4:139,266,165...139,280,225
Ensembl chr 4:139,266,165...139,280,225
JBrowse link
G MGAT2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MGAT2 mRNA CTD PMID:29432896 NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481
JBrowse link
G MLKL mixed lineage kinase domain like pseudokinase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MLKL mRNA CTD PMID:29432896 NCBI chr16:74,671,855...74,700,862
Ensembl chr16:74,671,855...74,700,960
JBrowse link
G MMACHC metabolism of cobalamin associated C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MMACHC mRNA CTD PMID:29432896 NCBI chr 1:45,500,300...45,513,382
Ensembl chr 1:45,500,300...45,513,382
JBrowse link
G MMS19 MMS19 homolog, cytosolic iron-sulfur assembly component multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MMS19 mRNA CTD PMID:29432896 NCBI chr10:97,458,324...97,498,794
Ensembl chr10:97,458,324...97,498,794
JBrowse link
G MPDZ multiple PDZ domain crumbs cell polarity complex component multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MPDZ mRNA CTD PMID:29432896 NCBI chr 9:13,105,707...13,279,692
Ensembl chr 9:13,105,706...13,279,692
JBrowse link
G MPZL2 myelin protein zero like 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MPZL2 mRNA CTD PMID:29432896 NCBI chr11:118,253,416...118,264,297
Ensembl chr11:118,253,416...118,264,536
JBrowse link
G MRPL32 mitochondrial ribosomal protein L32 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPL32 mRNA CTD PMID:29432896 NCBI chr 7:42,932,376...42,937,857
Ensembl chr 7:42,932,376...42,948,958
JBrowse link
G MRPL35 mitochondrial ribosomal protein L35 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPL35 mRNA CTD PMID:29432896 NCBI chr 2:86,199,433...86,213,794
Ensembl chr 2:86,199,355...86,213,790
JBrowse link
G MRPS18C mitochondrial ribosomal protein S18C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPS18C mRNA CTD PMID:29432896 NCBI chr 4:83,456,058...83,462,298
Ensembl chr 4:83,455,932...83,469,735
JBrowse link
G MRPS21 mitochondrial ribosomal protein S21 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPS21 mRNA CTD PMID:29432896 NCBI chr 1:150,293,861...150,308,979
Ensembl chr 1:150,293,861...150,308,979
JBrowse link
G MSH3 mutS homolog 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MSH3 mRNA CTD PMID:29432896 NCBI chr 5:80,654,652...80,876,815
Ensembl chr 5:80,654,652...80,876,815
JBrowse link
G MT1X metallothionein 1X multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MT1X mRNA CTD PMID:29432896 NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
JBrowse link
G MT2A metallothionein 2A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MT2A mRNA CTD PMID:29432896 NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
JBrowse link
G MTFR2 mitochondrial fission regulator 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MTFR2 mRNA CTD PMID:29432896 NCBI chr 6:136,231,034...136,250,311
Ensembl chr 6:136,231,024...136,250,335
JBrowse link
G MTIF3 mitochondrial translational initiation factor 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MTIF3 mRNA CTD PMID:29432896 NCBI chr13:27,435,643...27,450,564
Ensembl chr13:27,435,643...27,450,591
JBrowse link
G MTURN maturin, neural progenitor differentiation regulator homolog multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MTURN mRNA CTD PMID:29432896 NCBI chr 7:30,134,986...30,162,762
Ensembl chr 7:30,134,986...30,162,762
JBrowse link
G MVD mevalonate diphosphate decarboxylase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MVD mRNA CTD PMID:29432896 NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161
JBrowse link
G MYADM myeloid associated differentiation marker multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MYADM mRNA CTD PMID:29432896 NCBI chr19:53,865,628...53,876,435
Ensembl chr19:53,864,763...53,876,435
JBrowse link
G MYH9 myosin heavy chain 9 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MYH9 mRNA CTD PMID:29432896 NCBI chr22:36,281,280...36,387,967
Ensembl chr22:36,281,280...36,388,010
JBrowse link
G MYL6 myosin light chain 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MYL6 mRNA CTD PMID:29432896 NCBI chr12:56,158,359...56,161,579
Ensembl chr12:56,158,346...56,163,496
JBrowse link
G MYL6B myosin light chain 6B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MYL6B mRNA CTD PMID:29432896 NCBI chr12:56,152,587...56,157,982
Ensembl chr12:56,152,256...56,159,647
JBrowse link
G MYL9 myosin light chain 9 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MYL9 mRNA CTD PMID:29432896 NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
JBrowse link
G MYO1B myosin IB multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MYO1B mRNA CTD PMID:29432896 NCBI chr 2:191,245,404...191,425,386
Ensembl chr 2:191,245,185...191,425,389
JBrowse link
G MZF1 myeloid zinc finger 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MZF1 mRNA CTD PMID:29432896 NCBI chr19:58,561,932...58,573,573
Ensembl chr19:58,561,931...58,573,575
JBrowse link
G MZT2A mitotic spindle organizing protein 2A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MZT2A mRNA CTD PMID:29432896 NCBI chr 2:131,469,728...131,493,754
Ensembl chr 2:131,464,900...131,492,743
JBrowse link
G NASP nuclear autoantigenic sperm protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NASP mRNA CTD PMID:29432896 NCBI chr 1:45,584,041...45,618,893
Ensembl chr 1:45,583,846...45,618,904
JBrowse link
G NAV2 neuron navigator 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NAV2 mRNA CTD PMID:29432896 NCBI chr11:19,345,236...20,121,601
Ensembl chr11:19,350,724...20,121,601
JBrowse link
G NCAPD2 non-SMC condensin I complex subunit D2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NCAPD2 mRNA CTD PMID:29432896 NCBI chr12:6,494,102...6,531,955
Ensembl chr12:6,493,356...6,531,955
JBrowse link
G NDRG1 N-myc downstream regulated 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of NDRG1 mRNA CTD PMID:29432896 NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
JBrowse link
G NDUFA12 NADH:ubiquinone oxidoreductase subunit A12 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFA12 mRNA CTD PMID:29432896 NCBI chr12:94,971,333...95,003,697
Ensembl chr12:94,895,297...95,003,748
JBrowse link
G NDUFB3 NADH:ubiquinone oxidoreductase subunit B3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB3 mRNA CTD PMID:29432896 NCBI chr 2:201,072,001...201,085,750
Ensembl chr 2:201,071,433...201,085,750
JBrowse link
G NDUFB4P12 NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB4P12 mRNA CTD PMID:29432896 NCBI chr 4:43,898,938...43,899,403
Ensembl chr 4:43,898,962...43,899,351
JBrowse link
G NDUFB5 NADH:ubiquinone oxidoreductase subunit B5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB5 mRNA CTD PMID:29432896 NCBI chr 3:179,604,794...179,627,647
Ensembl chr 3:179,604,690...179,627,647
JBrowse link
G NDUFB6 NADH:ubiquinone oxidoreductase subunit B6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB6 mRNA CTD PMID:29432896 NCBI chr 9:32,553,001...32,573,159
Ensembl chr 9:32,553,001...32,573,184
JBrowse link
G NELFE negative elongation factor complex member E multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NELFE mRNA CTD PMID:29432896 NCBI chr 6:31,952,087...31,958,971
Ensembl chr 6:31,952,087...31,959,038
JBrowse link
G NEU1 neuraminidase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NEU1 mRNA CTD PMID:29432896 NCBI chr 6:31,857,659...31,862,821
Ensembl chr 6:31,857,659...31,862,905
JBrowse link
G NKIRAS2 NFKB inhibitor interacting Ras like 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of NKIRAS2 mRNA CTD PMID:29432896 NCBI chr17:42,017,576...42,025,641
Ensembl chr17:42,011,382...42,025,644
JBrowse link
G NOL6 nucleolar protein 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NOL6 mRNA CTD PMID:29432896 NCBI chr 9:33,461,353...33,473,924
Ensembl chr 9:33,461,353...33,473,930
JBrowse link
G NPM3 nucleophosmin/nucleoplasmin 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NPM3 mRNA CTD PMID:29432896 NCBI chr10:101,781,325...101,783,446
Ensembl chr10:101,781,325...101,783,446
JBrowse link
G NPTX1 neuronal pentraxin 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of NPTX1 mRNA CTD PMID:29432896 NCBI chr17:80,466,834...80,476,607
Ensembl chr17:80,466,834...80,477,843
JBrowse link
G NSL1 NSL1 component of MIS12 kinetochore complex multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NSL1 mRNA CTD PMID:29432896 NCBI chr 1:212,726,153...212,791,777
Ensembl chr 1:212,726,153...212,791,782
JBrowse link
G NUDT2 nudix hydrolase 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NUDT2 mRNA CTD PMID:29432896 NCBI chr 9:34,329,569...34,343,699
Ensembl chr 9:34,329,506...34,343,711
JBrowse link
G NUFIP2 nuclear FMR1 interacting protein 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NUFIP2 mRNA CTD PMID:29432896 NCBI chr17:29,255,839...29,294,148
Ensembl chr17:29,255,839...29,294,148
JBrowse link
G OSBP oxysterol binding protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of OSBP mRNA CTD PMID:29432896 NCBI chr11:59,574,398...59,615,774
Ensembl chr11:59,574,398...59,615,774
JBrowse link
G OST4 oligosaccharyltransferase complex subunit 4, non-catalytic multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of OST4 mRNA CTD PMID:29432896 NCBI chr 2:27,070,472...27,071,654
Ensembl chr 2:27,070,472...27,071,654
JBrowse link
G PABPC1L poly(A) binding protein cytoplasmic 1 like multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PABPC1L mRNA CTD PMID:29432896 NCBI chr20:44,910,060...44,939,316
Ensembl chr20:44,910,060...44,959,035
JBrowse link
G PAK1IP1 PAK1 interacting protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PAK1IP1 mRNA CTD PMID:29432896 NCBI chr 6:10,690,865...10,709,782
Ensembl chr 6:10,694,972...10,709,782
JBrowse link
G PBDC1 polysaccharide biosynthesis domain containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PBDC1 mRNA CTD PMID:29432896 NCBI chr  X:76,173,062...76,178,314
Ensembl chr  X:76,173,040...76,178,314
JBrowse link
G PCCB propionyl-CoA carboxylase subunit beta multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PCCB mRNA CTD PMID:29432896 NCBI chr 3:136,250,340...136,330,169
Ensembl chr 3:136,250,340...136,337,896
JBrowse link
G PDIA4 protein disulfide isomerase family A member 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PDIA4 mRNA CTD PMID:29432896 NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662
JBrowse link
G PFKFB4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PFKFB4 mRNA CTD PMID:29432896 NCBI chr 3:48,517,684...48,563,136
Ensembl chr 3:48,517,684...48,562,015
JBrowse link
G PHACTR3 phosphatase and actin regulator 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PHACTR3 mRNA CTD PMID:29432896 NCBI chr20:59,577,509...59,847,711
Ensembl chr20:59,577,509...59,847,711
JBrowse link
G PHLDB2 pleckstrin homology like domain family B member 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PHLDB2 mRNA CTD PMID:29432896 NCBI chr 3:111,732,496...111,976,517
Ensembl chr 3:111,732,497...111,976,517
JBrowse link
G PLAT plasminogen activator, tissue type multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLAT mRNA CTD PMID:29432896 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
JBrowse link
G PLEC plectin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLEC mRNA CTD PMID:29432896 NCBI chr 8:143,915,153...143,976,745
Ensembl chr 8:143,915,153...143,976,734
JBrowse link
G PLK2 polo like kinase 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLK2 mRNA CTD PMID:29432896 NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139
JBrowse link
G PLXNB2 plexin B2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLXNB2 mRNA CTD PMID:29432896 NCBI chr22:50,274,979...50,307,646
Ensembl chr22:50,274,979...50,307,646
JBrowse link
G POC1A POC1 centriolar protein A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of POC1A mRNA CTD PMID:29432896 NCBI chr 3:52,075,226...52,154,423
Ensembl chr 3:52,075,226...52,154,690
JBrowse link
G POGLUT3 protein O-glucosyltransferase 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of POGLUT3 mRNA CTD PMID:29432896 NCBI chr11:108,472,116...108,498,384
Ensembl chr11:108,472,112...108,498,405
JBrowse link
G POLE2 DNA polymerase epsilon 2, accessory subunit multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of POLE2 mRNA CTD PMID:29432896 NCBI chr14:49,643,555...49,688,214
Ensembl chr14:49,643,555...49,688,422
JBrowse link
G POLR3K RNA polymerase III subunit K multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of POLR3K mRNA CTD PMID:29432896 NCBI chr16:46,407...53,608
Ensembl chr16:46,407...53,608
JBrowse link
G POP5 POP5 homolog, ribonuclease P/MRP subunit multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of POP5 mRNA CTD PMID:29432896 NCBI chr12:120,578,764...120,581,402
Ensembl chr12:120,578,764...120,581,402
JBrowse link
G PPARGC1A PPARG coactivator 1 alpha multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPARGC1A mRNA CTD PMID:29432896 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
JBrowse link
G PPIC peptidylprolyl isomerase C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPIC mRNA CTD PMID:29432896 NCBI chr 5:123,023,250...123,036,725
Ensembl chr 5:123,023,250...123,036,725
JBrowse link
G PPIL3 peptidylprolyl isomerase like 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPIL3 mRNA CTD PMID:29432896 NCBI chr 2:200,870,907...200,889,291
Ensembl chr 2:200,870,907...200,889,303
JBrowse link
G PPP1R14C protein phosphatase 1 regulatory inhibitor subunit 14C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PPP1R14C mRNA CTD PMID:29432896 NCBI chr 6:150,143,044...150,250,392
Ensembl chr 6:150,143,044...150,250,392
JBrowse link
G PPP6R2 protein phosphatase 6 regulatory subunit 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPP6R2 mRNA CTD PMID:29432896 NCBI chr22:50,330,774...50,445,090
Ensembl chr22:50,343,304...50,445,090
JBrowse link
G PPWD1 peptidylprolyl isomerase domain and WD repeat containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPWD1 mRNA CTD PMID:29432896 NCBI chr 5:65,563,296...65,587,549
Ensembl chr 5:65,563,236...65,587,549
JBrowse link
G PRICKLE1 prickle planar cell polarity protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PRICKLE1 mRNA CTD PMID:29432896 NCBI chr12:42,456,757...42,589,746
Ensembl chr12:42,456,757...42,590,355
JBrowse link
G PSMB10 proteasome 20S subunit beta 10 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PSMB10 mRNA CTD PMID:29432896 NCBI chr16:67,934,506...67,936,850
Ensembl chr16:67,934,506...67,936,864
JBrowse link
G PSMB6 proteasome 20S subunit beta 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PSMB6 mRNA CTD PMID:29432896 NCBI chr17:4,796,164...4,798,495
Ensembl chr17:4,796,144...4,798,502
JBrowse link
G PSMG4 proteasome assembly chaperone 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PSMG4 mRNA CTD PMID:29432896 NCBI chr 6:3,254,404...3,268,049
Ensembl chr 6:3,231,403...3,303,373
JBrowse link
G PSTPIP2 proline-serine-threonine phosphatase interacting protein 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PSTPIP2 mRNA CTD PMID:29432896 NCBI chr18:45,983,536...46,072,260
Ensembl chr18:45,983,536...46,072,272
JBrowse link
G PTGES prostaglandin E synthase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PTGES mRNA CTD PMID:29432896 NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
JBrowse link
G PTPRE protein tyrosine phosphatase receptor type E multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PTPRE mRNA CTD PMID:29432896 NCBI chr10:127,907,103...128,085,855
Ensembl chr10:127,907,103...128,085,855
JBrowse link
G PTTG1 PTTG1 regulator of sister chromatid separation, securin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PTTG1 mRNA CTD PMID:29432896 NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
JBrowse link
G PYCARD PYD and CARD domain containing multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PYCARD mRNA CTD PMID:29432896 NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
JBrowse link
G QRICH1 glutamine rich 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of QRICH1 mRNA CTD PMID:29432896 NCBI chr 3:49,029,707...49,094,373
Ensembl chr 3:49,029,707...49,094,363
JBrowse link
G RAB25 RAB25, member RAS oncogene family multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RAB25 mRNA CTD PMID:29432896 NCBI chr 1:156,061,160...156,070,504
Ensembl chr 1:156,061,160...156,070,504
JBrowse link
G RAB38 RAB38, member RAS oncogene family multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RAB38 mRNA CTD PMID:29432896 NCBI chr11:87,803,715...88,175,443
Ensembl chr11:88,113,251...88,175,443
JBrowse link
G RAB8A RAB8A, member RAS oncogene family multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RAB8A mRNA CTD PMID:29432896 NCBI chr19:16,111,889...16,134,234
Ensembl chr19:16,111,889...16,134,234
JBrowse link
G RAD23B RAD23 homolog B, nucleotide excision repair protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RAD23B mRNA CTD PMID:29432896 NCBI chr 9:107,283,279...107,332,194
Ensembl chr 9:107,283,137...107,332,192
JBrowse link
G RASIP1 Ras interacting protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RASIP1 mRNA CTD PMID:29432896 NCBI chr19:48,720,585...48,740,610
Ensembl chr19:48,720,585...48,740,610
JBrowse link
G RBCK1 RANBP2-type and C3HC4-type zinc finger containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RBCK1 mRNA CTD PMID:29432896 NCBI chr20:408,299...432,139
Ensembl chr20:407,498...432,139
JBrowse link
G RBM33 RNA binding motif protein 33 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RBM33 mRNA CTD PMID:29432896 NCBI chr 7:155,644,661...155,781,480
Ensembl chr 7:155,644,451...155,781,485
JBrowse link
G RBM5 RNA binding motif protein 5 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RBM5 mRNA CTD PMID:29432896 NCBI chr 3:50,088,919...50,119,021
Ensembl chr 3:50,088,919...50,119,021
JBrowse link
G RBMS1 RNA binding motif single stranded interacting protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RBMS1 mRNA CTD PMID:29432896 NCBI chr 2:160,272,151...160,493,807
Ensembl chr 2:160,272,151...160,493,807
JBrowse link
G RER1 retention in endoplasmic reticulum sorting receptor 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RER1 mRNA CTD PMID:29432896 NCBI chr 1:2,391,841...2,405,436
Ensembl chr 1:2,391,775...2,405,442
JBrowse link
G RFXANK regulatory factor X associated ankyrin containing protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RFXANK mRNA CTD PMID:29432896 NCBI chr19:19,192,258...19,201,866
Ensembl chr19:19,192,229...19,201,869
JBrowse link
G RGL1 ral guanine nucleotide dissociation stimulator like 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RGL1 mRNA CTD PMID:29432896 NCBI chr 1:183,636,109...183,928,532
Ensembl chr 1:183,636,085...183,928,532
JBrowse link
G RGS17 regulator of G protein signaling 17 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RGS17 mRNA CTD PMID:29432896 NCBI chr 6:153,004,459...153,131,282
Ensembl chr 6:153,004,459...153,131,282
JBrowse link
G RGS20 regulator of G protein signaling 20 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RGS20 mRNA CTD PMID:29432896 NCBI chr 8:53,851,795...53,959,303
Ensembl chr 8:53,851,795...53,959,303
JBrowse link
G RHEB Ras homolog, mTORC1 binding multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RHEB mRNA CTD PMID:29432896 NCBI chr 7:151,466,012...151,519,895
Ensembl chr 7:151,466,012...151,520,120
JBrowse link
G RHOB ras homolog family member B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RHOB mRNA CTD PMID:29432896 NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
JBrowse link
G RHOQ ras homolog family member Q multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RHOQ mRNA CTD PMID:29432896 NCBI chr 2:46,542,490...46,584,688
Ensembl chr 2:46,541,806...46,584,688
JBrowse link
G RIPOR2 RHO family interacting cell polarization regulator 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FAM65B mRNA CTD PMID:29432896 NCBI chr 6:24,804,284...25,042,168
Ensembl chr 6:24,804,282...25,042,170
JBrowse link
G RNASET2 ribonuclease T2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RNASET2 mRNA CTD PMID:29432896 NCBI chr 6:166,922,113...166,956,550
Ensembl chr 6:166,922,113...166,957,191
JBrowse link
G RNF126 ring finger protein 126 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNF126 mRNA CTD PMID:29432896 NCBI chr19:647,526...663,214
Ensembl chr19:647,526...663,233
JBrowse link
G RNF20 ring finger protein 20 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNF20 mRNA CTD PMID:29432896 NCBI chr 9:101,533,853...101,563,344
Ensembl chr 9:101,533,853...101,563,344
JBrowse link
G RNH1 ribonuclease/angiogenin inhibitor 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNH1 mRNA CTD PMID:29432896 NCBI chr11:494,515...507,242
Ensembl chr11:494,512...507,300
JBrowse link
G RNU1-1 RNA, U1 small nuclear 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNU1-1 mRNA CTD PMID:29432896 NCBI chr 1:16,514,122...16,514,285
Ensembl chr 1:16,514,122...16,514,285
JBrowse link
G RNU6-1 RNA, U6 small nuclear 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RNU6-1 mRNA CTD PMID:29432896 NCBI chr15:67,839,940...67,840,045
Ensembl chr15:67,839,939...67,840,045
JBrowse link
G RNU6-15P RNA, U6 small nuclear 15, pseudogene multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RNU6-15P mRNA CTD PMID:29432896 NCBI chr10:21,321,961...21,322,066
Ensembl chr10:21,321,961...21,322,067
JBrowse link
G RNY1 RNA, Ro60-associated Y1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RNY1 mRNA CTD PMID:29432896 NCBI chr 7:148,987,136...148,987,248
Ensembl chr 7:148,987,136...148,987,248
JBrowse link
G RPL10A ribosomal protein L10a multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL10A mRNA CTD PMID:29432896 NCBI chr 6:35,468,401...35,470,780
Ensembl chr 6:35,468,401...35,470,785
JBrowse link
G RPL10P9 ribosomal protein L10 pseudogene 9 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL10P9 mRNA CTD PMID:29432896 NCBI chr 5:168,616,311...168,617,055
Ensembl chr 5:168,616,352...168,616,996
JBrowse link
G RPL12P32 ribosomal protein L12 pseudogene 32 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPL12P32 mRNA CTD PMID:29432896 NCBI chr12:31,948,246...31,948,871
Ensembl chr12:31,948,334...31,948,827
JBrowse link
G RPL21P119 ribosomal protein L21 pseudogene 119 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL21P119 mRNA CTD PMID:29432896 NCBI chr16:9,156,342...9,156,921
Ensembl chr16:9,156,402...9,156,881
JBrowse link
G RPL21P16 ribosomal protein L21 pseudogene 16 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL21P16 mRNA CTD PMID:29432896 NCBI chr10:120,354,645...120,355,226
Ensembl chr10:120,354,701...120,355,183
JBrowse link
G RPL21P28 ribosomal protein L21 pseudogene 28 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL21P28 mRNA CTD PMID:29432896 NCBI chr 1:212,051,486...212,052,051
Ensembl chr 1:212,051,524...212,052,006
JBrowse link
G RPL27 ribosomal protein L27 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPL27 mRNA CTD PMID:29432896 NCBI chr17:42,998,273...43,002,959
Ensembl chr17:42,998,273...43,002,959
JBrowse link
G RPL29P11 ribosomal protein L29 pseudogene 11 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL29P11 mRNA CTD PMID:29432896 NCBI chr 3:37,016,401...37,017,034
Ensembl chr 3:37,016,523...37,017,014
JBrowse link
G RPL34 ribosomal protein L34 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPL34 mRNA CTD PMID:29432896 NCBI chr 4:108,620,576...108,630,484
Ensembl chr 4:108,620,569...108,630,412
JBrowse link
G RPL36AP37 ribosomal protein L36a pseudogene 37 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL36AP37 mRNA CTD PMID:29432896 NCBI chr11:16,974,646...16,975,044
Ensembl chr11:16,974,693...16,975,013
Ensembl chr11:16,974,693...16,975,013
JBrowse link
G RPL6P27 ribosomal protein L6 pseudogene 27 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPL6P27 mRNA CTD PMID:29432896 NCBI chr18:6,462,110...6,463,029
Ensembl chr18:6,462,144...6,463,010
JBrowse link
G RPL7P22 ribosomal protein L7 pseudogene 22 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPL7P22 mRNA CTD PMID:29432896 NCBI chr 5:72,725,417...72,726,154
Ensembl chr 5:72,725,419...72,726,151
JBrowse link
G RPP25L ribonuclease P/MRP subunit p25 like multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPP25L mRNA CTD PMID:29432896 NCBI chr 9:34,610,495...34,612,097
Ensembl chr 9:34,610,486...34,612,104
JBrowse link
G RPS26P15 ribosomal protein S26 pseudogene 15 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPS26P15 mRNA CTD PMID:29432896 NCBI chr 1:58,056,062...58,056,504
Ensembl chr 1:58,056,133...58,056,480
JBrowse link
G RPS26P2 ribosomal protein S26 pseudogene 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPS26P2 mRNA CTD PMID:29432896 NCBI chr 9:30,831,609...30,832,249
Ensembl chr 9:30,831,878...30,832,225
JBrowse link
G RPUSD2 RNA pseudouridine synthase domain containing 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RPUSD2 mRNA CTD PMID:29432896 NCBI chr15:40,569,299...40,574,949
Ensembl chr15:40,569,299...40,574,949
JBrowse link
G RRAGD Ras related GTP binding D multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RRAGD mRNA CTD PMID:29432896 NCBI chr 6:89,364,616...89,412,273
Ensembl chr 6:89,364,616...89,412,273
JBrowse link
G S100A10 S100 calcium binding protein A10 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of S100A10 mRNA CTD PMID:29432896 NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859
JBrowse link
G S100A14 S100 calcium binding protein A14 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of S100A14 mRNA CTD PMID:29432896 NCBI chr 1:153,614,255...153,616,325
Ensembl chr 1:153,614,255...153,616,986
JBrowse link
G S100A8 S100 calcium binding protein A8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of S100A8 mRNA CTD PMID:29432896 NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
JBrowse link
G S100A9 S100 calcium binding protein A9 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of S100A9 mRNA CTD PMID:29432896 NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
JBrowse link
G SC5D sterol-C5-desaturase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SC5D mRNA CTD PMID:29432896 NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
JBrowse link
G SCARA3 scavenger receptor class A member 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SCARA3 mRNA CTD PMID:29432896 NCBI chr 8:27,633,463...27,734,141
Ensembl chr 8:27,633,868...27,676,776
JBrowse link
G SCD stearoyl-CoA desaturase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SCD mRNA CTD PMID:29432896 NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
JBrowse link
G SDHAF2 succinate dehydrogenase complex assembly factor 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SDHAF2 mRNA CTD PMID:29432896 NCBI chr11:61,430,124...61,446,733
Ensembl chr11:61,430,042...61,446,733
JBrowse link
G SDHAP2 SDHA pseudogene 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SDHAP2 mRNA CTD PMID:29432896 NCBI chr 3:195,658,039...195,688,871
Ensembl chr 3:195,658,096...195,685,904
JBrowse link
G SDHB succinate dehydrogenase complex iron sulfur subunit B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SDHB mRNA CTD PMID:29432896 NCBI chr 1:17,018,722...17,054,032
Ensembl chr 1:17,018,664...17,054,032
JBrowse link
G SEC13 SEC13 homolog, nuclear pore and COPII coat complex component multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC13 mRNA CTD PMID:29432896 NCBI chr 3:10,300,931...10,321,112
Ensembl chr 3:10,293,131...10,321,112
JBrowse link
G SEC61G SEC61 translocon subunit gamma multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC61G mRNA CTD PMID:29432896 NCBI chr 7:54,752,253...54,759,211
Ensembl chr 7:54,752,250...54,759,974
JBrowse link
G SELENON selenoprotein N multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SEPN1 mRNA CTD PMID:29432896 NCBI chr 1:25,800,193...25,818,221
Ensembl chr 1:25,800,193...25,818,221
JBrowse link
G SELENOS selenoprotein S multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SELS mRNA CTD PMID:29432896 NCBI chr15:101,270,809...101,277,485
Ensembl chr15:101,270,817...101,277,500
JBrowse link
G SEM1 SEM1 26S proteasome subunit multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEM1 mRNA CTD PMID:29432896 NCBI chr 7:96,481,626...96,709,846
Ensembl chr 7:96,481,626...96,709,880
JBrowse link
G SERPINB1 serpin family B member 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SERPINB1 mRNA CTD PMID:29432896 NCBI chr 6:2,832,332...2,841,863
Ensembl chr 6:2,832,332...2,841,959
JBrowse link
G SERPINB2 serpin family B member 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SERPINB2 mRNA CTD PMID:29432896 NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
JBrowse link
G SERPINE1 serpin family E member 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SERPINE1 mRNA CTD PMID:29432896 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SFN stratifin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA CTD PMID:29432896 NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
JBrowse link
G SFTA1P surfactant associated 1, lncRNA multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SFTA1P mRNA CTD PMID:29432896 NCBI chr10:10,784,439...10,794,914
Ensembl chr10:10,784,437...10,795,047
JBrowse link
G SFXN4 sideroflexin 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SFXN4 mRNA CTD PMID:29432896 NCBI chr10:119,140,767...119,165,714
Ensembl chr10:119,140,767...119,165,714
JBrowse link
G SGPP2 sphingosine-1-phosphate phosphatase 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SGPP2 mRNA CTD PMID:29432896 NCBI chr 2:222,423,988...222,562,621
Ensembl chr 2:222,424,543...222,562,621
JBrowse link
G SH2B3 SH2B adaptor protein 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SH2B3 mRNA CTD PMID:29432896 NCBI chr12:111,404,730...111,451,623
Ensembl chr12:111,405,923...111,451,623
JBrowse link
G SLC11A2 solute carrier family 11 member 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC11A2 mRNA CTD PMID:29432896 NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
JBrowse link
G SLC26A6 solute carrier family 26 member 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC26A6 mRNA CTD PMID:29432896 NCBI chr 3:48,625,723...48,635,461
Ensembl chr 3:48,625,723...48,635,493
JBrowse link
G SLC43A3 solute carrier family 43 member 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC43A3 mRNA CTD PMID:29432896 NCBI chr11:57,406,954...57,427,580
Ensembl chr11:57,406,954...57,427,580
JBrowse link
G SLC44A1 solute carrier family 44 member 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC44A1 mRNA CTD PMID:29432896 NCBI chr 9:105,244,651...105,438,504
Ensembl chr 9:105,244,622...105,439,171
JBrowse link
G SLF2 SMC5-SMC6 complex localization factor 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLF2 mRNA CTD PMID:29432896 NCBI chr10:100,912,963...100,965,134
Ensembl chr10:100,912,963...100,965,134
JBrowse link
G SNHG6 small nucleolar RNA host gene 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SNHG6 mRNA CTD PMID:29432896 NCBI chr 8:66,921,690...66,925,541
Ensembl chr 8:66,920,561...66,926,398
JBrowse link
G SNIP1 Smad nuclear interacting protein 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SNIP1 mRNA CTD PMID:29432896 NCBI chr 1:37,534,449...37,554,293
Ensembl chr 1:37,534,449...37,554,293
JBrowse link
G SNORD96A small nucleolar RNA, C/D box 96A multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SNORD96A mRNA CTD PMID:29432896 NCBI chr 5:181,241,818...181,241,889
Ensembl chr 5:181,241,814...181,241,892
JBrowse link
G SNRNP25 small nuclear ribonucleoprotein U11/U12 subunit 25 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SNRNP25 mRNA CTD PMID:29432896 NCBI chr16:53,828...57,669
Ensembl chr16:53,828...57,669
JBrowse link
G SNX5P2 sorting nexin 5 pseudogene 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SNX5P2 mRNA CTD PMID:29432896 NCBI chr12:101,066,607...101,070,000 JBrowse link
G SNX8 sorting nexin 8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SNX8 mRNA CTD PMID:29432896 NCBI chr 7:2,251,770...2,354,497
Ensembl chr 7:2,251,770...2,354,318
JBrowse link
G SOX15 SRY-box transcription factor 15 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SOX15 mRNA CTD PMID:29432896 NCBI chr17:7,588,178...7,590,094
Ensembl chr17:7,588,178...7,590,094
JBrowse link
G SPA17 sperm autoantigenic protein 17 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SPA17 mRNA CTD PMID:29432896 NCBI chr11:124,673,904...124,697,518
Ensembl chr11:124,673,844...124,697,518
JBrowse link
G SPATS2L spermatogenesis associated serine rich 2 like multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SPATS2L mRNA CTD PMID:29432896 NCBI chr 2:200,305,879...200,482,264
Ensembl chr 2:200,305,881...200,482,264
JBrowse link
G SPHK1 sphingosine kinase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SPHK1 mRNA CTD PMID:29432896 NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
JBrowse link
G SPHK2 sphingosine kinase 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SPHK2 mRNA CTD PMID:29432896 NCBI chr19:48,619,506...48,630,405
Ensembl chr19:48,619,291...48,630,717
JBrowse link
G SPRY2 sprouty RTK signaling antagonist 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SPRY2 mRNA CTD PMID:29432896 NCBI chr13:80,335,976...80,341,126
Ensembl chr13:80,335,976...80,341,126
JBrowse link
G SRP54 signal recognition particle 54 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SRP54 mRNA CTD PMID:29432896 NCBI chr14:34,982,992...35,029,567
Ensembl chr14:34,981,957...35,029,686
JBrowse link
G SRP9P1 signal recognition particle 9 pseudogene 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SRP9P1 mRNA CTD PMID:29432896 NCBI chr10:91,806,064...91,807,533
Ensembl chr10:91,807,179...91,807,439
JBrowse link
G ST14 ST14 transmembrane serine protease matriptase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ST14 mRNA CTD PMID:29432896 NCBI chr11:130,159,782...130,210,362
Ensembl chr11:130,159,782...130,210,362
JBrowse link
G STK26 serine/threonine kinase 26 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of STK26 mRNA CTD PMID:29432896 NCBI chr  X:132,023,302...132,075,943
Ensembl chr  X:132,023,302...132,075,943
JBrowse link
G STMN1 stathmin 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of STMN1 mRNA CTD PMID:29432896 NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
JBrowse link
G STX8 syntaxin 8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of STX8 mRNA CTD PMID:29432896 NCBI chr17:9,250,471...9,575,820
Ensembl chr17:9,250,471...9,576,591
JBrowse link
G TACSTD2 tumor associated calcium signal transducer 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TACSTD2 mRNA CTD PMID:29432896 NCBI chr 1:58,575,433...58,577,252
Ensembl chr 1:58,575,433...58,577,252
JBrowse link
G TAGLN transgelin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TAGLN mRNA CTD PMID:29432896 NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
JBrowse link
G TAMM41 TAM41 mitochondrial translocator assembly and maintenance homolog multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TAMM41 mRNA CTD PMID:29432896 NCBI chr 3:11,721,896...11,846,885
Ensembl chr 3:11,790,442...11,846,919
JBrowse link
G TBC1D31 TBC1 domain family member 31 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of WDR67 mRNA CTD PMID:29432896 NCBI chr 8:123,072,707...123,165,173
Ensembl chr 8:123,041,968...123,152,153
JBrowse link
G TBC1D32 TBC1 domain family member 32 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TBC1D32 mRNA CTD PMID:29432896 NCBI chr 6:121,079,494...121,334,729
Ensembl chr 6:121,079,494...121,334,745
JBrowse link
G TCEA2 transcription elongation factor A2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TCEA2 mRNA CTD PMID:29432896 NCBI chr20:64,055,596...64,072,347
Ensembl chr20:64,049,836...64,072,347
JBrowse link
G TCEAL3 transcription elongation factor A like 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TCEAL3 mRNA CTD PMID:29432896 NCBI chr  X:103,607,963...103,609,927
Ensembl chr  X:103,607,451...103,629,690
JBrowse link
G TCEAL9 transcription elongation factor A like 9 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TCEAL9 mRNA CTD PMID:29432896 NCBI chr  X:103,356,506...103,358,462
Ensembl chr  X:103,356,489...103,358,462
JBrowse link
G TCERG1 transcription elongation regulator 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TCERG1 mRNA CTD PMID:29432896 NCBI chr 5:146,447,330...146,511,961
Ensembl chr 5:146,447,311...146,511,961
JBrowse link
G TENT5B terminal nucleotidyltransferase 5B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FAM46B mRNA CTD PMID:29432896 NCBI chr 1:27,005,020...27,012,850
Ensembl chr 1:27,005,020...27,012,850
JBrowse link
G TFB1M transcription factor B1, mitochondrial multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TFB1M mRNA CTD PMID:29432896 NCBI chr 6:155,229,871...155,314,484
Ensembl chr 6:155,256,134...155,314,493
JBrowse link
G TFPI tissue factor pathway inhibitor multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TFPI mRNA CTD PMID:29432896 NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760
JBrowse link
G TGFA transforming growth factor alpha multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TGFA mRNA CTD PMID:29432896 NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
JBrowse link
G TGFBR2 transforming growth factor beta receptor 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TGFBR2 mRNA CTD PMID:29432896 NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,601...30,694,142
JBrowse link
G TGM2 transglutaminase 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TGM2 mRNA CTD PMID:29432896 NCBI chr20:38,127,385...38,168,475
Ensembl chr20:38,127,385...38,166,578
JBrowse link
G THBD thrombomodulin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of THBD mRNA CTD PMID:29432896 NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
JBrowse link
G TIMM22 translocase of inner mitochondrial membrane 22 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TIMM22 mRNA CTD PMID:29432896 NCBI chr17:997,129...1,003,671
Ensembl chr17:997,129...1,003,671
JBrowse link
G TIMM23 translocase of inner mitochondrial membrane 23 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TIMM23 mRNA CTD PMID:29432896 NCBI chr10:45,972,489...46,003,742
Ensembl chr10:45,972,489...46,003,742
JBrowse link
G TINF2 TERF1 interacting nuclear factor 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TINF2 mRNA CTD PMID:29432896 NCBI chr14:24,239,640...24,242,674
Ensembl chr14:24,238,286...24,242,663
JBrowse link
G TIPARP TCDD inducible poly(ADP-ribose) polymerase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TIPARP mRNA CTD PMID:29432896 NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770
JBrowse link
G TMEM44 transmembrane protein 44 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TMEM44 mRNA CTD PMID:29432896 NCBI chr 3:194,587,678...194,633,419
Ensembl chr 3:194,587,673...194,633,689
JBrowse link
G TMEM50B transmembrane protein 50B multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TMEM50B mRNA CTD PMID:29432896 NCBI chr21:33,432,486...33,479,974
Ensembl chr21:33,432,485...33,479,974
JBrowse link
G TMEM54 transmembrane protein 54 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TMEM54 mRNA CTD PMID:29432896 NCBI chr 1:32,894,595...32,901,389
Ensembl chr 1:32,894,594...32,901,438
JBrowse link
G TMUB2 transmembrane and ubiquitin like domain containing 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TMUB2 mRNA CTD PMID:29432896 NCBI chr17:44,186,972...44,191,929
Ensembl chr17:44,186,970...44,191,929
JBrowse link
G TNC tenascin C multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TNC mRNA CTD PMID:29432896 NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
JBrowse link
G TNFAIP3 TNF alpha induced protein 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TNFAIP3 mRNA CTD PMID:29432896 NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
JBrowse link
G TNFAIP8L3 TNF alpha induced protein 8 like 3 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TNFAIP8L3 mRNA CTD PMID:29432896 NCBI chr15:51,056,601...51,105,276
Ensembl chr15:51,056,598...51,105,276
JBrowse link
G TOMM6 translocase of outer mitochondrial membrane 6 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TOMM6 mRNA CTD PMID:29432896 NCBI chr 6:41,787,694...41,789,895
Ensembl chr 6:41,787,662...41,789,898
JBrowse link
G TOMM7 translocase of outer mitochondrial membrane 7 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TOMM7 mRNA CTD PMID:29432896 NCBI chr 7:22,812,974...22,822,849
Ensembl chr 7:22,812,628...22,822,849
JBrowse link
G TP63 tumor protein p63 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TP63 mRNA CTD PMID:29432896 NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
JBrowse link
G TPD52L1 TPD52 like 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TPD52L1 mRNA CTD PMID:29432896 NCBI chr 6:125,153,773...125,264,407
Ensembl chr 6:125,119,049...125,264,407
JBrowse link
G TPD52L2 TPD52 like 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which affects the expression of TPD52L2 mRNA CTD PMID:29432896 NCBI chr20:63,865,270...63,891,538
Ensembl chr20:63,865,228...63,891,545
JBrowse link
G TPM3P8 tropomyosin 3 pseudogene 8 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TPM3P8 mRNA CTD PMID:29432896 NCBI chr 2:230,571,895...230,573,956
Ensembl chr 2:230,573,167...230,573,809
JBrowse link
G TRIM33 tripartite motif containing 33 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TRIM33 mRNA CTD PMID:29432896 NCBI chr 1:114,392,790...114,511,203
Ensembl chr 1:114,392,790...114,511,203
JBrowse link
G TRIM47 tripartite motif containing 47 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TRIM47 mRNA CTD PMID:29432896 NCBI chr17:75,874,164...75,878,581
Ensembl chr17:75,874,164...75,878,581
JBrowse link
G TSEN15 tRNA splicing endonuclease subunit 15 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TSEN15 mRNA CTD PMID:29432896 NCBI chr 1:184,051,730...184,097,485
Ensembl chr 1:184,051,651...184,123,978
JBrowse link
G TSPAN9 tetraspanin 9 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TSPAN9 mRNA CTD PMID:29432896 NCBI chr12:3,077,379...3,286,559
Ensembl chr12:3,077,355...3,286,564
JBrowse link
G TSPO translocator protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TSPO mRNA CTD PMID:29432896 NCBI chr22:43,151,559...43,163,242
Ensembl chr22:43,151,547...43,163,242
JBrowse link
G TUBB2A tubulin beta 2A class IIa multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TUBB2A mRNA CTD PMID:29432896 NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
JBrowse link
G TWIST1 twist family bHLH transcription factor 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TWIST1 mRNA CTD PMID:29432896 NCBI chr 7:19,113,047...19,117,636
Ensembl chr 7:19,020,991...19,117,636
JBrowse link
G TXN thioredoxin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXN mRNA CTD PMID:29432896 NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
JBrowse link
G TXNIP thioredoxin interacting protein multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXNIP mRNA CTD PMID:29432896 NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
JBrowse link
G UBE2J1 ubiquitin conjugating enzyme E2 J1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UBE2J1 mRNA CTD PMID:29432896 NCBI chr 6:89,326,625...89,352,722
Ensembl chr 6:89,326,625...89,352,722
JBrowse link
G UBE2N ubiquitin conjugating enzyme E2 N multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UBE2N mRNA CTD PMID:29432896 NCBI chr12:93,405,684...93,441,947
Ensembl chr12:93,405,673...93,441,947
JBrowse link
G UIMC1 ubiquitin interaction motif containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UIMC1 mRNA CTD PMID:29432896 NCBI chr 5:176,905,005...177,022,602
Ensembl chr 5:176,905,005...177,022,633
JBrowse link
G UROS uroporphyrinogen III synthase multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UROS mRNA CTD PMID:29432896 NCBI chr10:125,784,980...125,823,258
Ensembl chr10:125,784,980...125,823,288
JBrowse link
G USP13 ubiquitin specific peptidase 13 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of USP13 mRNA CTD PMID:29432896 NCBI chr 3:179,653,040...179,789,401
Ensembl chr 3:179,653,032...179,804,366
JBrowse link
G VASN vasorin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of VASN mRNA CTD PMID:29432896 NCBI chr16:4,371,848...4,383,538
Ensembl chr16:4,371,848...4,383,538
JBrowse link
G VPS37B VPS37B subunit of ESCRT-I multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of VPS37B mRNA CTD PMID:29432896 NCBI chr12:122,865,330...122,896,124
Ensembl chr12:122,865,330...122,896,127
JBrowse link
G VPS72 vacuolar protein sorting 72 homolog multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of VPS72 mRNA CTD PMID:29432896 NCBI chr 1:151,176,304...151,190,197
Ensembl chr 1:151,176,304...151,195,321
JBrowse link
G WASF2 WASP family member 2 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WASF2 mRNA CTD PMID:29432896 NCBI chr 1:27,404,230...27,490,167
Ensembl chr 1:27,404,230...27,490,167
JBrowse link
G XPNPEP1 X-prolyl aminopeptidase 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of XPNPEP1 mRNA CTD PMID:29432896 NCBI chr10:109,864,766...109,923,511
Ensembl chr10:109,864,766...109,923,553
JBrowse link
G ZC3H4 zinc finger CCCH-type containing 4 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ZC3H4 mRNA CTD PMID:29432896 NCBI chr19:47,064,187...47,113,776
Ensembl chr19:47,064,187...47,113,776
JBrowse link
G ZNF185 zinc finger protein 185 with LIM domain multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ZNF185 mRNA CTD PMID:29432896 NCBI chr  X:152,898,067...152,973,481
Ensembl chr  X:152,898,067...152,973,481
JBrowse link
G ZSWIM1 zinc finger SWIM-type containing 1 multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ZSWIM1 mRNA CTD PMID:29432896 NCBI chr20:45,880,920...45,885,266
Ensembl chr20:45,881,227...45,885,266
JBrowse link
G ZYX zyxin multiple interactions EXP [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ZYX mRNA CTD PMID:29432896 NCBI chr 7:143,381,345...143,391,111
Ensembl chr 7:143,381,295...143,391,111
JBrowse link
isobutyl nitrite term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G FGF1 fibroblast growth factor 1 increases expression ISO isobutyl nitrite results in increased expression of FGF1 mRNA CTD PMID:16288974 NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
JBrowse link
G FGF4 fibroblast growth factor 4 increases expression ISO isobutyl nitrite results in increased expression of FGF4 mRNA CTD PMID:16288974 NCBI chr11:69,771,022...69,775,341
Ensembl chr11:69,771,022...69,775,341
JBrowse link
G HMOX1 heme oxygenase 1 increases expression ISO isobutyl nitrite results in increased expression of HMOX1 mRNA CTD PMID:16288974 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HSPA4 heat shock protein family A (Hsp70) member 4 increases expression ISO isobutyl nitrite results in increased expression of HSPA4 mRNA CTD PMID:16288974 NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
JBrowse link
G PF4 platelet factor 4 increases expression ISO isobutyl nitrite results in increased expression of PF4 mRNA CTD PMID:16288974 NCBI chr 4:73,980,811...73,982,124
Ensembl chr 4:73,980,811...73,982,027
JBrowse link
G SMAD7 SMAD family member 7 increases expression ISO isobutyl nitrite results in increased expression of SMAD7 mRNA CTD PMID:16288974 NCBI chr18:48,919,853...48,950,965
Ensembl chr18:48,919,853...48,950,965
JBrowse link
G VEGFA vascular endothelial growth factor A increases expression ISO isobutyl nitrite results in increased expression of VEGFA mRNA CTD PMID:16288974 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VEGFD vascular endothelial growth factor D increases expression ISO isobutyl nitrite results in increased expression of VEGFD mRNA CTD PMID:16288974 NCBI chr  X:15,345,596...15,384,413
Ensembl chr  X:15,345,596...15,384,413
JBrowse link
L-leucine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATG5 autophagy related 5 multiple interactions ISO Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] CTD PMID:31676321 NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
JBrowse link
G ATG7 autophagy related 7 multiple interactions ISO Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]] CTD PMID:31676321 NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
JBrowse link
G BECN1 beclin 1 multiple interactions ISO Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of BECN1 protein] CTD PMID:31676321 NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
JBrowse link
G CASP3 caspase 3 multiple interactions ISO Leucine inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]] CTD PMID:31676321 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G EGF epidermal growth factor multiple interactions ISO [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Leucine; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Leucine] CTD PMID:22689575 NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta multiple interactions ISO Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:31676321 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G MPO myeloperoxidase multiple interactions ISO Leucine inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]] CTD PMID:31676321 NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
JBrowse link
G SLC3A2 solute carrier family 3 member 2 affects import EXP SLC3A2 protein affects the import of Leucine CTD PMID:28786956 NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
JBrowse link
G SLC7A8 solute carrier family 7 member 8 affects import EXP SLC7A8 protein affects the import of Leucine CTD PMID:28786956 NCBI chr14:23,125,295...23,183,660
Ensembl chr14:23,125,295...23,183,674
JBrowse link
G SQSTM1 sequestosome 1 multiple interactions ISO Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in decreased expression of SQSTM1 protein] CTD PMID:31676321 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
JBrowse link
lacidipine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AR androgen receptor increases activity EXP lacidipine results in increased activity of AR protein CTD PMID:25257666 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G ESR1 estrogen receptor 1 increases activity EXP lacidipine results in increased activity of ESR1 protein CTD PMID:25257666 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G NCOA2 nuclear receptor coactivator 2 multiple interactions EXP lacidipine inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]] CTD PMID:27773686 NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 multiple interactions
increases activity
EXP lacidipine inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]]; lacidipine inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]; lacidipine inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
lacidipine results in increased activity of NR1H4 protein
CTD PMID:25257666 PMID:27773686 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
JBrowse link
G PPARD peroxisome proliferator activated receptor delta increases activity EXP lacidipine results in increased activity of PPARD protein CTD PMID:25257666 NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma increases activity EXP lacidipine results in increased activity of PPARG protein CTD PMID:25257666 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G VDR vitamin D receptor increases activity EXP lacidipine results in increased activity of VDR protein CTD PMID:25257666 NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
JBrowse link
Leu-enkephalin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DPP3 dipeptidyl peptidase 3 multiple interactions
increases cleavage
EXP spinorphin inhibits the reaction [DPP3 protein results in increased cleavage of Enkephalin, Leucine]; tynorphin inhibits the reaction [DPP3 protein results in increased cleavage of Enkephalin, Leucine] CTD PMID:10873616 NCBI chr11:66,480,434...66,509,657
Ensembl chr11:66,480,013...66,509,657
JBrowse link
G OPRD1 opioid receptor delta 1 increases activity EXP Enkephalin, Leucine results in increased activity of OPRD1 protein CTD PMID:26476280 NCBI chr 1:28,812,170...28,871,267
Ensembl chr 1:28,812,170...28,871,267
JBrowse link
G OPRM1 opioid receptor mu 1 increases activity EXP Enkephalin, Leucine results in increased activity of OPRM1 protein CTD PMID:26476280 NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
JBrowse link
methyl L-leucinate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TNF tumor necrosis factor multiple interactions ISO leucine methyl ester inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] CTD PMID:21748807 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
N-formyl-L-methionyl-L-leucyl-L-phenylalanine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADA adenosine deaminase multiple interactions EXP ADA protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides] CTD PMID:10947063 NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
JBrowse link
G AKT1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions
EXP
ISO
N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein
cyclosporin H inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein]; epsilon-viniferin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein]
CTD PMID:15925284 PMID:16621998 PMID:34144024 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G ALOX5 arachidonate 5-lipoxygenase multiple interactions EXP [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4]; ALOX5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein]; N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of ALOX5 protein; SB 203580 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of ALOX5 protein] CTD PMID:9495842 PMID:10779545 PMID:11116075 NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
JBrowse link
G ARF1 ADP ribosylation factor 1 affects localization EXP N-Formylmethionine Leucyl-Phenylalanine affects the localization of ARF1 protein CTD PMID:10931844 NCBI chr 1:228,082,708...228,099,212
Ensembl chr 1:228,082,708...228,099,212
JBrowse link
G ARF6 ADP ribosylation factor 6 multiple interactions
affects localization
EXP 1-Butanol inhibits the reaction [ARF6 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]]; 1-Butanol inhibits the reaction [ARF6 protein mutant form promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]]; 2,3-Diphosphoglycerate inhibits the reaction [ARF6 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]]; 2,3-Diphosphoglycerate inhibits the reaction [ARF6 protein mutant form promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]]; ARF6 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]; ARF6 protein mutant form promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]
N-Formylmethionine Leucyl-Phenylalanine affects the localization of ARF6 protein
CTD PMID:10931844 NCBI chr14:49,893,082...49,897,054
Ensembl chr14:49,893,079...49,897,054
JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases activity EXP N-Formylmethionine Leucyl-Phenylalanine results in increased activity of BAX protein CTD PMID:20130848 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G CASP3 caspase 3 multiple interactions
increases activity
EXP Melatonin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP3 protein] CTD PMID:20130848 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP9 caspase 9 multiple interactions
increases activity
EXP Melatonin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein] CTD PMID:20130848 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CD38 CD38 molecule increases cleavage
multiple interactions
EXP N-Formylmethionine Leucyl-Phenylalanine results in increased cleavage of CD38 protein
SB 203580 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased cleavage of CD38 protein]
CTD PMID:15494208 NCBI chr 4:15,778,328...15,853,232
Ensembl chr 4:15,778,275...15,853,232
JBrowse link
G CD63 CD63 molecule multiple interactions
increases expression
EXP Mustard Gas promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CD63 protein]; Quercetin affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CD63 protein]; SB 203580 inhibits the reaction [Mustard Gas promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CD63 protein]] CTD PMID:19887118 PMID:22036725 NCBI chr12:55,723,535...55,730,041
Ensembl chr12:55,725,323...55,729,707
JBrowse link
G CTSG cathepsin G multiple interactions
increases secretion
EXP cyclosporin H inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of CTSG protein]; epsilon-viniferin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of CTSG protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of CTSG protein] CTD PMID:25980585 PMID:34144024 NCBI chr14:24,573,518...24,576,250
Ensembl chr14:24,573,518...24,576,250
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression
increases secretion
multiple interactions
EXP N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CXCL8 mRNA; N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CXCL8 protein
N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of CXCL8 protein
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CXCL8 protein]; nimesulide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CXCL8 protein]; nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of CXCL8 mRNA]; nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of CXCL8 protein]
CTD PMID:11566077 PMID:12946449 PMID:17459229 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G CYBB cytochrome b-245 beta chain multiple interactions
increases activity
ISO diphenyleneiodonium inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein]; Genistein inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein] CTD PMID:29183754 NCBI chr  X:37,780,059...37,813,461
Ensembl chr  X:37,780,018...37,813,461
JBrowse link
G ELANE elastase, neutrophil expressed multiple interactions
increases secretion
EXP 2-(2-fluorobenzamido)benzoate ethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of ELANE protein]; [Cytochalasin B co-treated with N-Formylmethionine Leucyl-Phenylalanine] results in increased secretion of ELANE protein; pirinixic acid analog inhibits the reaction [[Cytochalasin B co-treated with N-Formylmethionine Leucyl-Phenylalanine] results in increased secretion of ELANE protein] CTD PMID:19686721 PMID:21457779 NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
JBrowse link
G ENPP3 ectonucleotide pyrophosphatase/phosphodiesterase 3 multiple interactions
increases expression
EXP Quercetin affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ENPP3 protein] CTD PMID:19887118 NCBI chr 6:131,637,302...131,747,410
Ensembl chr 6:131,628,442...131,747,418
JBrowse link
G FGR FGR proto-oncogene, Src family tyrosine kinase multiple interactions
increases phosphorylation
EXP 1-Butanol inhibits the reaction [[N-Formylmethionine Leucyl-Phenylalanine co-treated with dihydrocytochalasin B] results in increased activity of FGR protein]
N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of FGR protein
CTD PMID:11078731 PMID:25980585 NCBI chr 1:27,612,064...27,635,185
Ensembl chr 1:27,612,064...27,635,185
JBrowse link
G FPR1 formyl peptide receptor 1 multiple interactions EXP N-Formylmethionine Leucyl-Phenylalanine binds to and results in increased activity of FPR1 protein CTD PMID:17520823 NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115
JBrowse link
G GUSB glucuronidase beta increases secretion
multiple interactions
ISO
EXP
N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of GUSB protein
epigallocatechin gallate inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of GUSB protein]
CTD PMID:9545557 PMID:11944907 NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
JBrowse link
G HCK HCK proto-oncogene, Src family tyrosine kinase increases phosphorylation EXP N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of HCK protein CTD PMID:25980585 NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
JBrowse link
G IL1B interleukin 1 beta multiple interactions
increases expression
EXP N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of IL1B protein]; nimesulide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of IL1B protein] CTD PMID:12946449 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL3 interleukin 3 increases response to substance ISO IL3 protein results in increased susceptibility to N-Formylmethionine Leucyl-Phenylalanine CTD PMID:11145705 NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
JBrowse link
G IL6 interleukin 6 multiple interactions
increases expression
EXP N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of IL6 protein]; nimesulide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of IL6 protein] CTD PMID:12946449 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G ITGA2B integrin subunit alpha 2b multiple interactions EXP ITGA2B protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein] CTD PMID:11116075 NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,180...44,389,649
JBrowse link
G ITGAM integrin subunit alpha M multiple interactions
increases expression
EXP 2-(2-fluorobenzamido)benzoate ethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]; dimemorfan inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]; Foropafant inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]; KT 5720 inhibits the reaction [2-(2-fluorobenzamido)benzoate ethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [2-(2-fluorobenzamido)benzoate ethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Rolipram inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]; plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]; Rolipram inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]; Staurosporine inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]
fMLP increases expression of ITGAM protein on neutrophils and monocytes
[N-formyl-methionyl-leucyl-phenylalanine cotreated with midazolam] decreases expression of ITGAM protein on neutrophils
CTD
RGD
PMID:10215738 PMID:11116075 PMID:15774851 PMID:18500357 PMID:21457779 More... RGD:329901666, RGD:329853762 NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
JBrowse link
G ITGB2 integrin subunit beta 2 increases expression
multiple interactions
ISO
EXP
N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; acteoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; crenatoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]
CTD PMID:10215738 PMID:16393473 PMID:21664406 NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
JBrowse link
G ITGB3 integrin subunit beta 3 increases expression ISO N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB3 protein CTD PMID:21664406 NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
JBrowse link
G LYN LYN proto-oncogene, Src family tyrosine kinase multiple interactions
increases phosphorylation
EXP AG 1879 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of LYN protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of LYN protein] CTD PMID:25980585 NCBI chr 8:55,879,835...56,014,169
Ensembl chr 8:55,879,835...56,014,169
JBrowse link
G LYZ lysozyme increases secretion ISO N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of LYZ protein CTD PMID:9545557 NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions
increases phosphorylation
EXP
ISO
cyclosporin H inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]; epsilon-viniferin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]; Grape Seed Proanthocyanidins inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]; N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein; nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Pentoxifylline inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Qingdai compound inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]; Resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]
N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein; resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]
RAC2 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]
CTD PMID:11145705 PMID:11427526 PMID:15494208 PMID:16212921 PMID:16621998 More... NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 multiple interactions
increases phosphorylation
EXP
ISO
N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK14 protein; Omeprazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein] CTD PMID:16621998 PMID:17406807 NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation
EXP
ISO
cyclosporin H inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]; epsilon-viniferin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]; Grape Seed Proanthocyanidins inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]; N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein; nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Pentoxifylline inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Qingdai compound inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]; Resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]
N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein; resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]
RAC2 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]
CTD PMID:11145705 PMID:11427526 PMID:15494208 PMID:16212921 PMID:16621998 More... NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions EXP
ISO
N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK8 protein; nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK8 protein]
MAPK8 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Reactive Oxygen Species]; N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK8 protein
CTD PMID:17377739 PMID:17560994 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
JBrowse link
G MMP8 matrix metallopeptidase 8 increases expression ISO N-Formylmethionine Leucyl-Phenylalanine results in increased expression of MMP8 protein CTD PMID:32367270 NCBI chr11:102,711,796...102,724,954
Ensembl chr11:102,711,796...102,727,050
JBrowse link
G MPO myeloperoxidase multiple interactions
increases activity
increases secretion
increases expression
ISO
EXP
carvedilol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of MPO protein]
N-Formylmethionine Leucyl-Phenylalanine results in increased activity of MPO protein
N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of MPO protein
Carvedilol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of MPO protein]; diphenyleneiodonium inhibits the reaction [manganese chloride promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of MPO protein]]; manganese chloride promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of MPO protein]; Sodium Azide inhibits the reaction [manganese chloride promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of MPO protein]]; Wortmannin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of MPO protein]
CTD PMID:16601795 PMID:17159805 PMID:18987595 PMID:22906169 NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
JBrowse link
G NCF1 neutrophil cytosolic factor 1 multiple interactions
affects localization
EXP AG 1879 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine affects the localization of NCF1 protein]; bisindolylmaleimide I inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine affects the localization of NCF1 protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine affects the localization of NCF1 protein] CTD PMID:25980585 NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
JBrowse link
G PECAM1 platelet and endothelial cell adhesion molecule 1 increases expression ISO N-Formylmethionine Leucyl-Phenylalanine results in increased expression of PECAM1 protein CTD PMID:21664406 NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
JBrowse link
G PLA2G4A phospholipase A2 group IVA multiple interactions EXP PLA2G4A protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased metabolism of Leukotriene B4] CTD PMID:11741884 NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
JBrowse link
G PLA2G5 phospholipase A2 group V increases activity
multiple interactions
increases secretion
EXP N-Formylmethionine Leucyl-Phenylalanine results in increased activity of PLA2G5 protein
PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Arachidonic Acid]; PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4]
N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of PLA2G5 protein
CTD PMID:9495842 PMID:11741884 NCBI chr 1:20,028,408...20,091,911
Ensembl chr 1:20,028,179...20,091,911
JBrowse link
G PLCG2 phospholipase C gamma 2 multiple interactions
increases phosphorylation
EXP AG 1879 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of PLCG2 protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of PLCG2 protein] CTD PMID:25980585 NCBI chr16:81,779,291...81,962,685
Ensembl chr16:81,779,279...81,962,685
JBrowse link
G PLD1 phospholipase D1 multiple interactions EXP
ISO
PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein]
PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Reactive Oxygen Species]
CTD PMID:11427526 PMID:17560994 NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
JBrowse link
G PTAFR platelet activating factor receptor multiple interactions EXP PTAFR protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein] CTD PMID:11116075 NCBI chr 1:28,147,166...28,193,856
Ensembl chr 1:28,147,166...28,193,936
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases expression EXP N-Formylmethionine Leucyl-Phenylalanine results in increased expression of PTGS2 mRNA; N-Formylmethionine Leucyl-Phenylalanine results in increased expression of PTGS2 protein CTD PMID:12946449 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G RAC1 Rac family small GTPase 1 increases activity
multiple interactions
ISO N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC1 protein
6-amino-N-(3-(4-(4-morpholinyl)pyrido(3',2'-4,5)furo(3,2-d)pyrimidin-2-yl)phenyl)-3-pyridinecarboxamide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC1 protein]; apilimod inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC1 protein]; RHOG gene mutant form inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC1 protein]
CTD PMID:16621998 PMID:28779020 NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
JBrowse link
G RAC2 Rac family small GTPase 2 increases activity
multiple interactions
ISO N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC2 protein
6-amino-N-(3-(4-(4-morpholinyl)pyrido(3',2'-4,5)furo(3,2-d)pyrimidin-2-yl)phenyl)-3-pyridinecarboxamide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC2 protein]; apilimod inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC2 protein]; RAC2 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein]; RAC2 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein]; RHOG gene mutant form inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC2 protein]
CTD PMID:11145705 PMID:16621998 PMID:28779020 NCBI chr22:37,225,270...37,244,269
Ensembl chr22:37,225,270...37,259,594
JBrowse link
G RHOG ras homolog family member G multiple interactions
affects response to substance
ISO RHOG gene mutant form inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC1 protein]; RHOG gene mutant form inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of RAC2 protein]
RHOG protein affects the susceptibility to N-Formylmethionine Leucyl-Phenylalanine
CTD PMID:16621998 NCBI chr11:3,826,978...3,840,959
Ensembl chr11:3,826,978...3,840,959
JBrowse link
G SELL selectin L increases expression ISO N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELL protein CTD PMID:21664406 NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
JBrowse link
G SELP selectin P multiple interactions
increases expression
EXP ALOX5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein]; Foropafant inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein]; ITGA2B protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein]; MK-886 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein]; PTAFR protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein]; SR 121566 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein]; zileuton inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein] CTD PMID:11116075 NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase increases phosphorylation
multiple interactions
EXP N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of SRC protein
AG 1879 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of SRC protein]; cyclosporin H inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of SRC protein]; epsilon-viniferin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of SRC protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of SRC protein]
CTD PMID:25980585 PMID:34144024 NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
JBrowse link
G TEC tec protein tyrosine kinase multiple interactions
affects localization
EXP AG 1879 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine affects the localization of TEC protein]; honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine affects the localization of TEC protein] CTD PMID:25980585 NCBI chr 4:48,135,783...48,269,838
Ensembl chr 4:48,135,783...48,269,838
JBrowse link
G TNF tumor necrosis factor multiple interactions
increases expression
EXP [N-Formylmethionine Leucyl-Phenylalanine co-treated with TNF protein] results in increased abundance of Superoxides; Cyclosporine inhibits the reaction [[N-Formylmethionine Leucyl-Phenylalanine co-treated with TNF protein] results in increased abundance of Superoxides]; Tacrolimus inhibits the reaction [[N-Formylmethionine Leucyl-Phenylalanine co-treated with TNF protein] results in increased abundance of Superoxides]
N-Formylmethionine Leucyl-Phenylalanine results in increased expression of TNF protein
CTD PMID:11121130 PMID:12946449 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFAIP6 TNF alpha induced protein 6 decreases response to substance EXP TNFAIP6 protein modified form results in decreased susceptibility to N-Formylmethionine Leucyl-Phenylalanine CTD PMID:12401803 NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
JBrowse link
G VAV1 vav guanine nucleotide exchange factor 1 increases phosphorylation EXP N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of VAV1 protein CTD PMID:25980585 NCBI chr19:6,772,708...6,857,361
Ensembl chr19:6,772,708...6,857,366
JBrowse link
G VEGFA vascular endothelial growth factor A multiple interactions
increases expression
increases secretion
EXP Masoprocol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of VEGFA mRNA]; Masoprocol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of VEGFA protein]; nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of VEGFA mRNA]; nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of VEGFA protein]
N-Formylmethionine Leucyl-Phenylalanine results in increased expression of VEGFA mRNA; N-Formylmethionine Leucyl-Phenylalanine results in increased expression of VEGFA protein
CTD PMID:17377739 PMID:17459229 PMID:17520823 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
orlistat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABHD12 abhydrolase domain containing 12, lysophospholipase decreases activity EXP orlistat results in decreased activity of ABHD12 protein CTD PMID:18657971 NCBI chr20:25,294,743...25,390,835
Ensembl chr20:25,294,742...25,390,835
JBrowse link
G ABHD16A abhydrolase domain containing 16A, phospholipase decreases activity EXP orlistat results in decreased activity of ABHD16A protein CTD PMID:18657971 NCBI chr 6:31,686,955...31,703,324
Ensembl chr 6:31,686,955...31,703,356
JBrowse link
G ACACA acetyl-CoA carboxylase alpha multiple interactions
decreases expression
EXP Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]
Orlistat results in decreased expression of ACACA mRNA
CTD PMID:32347045 PMID:33476690 NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
JBrowse link
G ACHE acetylcholinesterase (Yt blood group) decreases activity EXP Orlistat results in decreased activity of ACHE protein CTD PMID:33844597 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
G ACOT8 acyl-CoA thioesterase 8 decreases expression EXP Orlistat results in decreased expression of ACOT8 protein CTD PMID:30667213 NCBI chr20:45,841,721...45,857,392
Ensembl chr20:45,841,721...45,857,405
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing multiple interactions ISO
EXP
orlistat inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein]
Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]
CTD PMID:25087745 PMID:33476690 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
JBrowse link
G AKT1 AKT serine/threonine kinase 1 multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Triglycerides]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein] CTD PMID:32045588 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G APP amyloid beta precursor protein multiple interactions EXP [1,1,1,2,2-pentafluoro-7-phenylheptan-3-one co-treated with Orlistat] inhibits the reaction [APP protein modified form results in increased secretion of Arachidonic Acid] CTD PMID:28721267 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
JBrowse link
G ATF4 activating transcription factor 4 increases expression EXP orlistat results in increased expression of ATF4 mRNA CTD PMID:17283163 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in increased expression of BAX mRNA] CTD PMID:32450208 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA] CTD PMID:32450208 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G CASP3 caspase 3 increases cleavage
multiple interactions
increases activity
EXP
ISO
orlistat results in increased cleavage of CASP3 protein
Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP3 mRNA]
orlistat results in increased activity of CASP3 protein
CTD PMID:17283163 PMID:20805790 PMID:21723078 PMID:32450208 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP8 caspase 8 multiple interactions EXP
ISO
orlistat analog results in increased cleavage of and results in increased activity of CASP8 protein; orlistat results in increased cleavage of and results in increased activity of CASP8 protein
Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP8 mRNA]
CTD PMID:18796435 PMID:20577697 PMID:32450208 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CASP9 caspase 9 increases activity
multiple interactions
ISO orlistat results in increased activity of CASP9 protein
Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP9 mRNA]
CTD PMID:20805790 PMID:32450208 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CAT catalase multiple interactions
decreases expression
ISO
EXP
Orlistat inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]; Orlistat inhibits the reaction [Dietary Fats results in decreased expression of CAT mRNA]; Orlistat inhibits the reaction [Dietary Fats results in decreased expression of CAT protein]
Orlistat results in decreased expression of CAT protein
CTD PMID:25087745 PMID:30667213 PMID:32450208 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCK cholecystokinin decreases secretion
multiple interactions
EXP orlistat results in decreased secretion of CCK protein
[[orlistat results in decreased abundance of Fatty Acids, Nonesterified] which results in decreased secretion of CCK protein] which results in decreased secretion of PNLIP protein; orlistat inhibits the reaction [Fats results in increased secretion of CCK protein]; orlistat inhibits the reaction [Olive Oil results in increased secretion of CCK protein]
CTD PMID:11408251 PMID:18303078 PMID:18647814 NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
JBrowse link
G CCNA2 cyclin A2 decreases expression EXP Orlistat results in decreased expression of CCNA2 protein CTD PMID:30667213 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
JBrowse link
G CCND1 cyclin D1 increases expression
multiple interactions
EXP Orlistat results in increased expression of CCND1 protein
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]
CTD PMID:30667213 PMID:32045588 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CCNE1 cyclin E1 increases expression EXP Orlistat results in increased expression of CCNE1 protein CTD PMID:30667213 NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
JBrowse link
G CD34 CD34 molecule multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein] CTD PMID:32045588 NCBI chr 1:207,880,972...207,911,125
Ensembl chr 1:207,880,972...207,911,402
JBrowse link
G CDK1 cyclin dependent kinase 1 decreases expression EXP Orlistat results in decreased expression of CDK1 protein CTD PMID:30667213 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
JBrowse link
G CDK2 cyclin dependent kinase 2 decreases expression EXP Orlistat results in decreased expression of CDK2 protein CTD PMID:30667213 NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
JBrowse link
G CDK4 cyclin dependent kinase 4 decreases expression EXP Orlistat results in decreased expression of CDK4 protein CTD PMID:30667213 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A increases expression EXP Orlistat results in increased expression of CDKN1A protein CTD PMID:30667213 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B increases expression EXP orlistat results in increased expression of CDKN1B protein CTD PMID:15138278 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
JBrowse link
G CEBPA CCAAT enhancer binding protein alpha multiple interactions EXP Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein] CTD PMID:33476690 NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
JBrowse link
G CEL carboxyl ester lipase decreases activity EXP orlistat results in decreased activity of CEL protein CTD PMID:11592731 PMID:12381337 NCBI chr 9:133,061,981...133,071,861
Ensembl chr 9:133,061,981...133,071,861
JBrowse link
G CLPS colipase multiple interactions EXP orlistat inhibits the reaction [[PNLIP protein co-treated with CLPS protein] results in increased hydrolysis of Olive Oil] CTD PMID:15158758 NCBI chr 6:35,794,982...35,797,323
Ensembl chr 6:35,794,982...35,797,344
JBrowse link
G CPB2 carboxypeptidase B2 decreases expression EXP orlistat results in decreased expression of CPB2 protein CTD PMID:16959692 NCBI chr13:46,053,186...46,105,033
Ensembl chr13:46,053,186...46,105,033
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A decreases expression EXP Orlistat results in decreased expression of CPT1A protein CTD PMID:30667213 NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
JBrowse link
G CPT2 carnitine palmitoyltransferase 2 decreases expression EXP Orlistat results in decreased expression of CPT2 protein CTD PMID:30667213 NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 multiple interactions EXP orlistat inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA] CTD PMID:21088047 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 increases expression EXP orlistat results in increased expression of CYP3A4 mRNA; orlistat results in increased expression of CYP3A4 protein CTD PMID:20599501 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G DAGLA diacylglycerol lipase alpha decreases activity EXP orlistat results in decreased activity of DAGLA protein CTD PMID:16466961 NCBI chr11:61,680,391...61,747,001
Ensembl chr11:61,680,391...61,747,001
JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP orlistat results in increased expression of DDIT3 mRNA CTD PMID:17283163 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
JBrowse link
G DDIT4 DNA damage inducible transcript 4 increases expression EXP orlistat results in increased expression of DDIT4 mRNA CTD PMID:18796435 NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
JBrowse link
G EIF2A eukaryotic translation initiation factor 2A increases phosphorylation
multiple interactions
ISO
EXP
orlistat results in increased phosphorylation of EIF2A protein
Cycloheximide inhibits the reaction [orlistat results in increased phosphorylation of EIF2A protein]
orlistat promotes the reaction [EIF2AK3 protein results in increased phosphorylation of EIF2A protein]
orlistat analog results in increased phosphorylation of EIF2A protein; orlistat results in increased phosphorylation of EIF2A protein
CTD PMID:17283163 PMID:20577697 NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
JBrowse link
G EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases response to substance
ISO orlistat promotes the reaction [EIF2AK3 protein results in increased phosphorylation of EIF2A protein]
EIF2AK3 gene mutant form results in increased susceptibility to orlistat
CTD PMID:17283163 NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
JBrowse link
G EIF4E eukaryotic translation initiation factor 4E increases phosphorylation EXP orlistat results in increased phosphorylation of EIF4E protein CTD PMID:18796435 NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133
JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 decreases expression
affects localization
affects response to substance
EXP orlistat results in decreased expression of ERBB2 mRNA; orlistat results in decreased expression of ERBB2 protein
orlistat affects the localization of ERBB2 protein
ERBB2 protein affects the susceptibility to orlistat
CTD PMID:15870086 NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 multiple interactions EXP orlistat affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA] CTD PMID:17283163 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
JBrowse link
G ETV4 ETS variant transcription factor 4 increases expression EXP orlistat results in increased expression of ETV4 protein CTD PMID:15870086 NCBI chr17:43,527,846...43,546,340
Ensembl chr17:43,527,844...43,579,620
JBrowse link
G FABP1 fatty acid binding protein 1 decreases expression EXP Orlistat results in decreased expression of FABP1 protein CTD PMID:30667213 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
JBrowse link
G FAS Fas cell surface death receptor decreases expression EXP Orlistat results in decreased expression of FAS mRNA CTD PMID:32347045 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FASN fatty acid synthase multiple interactions
decreases expression
affects response to substance
affects binding
decreases activity
ISO
EXP
[orlistat results in decreased activity of FASN protein] which affects the abundance of Fatty Acids, Nonesterified; orlistat inhibits the reaction [FASN protein results in increased chemical synthesis of Palmitic Acid]
Orlistat results in decreased expression of FASN protein
FASN protein affects the susceptibility to orlistat
orlistat analog binds to FASN protein
[Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Fatty Acids; [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphatidylcholines; [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine; [Orlistat results in decreased activity of FASN protein] which results in decreased chemical synthesis of Fatty Acids; [Orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein; Orlistat binds to and results in decreased activity of FASN protein; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Doxorubicin]; Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone]
orlistat analog results in decreased activity of FASN protein; orlistat results in decreased activity of FASN protein
CTD PMID:15026345 PMID:15138278 PMID:15870086 PMID:17012255 PMID:17618296 More... NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
JBrowse link
G GCG glucagon decreases secretion
multiple interactions
decreases expression
EXP orlistat results in decreased secretion of GCG protein
orlistat inhibits the reaction [Dietary Fats results in increased secretion of GCG protein]; orlistat inhibits the reaction [Olive Oil results in increased secretion of GCG protein]
orlistat results in decreased expression of GCG protein
CTD PMID:12915676 PMID:18647814 PMID:19837920 NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
JBrowse link
G GHRL ghrelin and obestatin prepropeptide multiple interactions EXP orlistat inhibits the reaction [Olive Oil results in decreased expression of GHRL protein]; orlistat inhibits the reaction [Triglycerides results in decreased secretion of GHRL protein] CTD PMID:15998659 PMID:17138722 NCBI chr 3:10,285,666...10,292,947
Ensembl chr 3:10,285,666...10,292,947
JBrowse link
G GIP gastric inhibitory polypeptide decreases expression EXP orlistat results in decreased expression of GIP protein CTD PMID:12915676 NCBI chr17:48,958,554...48,968,596
Ensembl chr17:48,958,554...48,968,596
JBrowse link
G GPT glutamic--pyruvic transaminase multiple interactions ISO orlistat inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein] CTD PMID:29479035 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
JBrowse link
G GPX1 glutathione peroxidase 1 multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in decreased expression of GPX1 mRNA] CTD PMID:32450208 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
JBrowse link
G GPX8 glutathione peroxidase 8 (putative) increases expression EXP orlistat results in increased expression of GPX8 mRNA CTD PMID:18796435 NCBI chr 5:55,160,171...55,167,297
Ensembl chr 5:55,160,167...55,167,297
JBrowse link
G GSR glutathione-disulfide reductase multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in decreased expression of GSR protein] CTD PMID:32450208 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G HBA1 hemoglobin subunit alpha 1 decreases expression EXP orlistat results in decreased expression of HBA1 protein modified form CTD PMID:19207292 PMID:19461584 NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions ISO orlistat inhibits the reaction [Dietary Fats results in increased expression of HMGCR protein] CTD PMID:25087745 NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression EXP orlistat results in increased expression of HSPA5 mRNA CTD PMID:17283163 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
JBrowse link
G IL10 interleukin 10 increases expression ISO Orlistat results in increased expression of IL10 mRNA CTD PMID:32450208 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in increased expression of IL1B mRNA] CTD PMID:32450208 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL6 interleukin 6 multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] CTD PMID:21088047 PMID:32045588 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G INS insulin increases expression
multiple interactions
affects expression
decreases expression
EXP orlistat results in increased expression of INS protein
[Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
orlistat affects the expression of INS protein
orlistat results in decreased expression of INS protein
CTD PMID:10095983 PMID:11274935 PMID:12915676 PMID:33476690 NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
JBrowse link
G INS-IGF2 INS-IGF2 readthrough multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in increased expression of INS1 protein] CTD PMID:25087745 NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
JBrowse link
G KDELR3 KDEL endoplasmic reticulum protein retention receptor 3 increases expression EXP orlistat results in increased expression of KDELR3 mRNA CTD PMID:18796435 NCBI chr22:38,468,096...38,483,447
Ensembl chr22:38,468,078...38,483,447
JBrowse link
G KDR kinase insert domain receptor decreases expression EXP orlistat results in decreased expression of KDR protein CTD PMID:17012255 NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
JBrowse link
G KRT81 keratin 81 increases expression EXP orlistat results in increased expression of KRT81 mRNA CTD PMID:18796435 NCBI chr12:52,285,913...52,308,624
Ensembl chr12:52,285,913...52,291,534
JBrowse link
G LCAT lecithin-cholesterol acyltransferase multiple interactions ISO orlistat inhibits the reaction [Dietary Fats results in decreased expression of LCAT protein] CTD PMID:25087745 NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
JBrowse link
G LEP leptin multiple interactions ISO orlistat inhibits the reaction [Dietary Fats results in increased expression of LEP protein] CTD PMID:21332399 PMID:25087745 NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
JBrowse link
G LIPF lipase F, gastric type decreases activity EXP orlistat results in decreased activity of LIPF protein CTD PMID:11408251 PMID:12381337 NCBI chr10:88,664,442...88,678,814
Ensembl chr10:88,664,441...88,678,814
JBrowse link
G LPL lipoprotein lipase multiple interactions
decreases activity
ISO
EXP
[orlistat results in decreased activity of LPL protein] which affects the uptake of Triglycerides
orlistat inhibits the reaction [Dietary Fats results in decreased expression of LPL protein]
orlistat inhibits the reaction [[LPL protein results in increased hydrolysis of Triglycerides] which results in increased uptake of Triglycerides]; orlistat inhibits the reaction [LPL protein results in decreased activity of TNF protein]; orlistat inhibits the reaction [very low density lipoprotein triglyceride results in increased activity of LPL protein]
CTD PMID:12388125 PMID:12573449 PMID:15910848 PMID:15994321 PMID:18698144 More... NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein] CTD PMID:32045588 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein] CTD PMID:32045588 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Triglycerides]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein] CTD PMID:32045588 NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
JBrowse link
G NAPEPLD N-acyl phosphatidylethanolamine phospholipase D decreases activity ISO orlistat results in decreased activity of NAPEPLD protein CTD PMID:16466961 NCBI chr 7:103,099,776...103,150,001
Ensembl chr 7:103,099,776...103,149,560
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 multiple interactions ISO
EXP
Orlistat inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA]
[Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA
CTD PMID:32450208 PMID:33476690 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in increased expression of NOS2 mRNA]; Orlistat inhibits the reaction [Dietary Fats results in increased expression of NOS2 protein] CTD PMID:32450208 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NPY neuropeptide Y increases expression EXP orlistat results in increased expression of NPY protein CTD PMID:15962606 NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP orlistat results in increased activity of NR1I2 protein CTD PMID:20599501 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 multiple interactions EXP Orlistat binds to and results in increased activity of NR1I3 protein alternative form CTD PMID:31312845 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
JBrowse link
G NTS neurotensin multiple interactions EXP orlistat inhibits the reaction [Fats results in increased secretion of NTS protein]; orlistat inhibits the reaction [Olive Oil results in increased secretion of NTS protein] CTD PMID:18303078 NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases cleavage
multiple interactions
EXP orlistat results in increased cleavage of PARP1 protein
[orlistat co-treated with Thapsigargin] results in increased cleavage of PARP1 protein
CTD PMID:15870086 PMID:17283163 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PCNA proliferating cell nuclear antigen multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein] CTD PMID:32045588 NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
JBrowse link
G PLA2G7 phospholipase A2 group VII multiple interactions
decreases activity
EXP [orlistat co-treated with Ezetimibe] results in decreased activity of PLA2G7 protein; [orlistat co-treated with Fenofibrate] results in decreased activity of PLA2G7 protein
orlistat results in decreased activity of PLA2G7 protein
CTD PMID:16911813 PMID:18513463 PMID:18657971 NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
JBrowse link
G PNLIP pancreatic lipase decreases secretion
multiple interactions
affects folding
decreases activity
EXP
ISO
orlistat results in decreased secretion of PNLIP protein
[[orlistat results in decreased abundance of Fatty Acids, Nonesterified] which results in decreased secretion of CCK protein] which results in decreased secretion of PNLIP protein; orlistat inhibits the reaction [[PNLIP protein co-treated with CLPS protein] results in increased hydrolysis of Olive Oil]
orlistat affects the folding of PNLIP protein
orlistat results in decreased activity of PNLIP protein
orlistat inhibits the reaction [Taurocholic Acid results in increased activity of PNLIP protein]
CTD PMID:11408251 PMID:11668201 PMID:12381337 PMID:15158758 PMID:19346257 NCBI chr10:116,545,931...116,567,855
Ensembl chr10:116,545,931...116,567,855
JBrowse link
G PNLIPRP2 pancreatic lipase related protein 2 (gene/pseudogene) decreases activity EXP
ISO
orlistat results in decreased activity of PNLIPRP2 protein
Orlistat results in decreased activity of PNLIPRP2 protein
CTD PMID:9822688 PMID:17401110 NCBI chr10:116,620,953...116,645,143
Ensembl chr10:116,620,953...116,645,143
JBrowse link
G PON1 paraoxonase 1 increases activity EXP orlistat results in increased activity of PON1 protein CTD PMID:11820148 PMID:17134960 NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
JBrowse link
G PPARD peroxisome proliferator activated receptor delta multiple interactions EXP Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA] CTD PMID:33476690 NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma increases expression EXP Orlistat results in increased expression of PPARG mRNA CTD PMID:32347045 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G PPT1 palmitoyl-protein thioesterase 1 decreases expression EXP Orlistat results in decreased expression of PPT1 protein CTD PMID:30667213 NCBI chr 1:40,071,461...40,097,252
Ensembl chr 1:40,072,710...40,097,260
JBrowse link
G PPY pancreatic polypeptide multiple interactions EXP orlistat inhibits the reaction [Triglycerides results in increased secretion of PPY protein] CTD PMID:15998659 NCBI chr17:43,940,804...43,944,215
Ensembl chr17:43,940,804...43,942,476
JBrowse link
G PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions ISO orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]
orlistat inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein]
CTD PMID:18390901 PMID:19167487 NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
JBrowse link
G PTEN phosphatase and tensin homolog multiple interactions
increases expression
EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]
Orlistat results in increased expression of PTEN protein
CTD PMID:32045588 NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein] CTD PMID:32045588 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G PYY peptide YY decreases secretion
multiple interactions
EXP orlistat results in decreased secretion of PYY protein
Orlistat inhibits the reaction [Olive Oil results in increased expression of PYY protein]; Orlistat inhibits the reaction [Triglycerides results in increased secretion of PYY protein]
CTD PMID:15998659 PMID:17138722 PMID:18647814 NCBI chr17:43,952,733...44,004,445
Ensembl chr17:43,952,733...44,004,469
JBrowse link
G RB1 RB transcriptional corepressor 1 decreases phosphorylation EXP orlistat results in decreased phosphorylation of RB1 protein CTD PMID:15138278 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in increased expression of RELA mRNA] CTD PMID:32450208 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
JBrowse link
G RPS6 ribosomal protein S6 multiple interactions EXP Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein] CTD PMID:32045588 NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
JBrowse link
G SEC24D SEC24 homolog D, COPII coat complex component increases expression EXP orlistat results in increased expression of SEC24D mRNA CTD PMID:18796435 NCBI chr 4:118,722,823...118,836,126
Ensembl chr 4:118,722,823...118,838,683
JBrowse link
G SKP2 S-phase kinase associated protein 2 decreases expression
multiple interactions
EXP orlistat results in decreased expression of SKP2 protein
[orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein
CTD PMID:15138278 NCBI chr 5:36,152,111...36,193,530
Ensembl chr 5:36,151,989...36,196,849
JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP orlistat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link
G SREBF1 sterol regulatory element binding transcription factor 1 decreases expression
multiple interactions
EXP Orlistat results in decreased expression of SREBF1 protein
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein]
CTD PMID:32045588 NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
JBrowse link
G TF transferrin multiple interactions EXP [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein] CTD PMID:33476690 NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions EXP [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA CTD PMID:33476690 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TNF tumor necrosis factor multiple interactions EXP
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [LPL protein results in decreased activity of TNF protein]
Orlistat inhibits the reaction [Dietary Fats results in increased expression of TNF mRNA]
CTD PMID:15994321 PMID:32045588 PMID:32450208 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFSF10 TNF superfamily member 10 increases response to substance EXP orlistat results in increased susceptibility to TNFSF10 protein CTD PMID:18796435 PMID:21406729 NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
JBrowse link
G TP53 tumor protein p53 multiple interactions ISO Orlistat inhibits the reaction [Dietary Fats results in increased expression of TP53 mRNA] CTD PMID:32450208 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G UCP1 uncoupling protein 1 multiple interactions EXP Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA] CTD PMID:33476690 NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
JBrowse link
G XBP1 X-box binding protein 1 multiple interactions EXP orlistat affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA] CTD PMID:17283163 NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
JBrowse link
tert-butanol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX5 arachidonate 5-lipoxygenase multiple interactions EXP tert-Butyl Alcohol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] CTD PMID:18218859 NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
JBrowse link
G CHRNA2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions EXP tert-Butyl Alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]] CTD PMID:11821649 NCBI chr 8:27,459,756...27,479,261
Ensembl chr 8:27,459,756...27,479,883
JBrowse link
G CHRNB4 cholinergic receptor nicotinic beta 4 subunit multiple interactions EXP tert-Butyl Alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]] CTD PMID:11821649 NCBI chr15:78,624,111...78,661,641
Ensembl chr15:78,624,111...78,727,754
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 increases expression ISO tert-Butyl Alcohol results in increased expression of CYP2B10 mRNA CTD PMID:19760798 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
JBrowse link
G GABBR1 gamma-aminobutyric acid type B receptor subunit 1 multiple interactions EXP tert-Butyl Alcohol inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of GABBR1 protein] CTD PMID:10683198 NCBI chr 6:29,602,238...29,633,183
Ensembl chr 6:29,555,629...29,633,976
JBrowse link
G GABRA2 gamma-aminobutyric acid type A receptor subunit alpha2 multiple interactions EXP tert-Butyl Alcohol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein binds to GABRB1 protein]] CTD PMID:10683198 NCBI chr 4:46,243,548...46,390,300
Ensembl chr 4:46,243,548...46,475,230
JBrowse link
G GABRB1 gamma-aminobutyric acid type A receptor subunit beta1 multiple interactions EXP tert-Butyl Alcohol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein binds to GABRB1 protein]] CTD PMID:10683198 NCBI chr 4:46,993,647...47,426,447
Ensembl chr 4:46,993,723...47,426,447
JBrowse link
G GH1 growth hormone 1 affects folding EXP tert-Butyl Alcohol affects the folding of GH1 protein CTD PMID:11064379 NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
JBrowse link
G GLRA1 glycine receptor alpha 1 multiple interactions EXP tert-Butyl Alcohol promotes the reaction [Glycine Agents results in increased activity of GLRA1 protein] CTD PMID:10683198 NCBI chr 5:151,822,513...151,924,851
Ensembl chr 5:151,822,513...151,924,851
JBrowse link
G IL2 interleukin 2 multiple interactions EXP tert-Butyl Alcohol inhibits the reaction [[4-O-methyl-12-O-tetradecanoylphorbol 13-acetate co-treated with Ionomycin] results in increased expression of IL2 protein] CTD PMID:18423386 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO tert-Butyl Alcohol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; tert-Butyl Alcohol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] CTD PMID:10231168 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G SIRT1 sirtuin 1 increases expression ISO tert-Butyl Alcohol results in increased expression of SIRT1 mRNA; tert-Butyl Alcohol results in increased expression of SIRT1 protein CTD PMID:29134718 NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
JBrowse link
G SLC12A2 solute carrier family 12 member 2 multiple interactions ISO tert-Butyl Alcohol results in increased oxidation of and results in increased expression of SLC12A2 protein; tert-Butyl Alcohol results in increased phosphorylation of and results in increased activity of SLC12A2 protein CTD PMID:25817889 NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO tert-Butyl Alcohol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] CTD PMID:10231168 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26040
    role 25956
      application 25180
        refrigerant 20346
          isobutane 1097
            2-hydroxy-2-methylpropanal 0
            2-methylpropane-1,2-diol 0
            isobutanol + 637
            isobutyl group + 169
            tert-butanol + 380
            tert-butyl group 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 26040
    subatomic particle 26015
      composite particle 26015
        hadron 26015
          baryon 26015
            nucleon 26015
              atomic nucleus 26015
                atom 26015
                  main group element atom 25840
                    main group molecular entity 25840
                      s-block molecular entity 25160
                        hydrogen molecular entity 24759
                          hydrides 22971
                            organic hydride 21922
                              organic fundamental parent 21922
                                hydrocarbon 21342
                                  alkane 15201
                                    isobutane 1097
                                      2-hydroxy-2-methylpropanal 0
                                      2-methylpropane-1,2-diol 0
                                      isobutanol + 637
                                      isobutyl group + 169
                                      tert-butanol + 380
                                      tert-butyl group 0
paths to the root